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Summary 
Legionella pneumophila is an environmental bacterium and a human pathogen causing life-
threating outbreaks of an atypical pneumonia called Legionnaires’ disease (LD). Studies of this 
pathogen have focused mainly on Europe and the United States. A shortage in L. pneumophila 
data is clearly observed for developing countries. To reduce this knowledge gap, L. pneumophila 
isolates were studied in two widely different geographical and climatic areas, i. e. Palestine and 
Germany, with emphasis on Palestine for the presented thesis. In addition, this thesis aimed to 
understand the diversity of L. pneumophila isolates, their clonal populations and the 
environmental driver of their abundance and prevalence.  
For this purpose, a multi-annual seasonal sampling of nine different drinking water sites in the 
West Bank were performed including a detailed recording of the respective physico-chemical 
and microbiological  parameters. Drinking water and its biofilm were sampled in eight hospitals 
and the Al-Quds University, providing an overview of the West Bank. A total of 180 L. 
pneumophila isolates were obtained and subsequently analysed by high resolution genotyping 
(Multi-Locus Variable Number of Tandem Repeats (MLVA-8(12) using 13 loci) in addition to 
standard characterization by 16S rRNA and serogroup. In addition, physiological and virulence 
traits were studied. Genotyping and the studied traits led to the selection of representative 
strains submitted to high through-put genome sequencing (Illumina HiSeq and Pacific 
Biosciences platforms). Analysis of genotype prevalence in correspondance to environmental 
factors was used to elucidate genotype consortia and their environmental niches. 
The one hundred eighty isolates represented twenty-six individual MLVA-8(12) genotypes (Gt). 
The most frequently isolated genotype was Gt4(17) (41.1%) and Gt6(18) (16.7%), both ST1, and 
Gt10(93) (9%, ST461). All MLVA genotypes were clustered into four MLVA clonal complexes 
(VACCs). The genotype composition showed a regional variability. Analysis of the prevalence of 
genotype in the light of environmental factors indicated genotype consortia that seemed to be 
triggered by a set of environmental drivers. The concentration of several ions (Mg, Ca, Cl, SO4 
and TDS) and turbidity seemed to determine niches for three different sets of genotypes and 
may thus explain their regional variability. To a certain extent, also the abundance of L. 
pneumophila was influenced by these environmental drivers with Mg having a negative effect. 
The virulence of a representative subset of sixty Palestinian environmental strains was assessed 
by five different in-vitro assays Virulence traits were shown to be genotype dependent, with 
high virulence observed for the highly abundant genotypes Gt4(17) and Gt6(18).   
A carefully selected subset of thirty-eight L. pneumophila isolates were genome sequenced 
(HiSeq) and compared to already published reference genomes, and two additionally Pac-Bio 
sequenced isolates providing needed complete reference genomes. Genome sequences from 
the thirty-eight isolates were aligned with the sequence of the respective reference genome 
and analysed with respect to core-single nucleotide polymorphisms (core-SNPs), genomic 
islands and genes related to virulence traits. Overall, the results obtained from this study 
provided important insights into detailed population structure, the ecology and pathogenicity of 
this pathogen in the West Bank.    
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1. Introduction 
1.1 Drinking water in the West Bank, Palestine 
The West Bank is landlocked territory located near to the Eastern coast of the 
Mediterranean Sea. It has land area of 5640km2 and 220km2 water area of the Dead 
Sea. It has Eastern boundaries across the Jordan valley with Jordan and surrounded by 
Israel from the other boundaries (Figure 1)(1). 
In the West Bank, the Palestinian Water Authority (PWA) is responsible and coordinates 
with Mekorot (The Israeli Water Company) the quality of drinking water. The PWA is 
analyzing microbial contaminants (total and fecal coliforms), chemical contaminants 
(inorganic contaminants, heavy metals and ions) and physic-chemical parameters 
(temperature, pH and conductivity). 
For the present thesis the drinking water of the West Bank was analyzed. The West 
Bank is supported by the PWA, which delivers drinking water to every city, where it is 
transferred to the municipal distribution network. The PWA provides a total of 
population 2.8 million inhabitants  (1) with domestic water that  has an average 
consumption of 70 L/day per person. This amount of water is 30 L/day less than WHO 
recommended amount (100 L/day) of water per person. Thus, Palestinians store water 
in collection tanks on their house’s roof for weeks or months because there is no 
continuous water supply (2).  
Ground water is the main source of raw water in the West Bank. More than 90% of the 
population is provided with drinking water coming from ground water. The main 
aquifers can be divided into three units: 1) the Western aquifer basin, 2) the North-
Eastern aquifer basin and 3) the Eastern aquifer basin (2, 3). Water is pumped from 
deep wells to 5000m3 tanks (balance tank) built on high altitude land to store raw water 
and provide pressure for the drinking water supply system (DWSS). Chlorination is only 
treatment process. The chlorine concentration is 0.5mg/l in water stemming from 
balance tanks (3).  
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 Figure 1: The West Bank map  
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1.2 Legionella pneumophila - a natural water-based pathogen 
In July 1976, an unknown bacterium causing a common source outbreak of pneumonia 
in Philadelphia, Pennsylvania USA, was identified. Approximately, 15% of the cases 
were fatal (4). By December 1976, Joseph McDade and coworkers’ isolated bacterium 
named it Legionella pneumophila (5). L. pneumophila is a gram negative, aerobic, rod 
shape flagellated bacterium that is naturally found in freshwater environments. Until 
now, there are 59 distinct Legionella species encompassing 70 serogroups or more. 
Approximately, half of these serogroups have been isolated from or detected in clinical 
samples. All these species are considered as potential human pathogens and their 
abundances should be controlled and/or regulated (6, 7).  
1.2.1 Ecology of Legionella 
Legionella spp are ubiquitous in natural freshwater habitats like rivers, lakes and hot 
springs. Naturally, species of Legionella are part of the freshwater microbiome (8). In 
these environments, Legionella species can be associated with complex biofilm 
communities which provide shelter, nutrients and support their survival and 
multiplication (9, 10). Also, Legionella have the ability to infect and replicate inside 
amoeba (11). The unique physiology of Legionella is adapted for survival and replication 
within amoeba, such as Acanthamoeba, (12, 13) and secondarily as free-living or 
biofilm-associated bacteria. The association with amoeba provides Legionella with 
different characteristics including induction of virulent phenotype, provision of 
protection from harsh conditions and support in distribution throughout the DWSS (14-
16). Legionella thrive  in freshwater ideally at 25-37°C but Legionella can survive at 
temperature below 20°C and above 55°C (17, 18). Since 1976, all Legionella studies 
demonstrates the adaptability and colonization in man-made aquatic environments 
mainly hospitals and hotels (19, 20).  
1.2.2 Virulence of Legionella 
Legionella spp have developed mechanisms for invasion and multiplication in protozoan 
hosts in the course of evolution. The same mechanisms of intracellular invasion that 
they use when multiplying in amoeba seem to operate in alveolar macrophages (21, 
22). When amoeba or macrophages have ingested virulent Legionella cells, a 
phagosome is established; this is surrounded by endoplasmic reticulum and becomes 
completely isolated from the endosomal pathway (21, 22). Initially, fusion with 
lysosomes is inhibited. It has been postulated that L. pneumophila converts to a 
replicate form in this protected environment (22). Accordingly, endosomes containing 
the pathogen are able to fuse with lysosomes enabling the intracellular bacteria to 
make use of a nutrient-rich niche, which in ordinary circumstances would kill other 
bacteria. When the amino acid supply is depleted, the cells convert to a stationary 
phase form, simultaneously developing features that are needed for transmission to a 
new phagocyte. Legionella cells released from eukaryotic cells are short, thick, and 
highly motile. Thus, they exist in nature in two phases. In this system, a number of 
factors are implicated including type II and IV secretion system, acquisition of iron, 
pore-forming toxins, and induction of apoptosis in the host cell. The intracellular 
 14 
establishment and trafficking of Legionella are believed to be regulated by the dot/icm 
(defective organelle trafficking/intracellular multiplication) gene complex, which 
encodes the compounds involved in the type IV secretion system (Figure. 2). Also, 
Legionella produce extracellular cytotoxins. Experimental work indicates that virulence 
is significantly reduced when the incubation temperature of a cultured inoculum is 
reduced from 37°C to 24°C (23). 
 
Figure 2: L. pneumophila infection of an amoeba/macrophage using the Dot/Icm secretion system 
Legionella infect humans by inhalation of contaminated aerosols (22, 24). This infection 
route is supported by the fact that patients in case control studies have been infected 
by passing outside buildings, where the source of the causative Legionella strain has 
been found (24). However, some authors suggest that aspiration is more important 
than inhalation as mode of transmission (25). This is likely in a hospital environment 
with immunocompromised patients who have poor respiratory tract reflexes. In such 
cases, drinking water contaminated with Legionella is a possible risk. In the Philadelphia 
outbreak, only drinking water at the hotel was the statistically significant relationship 
that could be associated with disease in a case control study (4). However, Inhalation of 
aerosols is perhaps an important factor (24). The sources of transmission are cooling 
towers, evaporative condensers, whirlpool spas and showers. An air conditioning 
system is only hazardous if a cooling tower or evaporative condenser is positioned in 
such a way that the generated aerosol can pass into the air intake of a building or be 
directly transmitted to a passerby bystander (24). 
Inhalation or microaspiration of amoeba could be a potential risk, since one single 
amoeba might harbor more than 1000 Legionella cells (12). Moreover, intracellular 
growth in Acanthamoeba castellanii affects monocyte entry mechanisms and enhances 
the virulence of L. pneumophila (21, 22). Thus, it is possible that infection in humans 
may require the presence of both Legionellae and an amoebal host (22). This might 
explain why the attack rate in outbreaks of Legionnaires’ disease (LD) is low, despite the 
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presence of Legionella spp in the plumbing system. Breiman et al described the 
occurrence of LD cases related to the presence of both protozoa and L. pneumophila 
(26). 
Before November 2014, there were no cases of LD transmitted from person to person 
reported, indicating that L. pneumophila is not completely adapted to infect humans 
(27). In November 2014, the first case was reported for person to person infection of LD 
in Portugal (28). This case for mother taking care of her son having LD who was 
maintenance worker at an industrial cooling tower. Both mother and her adult son died 
from severe complications of LD. The mother had never travelled to the site of the 
outbreak. Also, genetic analysis showed that the mother was infected by the identical 
strain of her son (28). 
1.2.3 Molecular identification and genomics of Legionella 
Molecular identification of Legionella spp is possible with an array of fast and widely 
used techniques. Several methods based on the analysis of DNA are available to classify 
Legionella at the genus- and species-level such as  PCR amplified DNA profiles (29) 
Restriction Fragment Length Polymorphism (RFLP) PCR (30, 31) and sequencing of the 
mip gene (32). Detection and identification techniques aim at the clinical diagnosis of 
legionellosis and identification of health risks in freshwater systems. However, until 
now the PCR assays and specific sequence techniques have good discriminative power 
(32). 
16S rRNA sequencing is the most common and widely used technique for phylogenetic 
classification of Legionella spp (31). Sequencing of the 16S rRNA gene for Legionella 
revealed high taxonomic resolution. Because Legionella exhibits multiple ribosomal 
operon copies with very little sequence heterogeneity of the most widely used fully 
sequenced genomes of L. pneumophila reference strains, i. e. Philadelphia, Paris and 
Corby (31).  
In fact, the discrimination of 16S rRNA gene on the species level is not good enough as 
on the genus level. Thus, phylogenetic studies using mip gene (33, 34), rpoB gene (35) 
and the hypervariable 23S-5S ribosomal intergenic spacer region (36) have been used 
among Legionella spp. In comparison  to 16S rRNA sequencing, the mip gene have been 
widely used for Legionella spp revealing that it has a higher variability (32). Moreover, 
there is mip gene sequence database (http://www.hpa-
bioinfotools.org.uk/mip_ID.html) to compare any unknown sequence with all available 
species. However, rpoB allows distinguishing the subspecies fraseri and pneumophila 
which is impossible by mip and 16S rRNA sequencing. The same discriminatory power 
has been observed for 23S-5S region allows differentiating the three subspecies 
pneumophila, pascuelli and fraseri. The progressive availability of genomic information 
for Legionella with allow the identification of a combination of genes with wide 
discriminatory power for developing an appropriate Multi-Locus Variable number of 
tandem repeat Analysis(MLVA).   
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Identifying L. pneumophila on a strain level helps to identify environmental sources 
giving arise to cases of legionellosis. Also, knowing the population structure of L. 
pneumophila, studying genetic diversity and clonal expansion helps in long-term 
epidemiological analyses of microbial populations. A lot of molecular techniques were 
developed for molecular typing and identification of L. pneumophila on strain level, 
such as  Amplified Fragment Length Polymorphism (AFLP), Restriction Fragment Length 
Polymorphism (RFLP), Sequence Based Typing (SBT) and MLVA (37, 38). The last two 
techniques are widely used nowadays and were developed by members of The 
European Working Group for Legionella Infection (EWGLI) and Pourcel et al 2007 (38), 
respectively. The gold standard for high resolution genotyping of L. pneumophila 
isolates is an SBT approach using 6 genes (flaA, pilE, asd, mip, mompS and proA). 
MLVA has exhibited higher discriminatory power than SBT (38, 39). Also, rapidity, 
typeability, reproducibility are better and a large database is available (http: //bacterial-
genotyping.igmors.u-psud.fr/Legionella2006/help.htm) on the web. This makes MLVA 
an excellent choice for studying and typing L. pneumophila. Molecular typing, either SBT 
or MLVA of L. pneumophila is not good enough to know 100% the source of outbreak. 
Phylogenetic top-down tree shows the detection limit for each molecular analysis 
techniques. Deep molecular techniques, like whole genome sequencing (WGS), are 
needed to analysis L. pneumophila on a clonal level (Figure.3).  
 
Figure 3. Upper limits of taxonomic identification based on DNA from the envrionment or cultured 
isolates.  For High resolution L. pneumophila genotyping sequncing of spefic genes (e.g. mip), MLV and 
WGA are the most appropiate diagnostics tools. MLVA = Multi Locus of Variable-number Tandem Repeats 
Analysis    WGA = Whole Genome Sequencing  . Adopted from Höfle et al. 2017  
The L. pneumophila genome size is 3.3-3.5 Mbp on a single circular chromosome (40). 
Also, L. pneumophila has more 3000 of genes. This reflecting the capacity of L. 
pneumophila to adapt different environments and hosts. High homogeneity of L. 
pneumophila with 38% CG content of coding regions and average length of coding 
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sequencing.  L. pneumophila str. Paris and Lens contains plasmid and L. pneumophila in 
general can be excised on contained plasmid (40).  
1.3 Legionellosis and country-specific epidemiology for the West Bank 
The term legionellosis or Legionnairs’ disease (LD)cause by two forms of disease: 1) a 
flu-like illness called Pontiac fever named after the city Pontiac, Michigan, USA where 
an explosive outbreak had occurred in this city (41)  and 2) a sever fatal pneumonia 
with multisystem failure  (5). Diabetic, cancer, AIDS and renal failure patients are at risk 
for LD. Also, elderly people, smokers, males and immunocompromised people or other 
risk groups (42). More than 650 outbreaks were reported until 2005 worldwide. In the 
last decade, the mortality rate is decreasing due to earlier detection and better 
treatment (43). 
According to the current epidemiological data available from the world, L. pneumophila 
has 15 serogroups, but majority of LD is caused by sg.1. Around 84% worldwide and 
87% in Europe has reported cases of L. pneumophila sg.1 LD (44, 45). The only 
exceptions are Australia and New Zealand having a lower percentage (50%) of L. 
pneumophila and exclusively 30% of LD caused by L. longbeachae (44). In Europe, 6,943 
cases of LD were reported during 2015 (45). France, Germany, Italy, Portugal and Spain 
accounted 74% of all notified cases(45). Whereas in the Middle East and in Arabic 
countries there is a shortage of epidemiological data for Legionella spp.  
In Israel, limited epidemiological data are available (46, 47). Two recent studies 
described the molecular epidemiology of L. pneumophila by SBT (48) and MLVA (49). 
Moran-Gilad et al (48) showed that 71.4% and 21.7% of the clinical and environmental 
strains were sg.1 respectively. However, sg.3 was responsible for 14.2% of the 
infections in Israel. The common sg.3 reported in drinking water as described by Yarom 
et al 2010 (50). Rodriguez-Martinez et al. 2015 (49) described the clonal populations of 
a set of environmental isolates of L. pneumophila from freshwater supply system of the 
Oranim campus in Haifa. Also, they found Sg.1 and Sg.3 dominated in this DWSS (49).  
In Turkey, Legionella spp contaminated 13.3% of hotels water system in Alanya. Sg.6 
was the dominant serogroup (55.6%) followed by sg.1 (22.2%) from the environmental 
samples (51). In Northern Africa, Legionella spp was identified and genotyped by PFGE 
from Tunisian hot water springs (52). Also, environmental L. pneumophila isolates were 
typed by PFGE from seven Moroccan towns (53). 
In Kuwait, Legionella was detected and quantified using RT-PCR from water systems in 
residential facilities. Serological typing of L. pneumophila isolates is in accordance with 
study of Yarom et al 2010 (50) and Rodriguez-Martinez et al 2015 (49) that sg.3 is the 
dominant serogroup in Kuwait (54). Recently, studies by Al-Matawah et al 2012 & 2015 
reported the presence of L. pneumophila in air conditioned buildings in Kuwait by using 
molecular techniques (55). More recently, the European Centre for Disease Prevention 
and Control (ECDC) reported increasing in LD in EU travelers returning from Dubai, UAE. 
26 cases of LD have been reported between October-December 2016 (56).  
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No study has been done previously in the West Bank employing the molecular 
identification, serotyping and genotyping of Legionella spp in freshwater samples which 
are considered as opportunistic pathogens causing Legionellosis. Only one study by 
Shareef and Mimi 2008  studied hospitals tap water systems but they only used culture-
based microbiological techniques for isolation and identification of L. pneumophila (57). 
In Palestine, there is no legislation, rules and protocols from the PWA about Legionella 
spp. Generally, they did not identify and test Legionella in freshwater system. 
Moreover, the Ministry of Health (MOH) does not have any legislation, rules, protocols 
and procedures how to identify legionellosis. In fact, urine antibody-based identification 
is used and rapid serological tests (IgG and IgM) are available in the main medical 
laboratories but these tests are rarely ordered by physicians.  
The traditional protocol for patient suspected pneumonia is chest X-ray and Complete 
Blood Count (CBC). Fluffy infiltrates in the chest by X-ray and granulocytosis in CBC 
indicate an atypical pneumonia with symptoms like malaise, cough, chills, dyspnea, 
headache and chest pain (58). Mainly, patients are then treated with appropriate 
antibiotics such as fluoroquinolones and macrolides (59).  
1.4 The genus Legionella, its ecophysiology and molecular taxonomy 
Legionella is a genus comprising about 60 species mostly of aquatic origin and with a 
large fraction of pathogenic species (60). Most relevant for human health and man-
made freshwater systems is L. pneumophila that is the most relevant causative agent of 
an atypical pneumonia, Legionnaires ’ disease (LD), and Pontiac fever, a self-limiting flu-
like disease (61). Anthropogenic fresh water systems are considered as the major 
source for Legionella infections (62, 63). Co-infections with aquatic bacteria of LD 
patients hint on a co-transfer of bacteria from freshwater to the patient presumably via 
protozoa and/or their bacteria containing vesicles (64, 65). LD is transmitted by 
inhalation or aspiration of aerosols from contaminated environmental sources. Thus, 
when a case of LD is diagnosed other persons in the same environmental conditions 
might be at high risk to become infected from the same environmental source. The 
source of such an outbreak can be determined by molecular characterization of 
Legionella isolates from the patient and from environmental samples (37).  
Environmentally, Legionellae are found in soil and water in a symbiotic close association 
with amoebae (14, 66). L. pneumophila life cycle alternates between a replicative 
intracellular phase and a transmissive extracellular phase in response to different life 
conditions (67). When the conditions are favorable, it can replicate within the host cell 
vacuole. Contrary, when the conditions are limited, it becomes cytotoxic, resistant to 
osmotic stress, sensitive to sodium and competent to evade phagosome-lysosome 
fusion (67). These traits enable L. pneumophila to survive and replicate in the 
environment.  
In humans, the inhalation of L. pneumophila contaminated aerosols may cause LD (4). It 
replicates inside alveolar macrophages and epithelial cells (68, 69) in a similar 
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mechanism to its invasion of amoeba host (68). After phagocytosis by mammalian and 
amoeba cells, L. pneumophila modulate the biogenesis of their vacuole which becomes 
surrounded by mitochondria and rough endoplasmic reticulum (70) then, L. 
pneumophila starts replicating. 
Many factors promote L. pneumophila virulence in the alveolar macrophages, survival 
and replication in amoeba. The most important one is Dot (Defect in Organelle 
Trafficking)/icm (intracellular multiplication). Supported by the Dot/Icm type IV 
secretion system, the bacteria avoid phagolysosome fusion and replicate within alveolar 
macrophages and epithelial cells (71, 72). The Dot/Icm is essential for pore-formation 
mediated lysis of the host cell (69, 73).  
In vitro, L. pneumophila in Post Exponential (PE) phase is most infectious and more 
resistant to many stresses. L. pneumophila in PE phase displays shortened cell body, 
flagellin expression, pigment accumulation and reduced sodium sensitivity. These traits, 
together with virulence markers such as cytotoxicity, intracellular growth and 
phagocytosis are recognized as the transmission traits of L. pneumophila (74, 75). 
The West Bank is a semi-arid region in the Middle East with hot and dry summers and 
cool winters with substantial water scarcity problems. Main precipitation falls in winter 
leading to an often only partial recharge of groundwater aquifers. The source for 
drinking water is mostly groundwater that is pumped into a storage reservoir and 
chlorinated, before delivered to the drinking water distribution system (DWDS). Due to 
frequent water shortage and supply interruption, water is stored in private containers, 
mostly on the roof, by the end users (3). All these factors, but especially the warm 
climate, intermittent water supply and storage in roof containers may cause hygienic 
water problems in general and may lead to high Legionella abundance in the drinking 
water as used by the end user. 
The contamination of hospitals’ water systems with Legionella is considered as a high 
risk for patients especially for those with severe diseases hospitalized for a long period 
of time. It is well known that LD is an important cause of hospital-acquired pneumonia 
(76). Presence of Legionella in water distribution systems actually is a serious health risk 
to hospital staff and patients, but the magnitude of the problem is generally 
unrecognized (24, 76, 77). As for Palestine the problem is that clinical awareness about 
the prevalence of L. pneumophila or LD is lacking. Furthermore, there are no specific 
guidelines for Legionella spp surveillance and thus protection from exposure in 
hospitals or public buildings.   
Cultivation Dependent Analysis (CDA) (culturing) is the standard and recommended 
technique used for environmental surveillance of L.pneumophila (78). One major hassle 
in the isolation and quantification of L. pneumophila by culture is the Viable But Non 
Culturable (VBNC) state and its overgrowth by competing bacteria (61, 79, 80). On the 
other hand Cultivation Independent Analysis (CIA) are rapid, sensitive and widely used 
methods for detection and identification of L. pneumophila (81). Multi Locus Variable 
number of tandem repeats Analysis (MLVA) is the molecular typing method used to 
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assess the genetic diversity among L. pneumophila isolates and identification of L. 
pneumophila at the strain level. MLVA genotyping has exhibited high resolution in 
comparison with other typing methodologies for multiple microorganisms (82-84). In 
the case of L. pneumophila, MLVA genotyping presented higher discrimination than 
Sequence Based Typing (SBT) (38, 39) and a very high concordance with the gold 
standard method as described by Pourcel et al. (2007), Visca et al. (2011) (38, 39).  
The standard method for genotype assessment of L. pneumophila is sequence based 
typing (SBT) (60). Sobral et al. and Visca et al (2011) (39, 85) showed that multi-locus 
variable number of tandem repeat analysis (MLVA), a less laborious method, can be 
very well matched with the sequence types (ST) generated by SBT. In addition, the 
genotypes of ST1 are better resolved by MLVA. ST 1 resolution had been shown to be of 
special relevance for drinking water in the study by Rodriguez et al. (2015) (49), for 
environmental studies as well as for virulence aspects (49, 86). Furthermore, ST1 is 
considered of high relevance for man-made freshwater systems and human health on a 
global scale (87, 88).  
LD is primarily caused by the species L. pneumophila that is widely distributed in the 
natural and man-made freshwater environments. Differentiation of isolates from this 
species by molecular typing methods is important to identify the source of outbreak. 
Many molecular typing methods have been used for epidemiological purposes, 
including the commonly used method Sequence Based Typing (SBT) (60) and Multi-
Locus of Variable Number of Tandem Repeats Analysis (MLVA) with slightly higher 
discriminatory power (38). However, the discriminatory power of MLVA is still limited 
by their utility for investigating the intra-clonal level of diversity among outbreaks and 
often cannot distinguish between outbreak and non-outbreak isolates (39, 85). 
Nowadays, whole genome sequencing (WGS) has been successfully applied for L. 
pneumophila, which provides the highest conceivable discriminatory power to 
distinguish outbreak from non-outbreak isolates (89, 90).   
L. pneumophila strains Philadelphia, Paris and Lens were the first whole genomes that 
have been sequenced (40, 91). These L. pneumophila strains contain one circular 
chromosome of a size 3.3 to 3.5 Mb and have more than 3000 protein coding genes 
representing 88% of the genome sequence. In fact, the genome of L. pneumophila has 
been shown to be highly plastic (40), including Horizontal Gene Transfer (HGT), mobile 
elements and Genomic Islands (GIs) (92). Generally, most WGS studies focused on 
outbreak isolates (93, 94) if they are not dealing with the genetics and evolution of L. 
pneumophila (87). The use of WGS for isolates typing is generally based on either Single 
Nucleotide Polymorphism (SNPs) comparison or gene by gene comparison (95, 96). In 
this study, we used MLVA to assess the genotypic characteristics and biogeographical 
distribution of L. pneumophila strains isolated from freshwater system in hospitals 
across the West Bank and revealed four clonal complexes, some of them were also 
prevalent in Germany (97). 
Ecologically, the abundance of Legionella is considered to be enhanced by high water 
temperature and low chlorine concentrations (98-100). However, recent studies have 
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indicated that it is of high value to study the ecology of Legionella on the genotype 
level. Drinking water distribution systems can be dominated by a few or even a single 
genotype (49, 85). In addition, the study by Rodriguez et al (2015) performed in a 
similar climatic region (around Haifa, Israel) hints on a link between the genotypic 
composition of L. pneumophila and the abundance of Legionella species. In their study a 
specific genotype (MLVA-Gt4) closely related to L. pneumophila strain Paris showed a 
correlation with very high Legionella plate counts and surprisingly low water 
temperature (around 22°C). The authors suggested that specific genotypes might act as 
triggers of Legionella abundance, even at low temperature. In addition, genotype 
assessment is also of interest for tracking the source of Legionella infections and the 
virulence itself is considered to be genotype dependent (86, 101). 
1.5 Objectives of the Thesis and used approaches 
The overall goal of the Thesis to advance current knowledge on the environmental 
reservoirs of L. pneumophila in fresh water systems, the environmental, geographical, 
physiochemical, virulence and genomic factors affecting their clone specific occurrence 
and virulence to humans.  The following three detailed objectives are pursued in this 
Thesis: 
Objective 1: Assessment of the biogeographical distribution of L. pneumophila isolates 
according to genotype compostion across the West Bank and identification of its 
environmental drivers.  
Objective 2: Determination of virulence potential of L. pneumophila isolates from 
hospital water systems according to genotypes and clonal complex classification.  
Objective 3: Genome comparison of L. pneumophila isolates from the West Bank and 
Germany regarding different criteria: identification of virulence genes and genomic 
islands.  
In the current study these detailed objectives were approached by a seasonal 
assessment of Legionella abundance in water and biofilm in eight sampling sites 
covering the whole West Bank was approached. The eight sampling sites were eight 
hospitals in the West Bank, i.e. tap water and the respective biofilms were sampled. The 
abundance of L. pneumophila was assessed by cultivation and PCR concomitantly with a 
record of major bacteriological and physico-chemical parameters of the drinking water 
during a period of 2.3 years. L. pneumophila isolates obtained from water and biofilm 
were identified by 16S rRNA partial sequencing. Genotypes of L. pneumophila were 
assessed by a high resolution MLVA using 13 loci (39). Correlation analysis and principal 
component analysis (PCA) were used to identify the niches of relevant L. pneumophila 
genotypes and to identify environmental drivers of L. pneumophila abundance in water 
and biofilm. The study promotes a genotype-based ecology of L. pneumophila and 
sheds light on so far not yet considered mechanisms of L. pneumophila prevalence at 
the level of individual genotypes. Furthermore, the virulence of the L. pneumophila 
genotypes and VACCs was assessed and compared by five different in-vitro assays. 
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Lastly, the study aimed at comparing representative L. pneumophila isolates from two 
very different geographical areas namely the West Bank and Germany at the level of 
their whole genome sequences to reveal their differences across large and small 
geographical distances, their genome dynamics and to understand their genetic make-
up for virulence. For the achievement of this aim genome sequences from L. 
pneumophila reference strains and our isolates were compared using SNPs comparison. 
This analysis is based on complete genome sequencing of already published reference 
genome strains of L. pneumophila strain Lpn-Paris (40), Lpn-Corby (102), Lpn-
Philadelphia (91), Lpn-Alcoy 2300/99 (103), Lpn-Lorraine, Lpn-Thunderbay (104), Lpn-
D7630, Lpn-Pontiac (105), Lpn-OLDA (105), Lpn-ATCC43290 (106) and two isolates. In 
addition to deep sequencing on the Illumina platform, an environmental isolate from 
the West Bank and a clinical isolate from Germany were sequenced using the Pacific 
Bioscience (PacBio) platform. Finally, the genome dynamics of L. pneumophila strains 
was investigated by analyzing Genomic islands, mobile elements and virulent genes of 
the whole genome sequences. 
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2. Materials and Methods 
2.1 Study sites, water and biofilm sampling  
Water samples and biofilm swabs were sampled six times during the period from 
October 2012 till December 2014 from eight hospitals across the West Bank (WB).  The 
six samplings covered twice the main seasons, i.e. spring (March-May), summer (June-
August), and autumn (October - December). 
Sampling was achieved on tap water and biofilm of faucets and shower heads of eight 
different hospitals (Figure 4): Hospital A (coordinates: 32° 27' N, 35° 17' E), hospital B 
(32° 13' N, 35° 14' E) and hospital C (32° 13' N, 35° 15' E) from Northern WB, hospital D 
(31° 53' N, 35° 12' E) and hospital E (31° 46' N, 35° 14' E) from Central WB, and hospital 
F (31° 42' N, 35° 11' E), hospital G (31° 33' N, 35° 4' E) and hospital H (31° 31' N, 35° 5' E) 
from Southern WB. Also, samples were taken occasionally from Al-Quds University 
(AQU) main campus, Abu Dies, Jerusalem (31° 45' 18.07'' N, 35° 15' 37.614'' E). These 
samples from Al-Quds were not included in the overall comparison on Legionella 
ecology but only used for comparison. 
Cold and hot water (if available) was collected from 
the main water source of each site and a defined 
set of biofilm swabs from faucets, showerheads 
and hoses. The sampled drinking water is 
considered as representative for the cities of Jenin, 
Nablus, Ramallah, Jerusalem, Bethlehem and 
Hebron, going from the north towards the south 
across the West Bank.  
 
 
 
 
 
 
 
Figure 4: Sampling map of the eight hospitals and Al-Quds University in the West Bank, Palestine. 
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2.2 Physico-chemical analysis of the water 
Cold and hot water samples were tested for temperature, pH and conductivity using 
probes and chlorine (Quantofix) directly upon collection. After return to the laboratory 
water samples were tested for total iron, nitrate, nitrite, ammonia, copper, phosphate, 
zinc, carbonate hardness, total hardness using Quantofix sticks (Macherey-Nagel GmbH 
& co.KG, Germany). Magnesium and calcium concentrations were measured 
photometrically using Nanocolor assays (Macherey-Nagel GmbH & co.KG, Germany). 
Data on turbidity, bicarbonate, chloride, sulfate, total dissolved solids (TDS) and fluoride 
were provided by the Palestinian Water Authority (3).  
2.3 Cultivation dependent analysis of water and biofilm 
A total of 72 water samples were collected from the main hospital tanks in sterile 1L 
plastic bottles after a brief flow time (2-3 min), to permit clearing of the service line. 
One liter of each cold and hot water was collected for Heterotrophic Plate Count (HPC) 
and one liter of each cold and hot water was collected for Legionella count from the 
hospitals. To neutralize residual free chlorine, 0.5ml of 0.1N sodium thiosulphate was 
added in the sterile bottles for Legionella count analysis (107).  
Biofilm swabs were sampled from the anterior surfaces of faucets, showerheads or 
shower hoses in all hospitals wards. Per sampling and sampling site 20 biofilm swabs 
were taken, except for the first sampling when 44 swabs were sampled per site in order 
to check the variability per sampling site. Swabs for Legionella identification were 
processed immediately by culturing on GVPC (M809, Himedia, India) medium and 
procedure based on ISO 11731:2004 (108).  
From all water and biofilm samples with visible growth on Legionella-like colonies on 
agar plates, representative isolates were chosen and purified. Isolates were later 
characterized by L. pneumophila specific PCR, 16S rRNA gene sequence, serogroup and 
genotype assignment using MLVA (see below). A subset of MLVA genotypes was 
characterized by sequence based typing. 
2.4 Cultivation independent analysis of water and biofilm 
Five liters of each cold and hot water were collected per sampling and site from the 
main water source for DNA extraction. Water samples were filtered onto sandwich 
membrane filters composed of nucleopore-filter (Nuclepore Track-Etch Membrane, MB 
90mm, 0.2µm, Whatman, England) and glass fiber-microfilter (GF/F) (GFF, 90mm, 
Whatman, England).  Filter was stored frozen for later DNA extraction. 
For biofilm, 5 swabs were taken per sampling and site from the anterior surfaces of 
faucets, showerheads or shower hoses using sterile cotton swabs (Cotton Tipped 
Applicator, China). Swabs were stored frozen for later DNA extraction. 
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For the extraction of DNA from the ﬁlter sandwiches and the swabs, a modiﬁed DNeasy 
protocol (Qiagen 69506, Germany) was used. Briefly, sandwich ﬁlters were cut into 
small pieces and incubated with enzymatic lysis buffer (20 mM Tris-HCl, 2 mM EDTA, 
1.2% Triton X-100 (pH 8.0)) containing 10 mg/ml lysozyme for 60 min in a 37°C water 
bath. After the addition of AL buffer from the kit, the samples were incubated at 78°C in 
a shaking water bath for 20 min. After ﬁltration through a cell strainer 100 µm (DB 
falcon 352360, USA), absolute ethanol was added to the ﬁltrate (ratio of ﬁltrate to 
ethanol is (2:1)), and the mixture was applied onto the spin column of the kit. After this 
step, the protocol was followed according to the manufacturer’s instructions.  
Three PCRs with different targets were carried out as follows; for the detection of any 
bacteria the complete 16S rRNA gene primers, Com1F (5’-CAGCAGCCGCGGTAATAC-3’) 
and Com2R (5’-CCGTCAATTCCTTTGAGTTT-3’) were used. For the classification of 
Legionella like colonies a Legionella genus-specific PCR using primers Lgsp17F (5’-
GGCCTACCAAGGCGACGATCG-3’) and Lgsp28R (5’-CACCGGAAATTCCACTACCCTCTC-3’) 
and an L. pneumophila-specific PCR using primers Lp-16S_246-248F 
(CCTGGGCTTAACCTGGGAC) and Lp-16S_246-248R (CTTAGAGTCCCCACCATCACAT) were 
applied (109). Each reaction was carried out by using 3l (100mg/µl) of DNA template in 
a final volume of 25l. Amplification was achieved by using PCR-ready Master Mix 
(GoTaq, Green Master Mix, Promega, USA). 
On all samples, used for PCR based analysis, cultivation dependent analysis for 
Legionella was additionally performed to allow a direct comparison. Sequencing of the 
16S rRNA gene of the six isolates was confirmed as L. pneumophila (≥99.8% 16S rRNA 
gene similarities). 16S rRNA sequences of L. pneumophila isolates were submitted to 
the GeneBank database (KX778102 - KX778107).  
2.5 Genotyping of L. pneumophila isolates 
For molecular typing of L. pneumophila at the strain level. MLVA-8(12) analysis was 
performed for 180 isolates. DNA extraction was done either directly from living biomass 
using (Qiagen kit lot No: 69504) according to the manufacturer protocol or from 
biomass on FTA cards (Whatman, Sigma-Aldrich, Germany). DNA was finally quantified 
by Nanodrop spectrophotometer (NanoDrop, Thermo Scientific, Germany). 
For DNA extraction out of the FTA cards, the area of the card containing the biomass 
was punched with a puncher into 3 mm circular punches. Punches were transferred to 
0.5 ml sterile water (Roth, Germany). It was incubated for 3 min at room temperature 
and vortexed three times (after water addition, after 1 min and after 3 min incubation). 
The FTA punch was removed and 1x Tris-EDTA buffer (Sigma-Aldrich, Germany) was 
added to the water to preserve the DNA from degradation. MLVA-8 and MLVA-12 
molecular genotyping assays by capillary electrophoresis were carried out for all 
isolates as detailed by (38, 39, 97). For the final MLVA thirteen loci were used, i.e. the 
twelve loci of MLVA-12 (85) plus the one additional locus of MLVA-8 not used in MLVA-
12. 
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2.6 Serogrouping of Legionella isolates  
The serogrouping of subset of 180 L. pneumophila isolates was identified by an 
agglutination test using (Oxoid DR0800) Legionella Latex L.pneumophila was 
serogrouped as Sg1 and Sg 2-14. Moreover, 47 isolates were sent to the National 
Reference laboratory for Legionella infections in Dresden for analyzes by monoclonal 
antibody subgrouping (110). 
2.7 Legionella species, Acanthamoeba castellanii cells and Cell culture 
Sixty L. pneumophila environmental isolates from the West Bank-Palestine were used 
for different virulence assessment tests for the genotypes Gt4(17), Gt6(18), Gt10(93), 
Gt10(141), Gt12(84), Gt40(47), Gt13(72), Gt9(92) and Gt64(74) and the four clonal 
complexes (VACC1, VACC2, VACC5 and VACC11).  
The virulent clinical isolate of L. pneumophila strain AA100 and its isogenic dotA mutant 
was used in this study and have been described previously (111). L. pneumophila str. 
Corby (CP000675), L. pneumophila str. Paris (CIP 107629), L. pneumophila str. 
Philadelphia-1 (ATCC 33152) were used as L. pneumophila reference strains. 
L. pneumophila strains were grown in Yeast Extract Broth (YEB) until the Post 
Exponential (PE) phase. All L. pneumophila strains were plated on BCYE agar plates and 
incubated at 37°C for 72 h. To standardize the inoculum for all tests, all strains were 
additionally pre-cultured in broth until the bacteria had reached the PE phase. For that, 
50 ml of 1:2 diluted YEB liquid medium [10 g N-(2-Acetamido)-2-aminoethanesulfonic 
acid (ACES), 10 g yeast extract, 0.4g L-cysteine and 0.25g ferric nitrate and 1 g α-
ketoglutaric acid per liter of sterile water] were inoculated with fresh biomass and 
incubated at 37°C with agitation (100 RPM) for 48 h. After incubation, pre-cultures were 
diluted with fresh medium and the optical density at 600 nm (OD 600nm) of all the 
strains were set to 0.01 (equivalent to cell density of 107 cells/ml) to standardize the 
initial inoculum. Each strain was studied using triplicates for each assay. THP-1 
macrophages were cultured in RPMI 1640 medium containing 10% bovine fetal serum 
(Gibco). THP-1 macrophages were differentiated with phorbol 12-myristate 13-acetate 
(PMA) (sigma) for 24 h before use as described previously (97, 111). A. castellanii cells 
were maintained in Peptone Yeast Extract Glucose (PGYE) medium. 
2.8 Pore-Forming Mediated Cytotoxicity assay 
The virulence of the previously mentioned isolates were assessed by contact-
dependent pore formation of sRBC’s by L. pneumophila at multiplicity of infection (MOI) 
of 25 after 2 hours of bacterial-sRBC’s contact, as described previously (69, 112). The 
release of hemoglobin from lysed red blood cells was measured by spectrophotometry 
at 415 nm. Pore forming cytotoxicity was expressed as percentage of hemolysis 
compared to 100% fully hemolyzed blood cells.  
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L. pneumophila isolates were plated and cultured on BCYE medium for 72 h. Packed 
sRBCs (Catalog No.: IC100-0210, Innovative research, USA) were prepared for the assay. 
SRBCs (250 ul) were diluted in 50 ml of Phosphate Buffered Saline (PBS). The cells were 
then washed three times by centrifugation for 15 min at 2,000 RPM at 4°C, 3 times.  The 
sRBCs were re-suspended in 25ml RPMI-1640 modified medium  
(Gibco, Germany) and counted using a Neubauer microscopy chamber. The number of 
SRBCs was adjusted to a concentration of 1x108 and 1.5x108 cells/ml. L. pneumophila 
isolates were suspended in 7 ml PBS, and then diluted to 1:20 and the O.D was 
measured at 600nm using spectrophotometer Nanocolor Vis (Macherey-Nagel, 
Germany). Legionella cultures OD 600 nm was adjusted to MOI of 25. Bacterial cells 
were pelleted at 13,000 RPM for 2 min. Then, 0.5 ml of the sRBCs (1x108 cells/ml) were 
added to the bacterial cells, Bacterial-sRBCs mixture were centrifuged at 13,000 RPM 
for 2 minutes and the mixture incubated at 37°C for 2 h. After incubation, the mixture 
was re-suspended thoroughly and OD was measured at 415 nm in order to determine 
the amount of remaining intact RBCs. 
2.9 Acanthamoeba castellanii infection assay  
The virulence of the previously mentioned isolates was assessed by infecting A. 
castellanii by L. pneumophila at MOI of 10 for 24hrs as previously described (113). The 
percentage of survived A. castellanii was calculated as (A. castellanii infected with L. 
pneumophila/ A. castellanii concentration of positive control well) X 100%. Then, the 
percentage of killed A. castellanii was measured as (100% - the percentage of survived 
A. castellanii). 
A. castellanii was cultured in PYGE medium at 30°C for 72 h in cell culture flask. A. 
castellanii cells were washed three times with PYGE medium and 5 ml of PYGE medium 
were added for the detachment of A. castellanii cells from the flask surface. Then, A. 
castellanii cells were counted in Neubauer microscopy chamber and cell concentrations 
were adjusted to 1.25x104 cell/ml suspension in PYGE. Two ml of A. castellanii cells 
were pipetted in each well of twelve well plates. Then, the plate was centrifuged for 
2min at 500xg. The plate was incubated for 3 hours at 30°C in order for cells to adhere 
properly to the wells surface. Each L. pneumophila isolate was inoculated in 20ml YEB 
with initial OD600 of 0.1. Bacterial cultures were incubated at 37°C until they reach the 
post exponential phase of growth and then Centrifuged at 2500xg for 15 min. 
Supernatant was discarded and bacterial pellet was washed with PBS and re-suspended 
in PYGE medium to a final OD600 of 0.078 (equals to 6.25x107 CFU/ml). The appropriate 
volume, which corresponds to a 1:10 ratio with A. castellanii, was calculated and added 
to the 12 well plates. Plates were centrifuged for 5 min at 500xg to allow contact 
between A. castellanii and L. pneumophila. Each L. pneumophila isolate was added in 
triplicate wells containing identical A. castellanii concentrations. Positive control (only 
A. castellanii in PYGE medium) was added in triplicate wells. Negative control (only 
PYGE medium) was added in two wells. Then, plates were incubated at 30°C for 24h. 
Afterwards plates were placed on ice for 30 minutes for proper detachment of A. 
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castellanii cells from the bottom of the wells. Intact A. castellanii cells were counted in 
Neubauer chambers.  
2.10 Heat shock and sodium chloride tolerance assays 
The virulence of the previously mentioned isolates were assessed by heat shock at 60°C 
by (1.00E+08) L. pneumophila cells/ml after 30 min incubation as described previously 
(74). In detailed, L. pneumophila isolates were plated and cultured on BCYE medium for 
72 h. L. pneumophila isolates were suspended in 5 ml PBS, and then diluted to 1:100 
and the O.D was measured at 600nm using spectrophotometer (Human, Germany). L. 
pneumophila cultures O.D600 were adjusted to 0.1 equivalents to (1.00E+08) cells. 
Then, L. pneumophila cells suspension were incubated at 60°C for 30 min. Then, L. 
pneumophila cells were cultivated on BCYE medium for 72 h. Heat resistance of L. 
pneumophila was calculated as [(stressed sample CFU/ml)/(control sample CFU/ml)] × 
100.  Also, the virulence assessment of (1.00E+08) L. pneumophila cells/ml with 100mM 
NaCl was performed as previously described (75, 114). L. pneumophila isolates were 
plated and cultured on BCYE medium for 72 h. L. pneumophila isolates were suspended 
in 5 ml PBS, and then diluted to 1:100 and the O.D was measured at 600nm using 
spectrophotometer (Human, Germany). L. pneumophila cultures O.D600 were adjusted 
to 0.1 equivalents to (1.00E+08) cells. Then, L. pneumophila cells were cultivated on 
BCYE containing 100mM NaCl medium and BCYE medium as control 72 h for CFU 
counts. Sodium sensitivity was calculated as [(BCYE-100mM NaCl CFU/ml)/(BCYE 
CFU/ml)] × 100. 
2.11 Cytopathogenicity of THP-1 Macrophages assay 
The virulence of the previously mentioned isolates were assessed by infecting THP-1 
macrophages by L. pneumophila at MOI of 10 after 24 h of L. pneumophila-THP-1 
macrophages infection as previously described (68, 97). The relative degree of 
cytopathogenicity was expressed as percent of inhibition compared to non-infected 
cells; calculated as (Y= [(K-Y)/K]*100. As K: mean OD of non-infected cells and Y: OD of 
infected cells. 
Bacterial density was assessed by the absorbance at 600 nm with a spectrophotometer 
Nanocolor Vis (Macherey-Nagel, Germany). Briefly, 10 ml of bacterial culture was 
centrifuged at 3500 RPM for 15 min, the pellet was suspended in 5 ml of PBS and the 
optical density at 600nm was adjusted to 0.7 equivalents to 109 bacteria/ml. The 
number of cells was checked by plating on BCYE agar plates and counting the CFU. 
Bacteria was diluted with RPMI-1640 modified medium (Gibco, Germany) to the desired 
MOI. THP-1 cells (ATCC TIB-202TM) were maintained in RPMI-1640 modified medium 
(Gibco, Germany) containing 10% fetal bovine serum (FBS) (Gibco, Germany) and 2mM 
L-Glutamine (Gibco, Germany) in a humid atmosphere containing 5% CO2 at 37°C. 
Before each infection experiment, exponentially growing THP-1 monocytes were 
washed with complete medium, counted and incubated with phorbol-12-myristate-13-
acetate (PMA) (Sigma Aldrich, Germany) at a concentration of 100ng/ml for 48h in 5% 
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CO2 at 37°C to induce maturation of the monocytes into macrophage-like adherent 
cells. Adherent cells were washed three times with PBS prior to infection. 
Intracellular multiplication assays of L. pneumophila strains were carried out as 
previously described (68, 111). Briefly, differentiated THP-1 macrophages (2X105 cells 
per well) in 24-well plates were infected in triplicate with 1 ml of bacterial suspension at 
a MOI of 10. After 1 h incubation, cells were washed twice with PBS and incubated with 
1 ml of RPMI medium containing 100 ug /ml gentamycin (Sigma-Aldrich, Germany) for 1 
h at 5 % CO2 at 37°C to kill extracellular bacteria. Infected macrophages were lysed after 
1 h, 24 h and 48 h using 1 ml of 0.25% Triton 100X (Sigma-Aldrich, Germany) for 20 sec. 
Dilutions of the lysate were plated in triplicates in BCYE agar plates and incubated at 
37°C to determine the CFU. Cytotoxicity assays were carried out by infecting THP-1 
macrophages seeded in 96- well plates at a density of 105 cells per well with L. 
pneumophila strains at MOI 10 during 1 h at 5% CO2. To measure the percentage of 
viable macrophages after the infection, a colorimetric assay based on the oxidation-
reduction of resazurin acid (Alamar blue) (Sigma Aldrich, Germany) was used. After 
infection and washing with PBS, macrophages were incubated with 200 µl of RPMI 
medium supplemented with 10% Alamar blue (Sigma-Aldrich, Germany). Absorbance 
was measured at 600 nm after 24 h using a Synergy 2 microplate reader (Biotek, 
Germany). 
2.12 Selection of strains and reference genomes 
A total of 180 MLVA-8(12) genotyped environmental isolates from the West Bank and 
260 clinical and environmental isolates from Germany were used for this study (97). The 
selection of a subset of L. pneumophila isolates for whole genome sequencing faced 
many challenges since we had a large set of isolates (440 isolates) analyzed by MLVA-
8(12) typing technique.  
Different criteria have been discussed before selection. Reasonably, the most important 
criterion was the clonal relatedness based on MLVA-8(12) genotyping. Using thirteen 
selected loci on the L. pneumophila genome has high discriminatory power (ID=0.964, 
95% CI 0.949-0.980) distinguishing L. pneumophila strains at the clonal level (85, 97). 
Thus, this relatively high resolution in identification and classification of L. pneumophila 
makes MLVA genotyping the first rank for selection. Genotype abundance, source of 
sample and site of isolation are in the second rank. Genome sequences of seventeen L. 
pneumophila reference strains retrieved from GenBank database 
(http://www.ncbi.nlm.nih.gov/GenBank/index.html) were used as reference sequences. 
Sixteen environmental isolates from the West Bank were selected. Furthermore, 
fourteen clinical isolates across Germany and eight environmental isolates from 
Helmholtz Center for Infection Research (HZI) cooling tower, Braunschweig Germany 
were used in this study (Table A1).  Also, the two L. pneumophila isolates 
(A194_Gt40(47)_Ps and H3_Gt14(31)_D) were carefully selected for PacBio whole 
genome sequencing for a robust comparison with the newly sequenced genomes.   
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2.13 Illumina Hiseq and Pacific Bioscience genome sequencing, assembly 
and annotation 
Nowadays, several DNA sequencing platforms are available as e.g. the Illumina Hiseq 
and PacBio sequencers. The output varies considerable concerning the sequencing 
method (115). The Illumina Hiseq 2500 is a high-throughput sequencing system. The 
Illumina Hiseq displays a high sequencing accuracy with error rates smaller than 0.5 
percent, but read lengths are limited to a maximum of 2x250 bp with throughput 125-
150Gb and 600M reads with $40 cost per Gb (116, 117). In contrast, the PacBio system 
provides much longer sequence reads of an average of 10 kbp with high throughput up 
to 7Gbp and around 350,000 reads (117). This 3rd generation sequencing technology is 
based on Single Molecular Real-Time (SMRT) sequencing. About 150,000 up to one 
million zero-mode wave guides per SMRT cell are provided on the RSII and Sequel 
platforms, respectively (118, 119). Meanwhile, there are hundreds of bacterial genome 
studies performed with PacBio SMRT sequencing including, epigenetic studies, full 
length mRNA sequencing, targeted sequencing, de novo assembly and whole genome 
sequencing. This ground-breaking technology provides new discoveries in genomic 
sciences, understanding biology diseases and outbreaks.   
Both above-mentioned techniques were applied in this study. Both platforms are well-
established and complementary in terms of read length and error types (116, 119). 
Thirty six clinical and environmental isolates from the West Bank and Germany were 
sent to the Illumina Hiseq sequencing. Furthermore, the two environmental isolates 
A194 and H3 from the West Bank and Germany, respectively were selected and 5g 
weighted cells grown in YEB medium were sent to the German Collection for 
Microorganisms and Cell Cultures (Leibniz-Institute DSMZ) for PacBio complete genome 
sequencing. 
Genomic DNA libraries for the Illumina sequencer were prepared using the NEBNext 
Ultra kit according to the manufacturer’s instructions (NEB, Ipswitch, MA, USA), and 
sequenced using 100 bp paired-end runs on an Illumina Hiseq 2500. Processed 
sequence reads for each isolate were assembled using Velvet version 1.2.10 with k-mer 
size of 61. Roughly, each L. pneumophila genome was targeted to be at 100X coverage 
within Hiseq sequencing. Hereby, dozens of contigs are retrieved, but no complete 
genomes. 
Genomic DNA of strains A194 and H3 were extracted using Genomic Tip 100/G kit 
(Qiagen, Hilden, Germany) and a > 4 kb SMRTbellTM template library was prepared 
according to the manufacturer’s instructions (Pacific Biosciences, Menlo Park, CA, USA). 
Processed sequence reads were assembled into complete genomes using HGAP3 
(within SMRT Portal 2.3.0) applying default settings. 
Assembled contigs for all sequenced isolates were annotated using the Prokka pipeline 
v1.11 (120). Prokka relies on external prediction tools to identify the coordinates of 
CDS, tRNAs, rRNAs, CRISPRs and other genomic features encoded on contigs and 
chromosomes. All L. pneumophila genomes were annotated using a species-specific 
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database created from the published, manually annotated L. pneumophila strain Lpn-
Corby (102). 
2.14 Genome analysis 
The software Parsnp was used for SNP analysis and to construct a phylogenomic tree 
for the core genome of the completed L. pneumophila genomes (A194_Gt40(47)_Ps, 
H3_Gt14(31)_D and already published L. pneumophila genomes) (121). Parsnp 
generated results were visualized using Gingr (121).  Gingr provides an interactive 
display of multi-alignment variants and phylogenetic trees estimated from the core 
genome alignment. 
Additionally, assembled contigs of L. pneumophila isolates along with genome 
sequences of published strains from GenBank database were aligned, generated and 
visualized using progressive MAUVE algorithm multiple genome alignment software 
with default parameters.  A comparative analysis among L. pneumophila strains has 
been carried out using MAUVE (122, 123). 
Genomic islands (GI) regions were identified using a web-based tool called IslandViewer 
4 (http://www.pathogenomics.sfu.ca/islandviewer) (124) that combines the prediction 
results of three genomic island identification algorithms: Island pick, this is an 
automated comparative genomics method that selects related genomes for a given 
query (125). Score Based Identification of Genomic Island Using Hidden Markov Models 
(SIGI-HMM). SIGI-HMM uses the codon usage frequency table of organisms as their 
distinctive signatures (126). The SIGI-HMM procedure exploits the difference in codon 
usage bias between recipient and donor organisms to infer 
putatively alien DNAs. The visualization tool IslandPath –DIMOB presents a gene map 
where the potential GI harbored genes, inferred by their significant difference from the 
GCC content and dinucleotide composition of the genome, and GI specific features such 
are tRNA genes are indicated by special colors markings. IslandPath-DIMOB identifies 
GIs through their dinucleotide bias and the presence of mobility genes (127). The 
outcome of three Genomic Island (GI) prediction programs, i. e. IslandPath-DIMOB, 
SIGI-HMM, and IslandPick, are integrated by IslandViewer4 into a web interface. It 
reports better accuracy than any of these three methods alone. Genomic islands 
present in L. pneumophila isolates were predicted by at least one method.  
BLASTp was applied to align the amino acid sequences against the Virulence Factors of 
Pathogenic Bacteria (VFDB) database (128, 129). Amino acid sequences with 75% match 
identity was chosen and the description of the best hit was assigned as the annotation 
of predicted gene compared to L. pneumophila strain Philadelphia as default bacteria 
on the webpage. 
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2.15 Statistical Analysis 
Statistical analysis was performed using SPSS 20 and multivariate analyses using 
PRIMER (version 7.0.7). Non-Normalized data were normalized. Then, repeated 
measures ANOVA with post-hoc analysis using the Bonferroni test were conducted for 
determining site-differentiation of water turbidity, HCO3, chloride, SO4, hardness, TDS, 
magnesium, calcium and calcium/ magnesium ratio and one-way ANOVA was 
performed to estimate statistical differences among virulence assays and between the 
isolates from different hospitals. Also, independent t-test was performed to estimate 
differences among the five virulence assays. All tests were applied at a 95% and 99% 
level of confidence. 
Association between genotypes were calculated using the Similarity Profile Analysis 
(SIMPROF) (130) based on Spearman rank correlation. If p<0.05, groups of samples 
were considered significantly different. To determine the effect of physiochemical 
parameters on L. pneumophila genotypes, Principal Component Analysis (PCA) were 
used for visualization of cluster identification. PCA was included 8 parameters. To 
determine the parameters that affect water quality, PCA was used for visualization of 
cluster identification. PCA was conducted on conveniences and included 22 variables.  
Capillary electrophoresis data analysis and calculation of the number of repeats for 
each VNTR marker were achieved as described in (38). The numerical code used to 
designate MLVA-8 and MLVA-12 genotypes, as well as the joint code for MLVA-8(12) 
genotypes, was continued for the isolates. Null alleles (“0”) were assigned when no 
amplicon was detected. Clustering analysis was performed in Bionumerics (version 5.0, 
Applied Maths). UPGMA (Unweighted Pair Group Method with Arithmetic Mean) 
method using a categorical coefficient was applied to define the clusters. MLVA profiles 
obtained in this study were compared to those from the Legionella database and 
clusters were defined applying as criteria a cut-off of 60% similarity as previously done 
(Sobral et al. 2011). Minimum spanning trees were performed using the categorical 
coefficient. Simpson's Index of Diversity coefficient was calculated using the online tool 
provided in http://darwin.phyloviz.net/ComparingPartitions/. To measure the variation 
of the number of repeats at each VNTR locus, the Hunter-Gaston Discrimination Index 
(HGDI), which is a modification of the Simpson's Index of Diversity, was calculated using 
http://www.hpa-bioinfotools.org.uk/cgi-bin/DICI/DICI.pl. Prism 5 was used to draw the 
bar charts. 
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3. Results 
The occurrence of Legionella species, with emphasis on L. pneumophila, in the drinking 
water of the West Bank was determined by cultivation and molecular approaches. Eight 
sites were sampled over a period of 2.3 years covering two seasonal cycles and the 
major geographical regions. To gain insight into potential environmental drivers, a 
broad set of physico-chemical and microbiological parameters were determined. 
Sampling included bulk water of the DWDS and biofilm analysed by genus-specific plate 
counts and PCR based methods using environmental DNA extracted directly from the 
sample material. 
3.1 Abundance of L. pneumophila in water and biofilm as assessed by 
cultivation and PCR-based methods 
A period of 2.3 years was covered by six sampling campaigns targeting eight drinking 
water sites associated with local hospitals representative for different regions of the 
West Bank. The six sampling campaigns targeted the main seasons in Palestine, i.e. 
spring (March to May), summer (June to August), and autumn (October to December). 
These seasons were sampled twice from 2012 to 2014.  
For culture-based assessment of Legionella species, 20 biofilm swab samples were 
analysed per sampling site and sampling campaign, except for the first sampling in 
autumn 2012 when 44 samples were taken per site to check the variability among 
samples. DNA was extracted for PCR-based analysis, 5 biofilm swab samples and 1 to 2 
representative bulk water samples were taken per sampling campaign that all had been 
concomitantly analysed by cultivation. Data on sampling per site and sampling 
campaign are given in detail in supplementary Table A1. An overview on the Legionella 
abundances in the bulk water and biofilm is given in Table 1. 
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For water samples, 
Legionella plate counts 
were mostly below 
detection level, with 
only three sampling sites 
out of eight where 
Legionella were 
detected at all, and only 
one site with more 
frequent observation of 
Legionella in summer 
and autumn (site F). In 
biofilm, culturable 
Legionella were 
detected at all sampling 
sites. Average Legionella 
positive swabs per 
sampling site ranged 
from 3 to 30%.  
PCR detection of 
Legionella spp. and L. 
pneumophila showed a 
higher fraction of 
Legionella positive 
samples. In water samples, at seven out of eight sampling sites L. pneumophila was 
detected with an average detection rate per sampling site ranging from 0 to 100%. In 
biofilm samples, Legionella was regularly detected at all sites at an average detection 
rate ranging from 40 to 93% per site.   
For water samples, L. pneumophila-specific PCR was more sensitive than plate counts. 
The observations by culture and PCR were consistent in a way that whenever plate 
counts were observed, PCR gave positive results; whereas a large set of PCR-positive 
samples did not show any plate counts (Figure 5A).  
Culture based detection of L. pneumophila in biofilms was much more successful than 
in water samples. Legionella plate counts from water samples were only positive when 
about half or more of the biofilm swabs were positive for L. pneumophila cultivation 
(Figure 5B). 
 
Table 1: Average L. pneumophila abundance per sampling site in water 
and biofilm as determined by cultivation and PCR. 
Sampling site 
(North to 
South) 
Coordin-
ates 
water/
culture: 
Legion-
ella 
CFU/L    
± SD 
water/ 
PCR: % 
L. 
Pneum-
ophila 
positive 
± SD 
biofilm/ 
culture: 
% 
Legio-
nella 
positive 
± SD 
biofilm/
PCR: % 
L. 
Pneum-
ophila 
positive 
± SD 
Hospital A 
(Jenin) 
32°27' N, 
35°17' E 
43.3 
(106.1) 
66.7 
(51.6) 
14.6 
(20.0) 
73.3 
(24.2) 
Hospital B 
(Nablus) 
32°13' N, 
35°14' E 
0 (0) 33.3 
(40.8) 
21.4 
(10.8) 
63.3 
(8.2) 
Hospital C 
(Nablus) 
32°13' N, 
35°15' E 
0 (0) 16.7 
(40.8) 
2.8 (4.5) 40.0 
(25.3) 
Hospital D 
(Ramallah) 
31°53' N, 
35°12' E 
0 (0) 33.3 
(28.9) 
14.5 
(21.0) 
66.7 
(11.5) 
Hospital E (East 
Jerusalem) 
31°46' N, 
35°14' E 
0 (0) 0 (0) 6.4 (7.2) 60.0 
(28.3) 
Hospital F 
(Bethlehem) 
31°42' N, 
35°11' E 
148.0 
(229.7) 
100.0 
(0.0) 
29.9 
(25.8) 
90.0 
(11.0) 
Hospital G 
(Hebron) 
31°33' N, 
35° 04' E 
8.3 
(20.4) 
100.0 
(0.0) 
23.8 
(18.8) 
93.3 
(16.3) 
Hospital H 
(Hebron) 
31°31' N, 
35° 05' E 
0 (0) 16.7 
(40.8) 
4.5 (6.4) 60.0 
(17.9) 
 Mean + (SD)  25.0 
(51.9) 
45.8 
(38.6) 
14.8 
(9.8) 
68.3 
(17.3) 
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Figure 5: Legionella plate counts vs. L. pneumophila specific PCR-detection in cold water samples (A), and 
vs. culture-based positive biofilm swabs (B) (A, B: n = 45) 
3.2 Comparison of abundance of culturable Legionella in hot and cold 
water 
Hot water was available at five of the eight sampling sites with the exception of spring 
2013.  At the five sites, sampling was achieved in parallel for hot and cold water. There 
was no significant difference observed for the Legionella plate counts. These counts 
were usually below detection limit in hot water as in cold water. Only for site F 
(Bethlehem), there was an increased level of Legionella counts in summer 2013 and 
2014: in cold water 467 CFU/l in 2013 and 421 CFU/l in 2014; in hot water plate counts 
were similar (508 CFU/l) in 2013, while in 2014 no Legionella were detected. The 
generally low level of culturable Legionella was observed also for the hot water in this 
sampling comparison (linear correlation: r2 = 0.52, Figure 6).  
 
Figure 6: Correlation of Legionella plate counts of cold versus hot water (n=24).  
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3.3 Seasonal dynamics of L. pneumophila in biofilm and water 
L. pneumophila showed an increase in biofilm samples from spring to autumn across all 
sampling sites. Both culture based and PCR based methods showed this increase. For 
PCR based detection, the ratio of positive swabs was in general higher than for culture 
based detection. Culture based methods and L. pneumophila specific PCR based 
methods showed a good correlation (r2 = 0.83, correlation with Legionella genus 
specific PCR: r2 = 0.78, Figure 7A). The relative increase was higher for culture along the 
year (increase from about 10 to 20% of positive swabs) compared to the PCR based 
detection (increase from about 60 to 80% of positive swabs). The comparison of culture 
based and PCR based detection of L. pneumophila indicated an increase of culturability 
of L. pneumophila from biofilm during the year and the respective exposure to higher 
temperature from about 15% in spring to about 27% in autumn as shown by the 
respective ratios (Figure  7D). 
In contrast, L. pneumophila abundance in bulk water showed a maximum in summer as 
detected by L. pneumophila specific PCR detection and by cultivation (Figure 8A-C). 
Detection by PCR was more sensitive than plate counts; plate counts were only 
recorded when more than 50% of the samples were positive by PCR. The correlation 
between PCR detection and plate counts (CFU/l) was r2 = 0.69 (Figure 8A). On a 
seasonal basis, there was no correlation between biofilm and water samples neither by 
culture nor by PCR based detection. The different seasonal maxima for biofilm and 
water may be the reason for this discrepancy. 
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Figure 7: Seasonal variation of abundances of L. pneumophila in biofilm of eight sampling sites (average 
values) of the West Bank sampled from 2012 to 2014. A: swabs positive by culture vs. swabs positive by L. 
pneumophila specific (L1-primer) PCR, B:  swabs positive by L. pneumophila specific (L1-primer) PCR vs. 
seasons, C: swabs positive by culture vs. seasons, D:  ratio of swabs positive by culture vs. swabs positive 
by L. pneumophila specific PCR vs. seasons (n=45, average n=6). Legend: seasons: 1, spring (March-May); 
2, summer (June-September), 3, autumn (October-December).  
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Figure 8: Seasonal variation of abundances of L. pneumophila in water of eight sampling sites (average 
values) of the West Bank sampled from 2012 to 2014. A: Legionella plate counts vs. water samples 
positive by L. pneumophila specific (L1-primer) PCR, B:  water samples positive by L. pneumophila specific 
(L1-primer) PCR vs. seasons, C: Legionella plate counts of water samples vs. seasons (n=45, average n=6). 
Legend: seasons: 1, spring (March-May); 2, summer (June-September), 3, autumn (October-December). 
  
3.4 Influence of physico-chemical and bacteriological parameters on 
Legionella abundance in water and biofilm 
For the assessment of the relationship between Legionella abundance in water and 
biofilm with bacteriological and physico-chemical parameters in water, these 
parameters were pairwise compared and displayed in a correlation matrix (Table 2). 18 
quantitatively determined parameters were used to define the physico-chemical 
background. Heterotrophic plate counts incubated at 25 °C and 37°C were used as 
general bacteriological parameters. Culturable Legionella counts were used for water 
and biofilm (headline highlighted in yellow). PCR detection of L. pneumophila and 
Legionella genus were added for biofilm swabs. For the subspecies level of L. 
pneumophila, the incidence of highly MLVA abundant genotypes and clonal complexes 
(VACC) were included. 
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Correlation analyses of the abundance of L. pneumophila in water and biofilm vs. the 
physico-chemical parameters showed a correlation with the magnesium concentration 
and the Ca/Mg ratio in the sampled tap water, but not with any other of the analysed 
physico-chemical parameters (Table 2). Surprisingly, there was no significant correlation 
with chlorine concentration or temperature. Abundance of culturable Legionella in 
water and biofilm were correlated; furthermore both parameters were correlated with 
occurrence of specific L. pneumophila genotypes and clonal complexes (VACC). The 
magnesium concentration in water showed a relationship not only with the abundance 
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of Legionella in water and biofilm, but also with some genotypes and clonal complexes. 
Findings of the correlation matrix are elaborated in more detail in the following 
paragraphs.   
As shown in (Figure 9), there was a tight correlation between the Ca/Mg ratio and the 
Mg concentration for the total data set (Figure 9A) as for the average of the eight 
sampling sites (Figure 9B). There was no correlation between Ca and Mg; Ca varied 
between 103 and 78 mg/l with no correlation with the Mg concentration. 
 
 
Figure 9: Correlation between the Ca/Mg ratio and the Mg concentration for the total data set (n=45) 
(Figure 6A) and for the average values of the eight sampling sites (n= 45, average n=8) (Figure 6B).  
For the water samples (Figure 10), the plate counts of L. pneumophila showed a 
negative correlation with increasing Mg concentrations. This was observed for the 
overall set of samples as well as for the averages for each sampling site (Figure 10A). 
For both data sets, the correlation could be best described by a power function with a 
correlation coefficient of r2 = 0.54 and 0.78, respectively. Figure 10B shows the 
correlation with the Ca/Mg-ratio that is best described by an exponential function (r2 = 
0.63). Abundance of culturable L. pneumophila increased with increasing Ca/Mg ratio as 
expected from the above described (Figure 9) correlation of Mg with the Ca/Mg-ratio. L. 
pneumophila-specific PCR of water samples confirmed the negative correlation of L. 
pneumophila abundance with increasing Mg concentrations (linear correlation of 
average per sampling site r2 = 0.49) (Figure 10C). 
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Figure 10: Correlation of L. pneumophila abundance with Mg and the Ca/Mg ratio of the water samples 
as detected by plate counts (A,B) and L. pneumophila specific PCR (C) (n=45, average n=8). 
For the biofilm samples, a correlation between the magnesium concentration and the 
PCR based detection of Legionella spp. and L. pneumophila was observed as shown for 
the average of each sampling site in Figure 11. By contrast, culture based analyses of 
swabs did not show a clear trend. As for the water samples, increasing Mg 
concentrations yielded a lower percentage of positive biofilm samples (swabs), both for 
genus-specific PCR (Figure 11A) and L. pneumophila- specific PCR (Figure 11B).   
 
   
 Figure 11: PCR-based detection of the genus Legionella (a) and L. pneumophila (b) in biofilm swabs vs. 
magnesium concentration in bulk water (n=45, average n=8). 
For culture-based and PCR-based detection of L. pneumophila in water and biofilm, 
correlations with the Ca/Mg ratio yielded similar correlation coefficients as with Mg, 
but with an increase of Legionella abundance with an increasing Ca/Mg ratio as 
expected from the correlation between Mg and the Ca/Mg ratio (see Figure 10 and 
correlation matrix, Table 2).  
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3.5 Serotype distribution of L. pneumophila isolates 
A total of 180 PCR confirmed L. 
pneumophila environmental isolates 
from eight hospitals across the West 
Bank and AQU campus were tested for 
serotyping. The majority of the isolates 
were characterized as serogroup 1 
(Sg.1) (n=112, 62.2%), the remaining 
isolates (n= 68, 37.8%) were non Sg 1. 
A subset of 10 Sg1 isolates was 
subgrouped by monoclonal antibody 
and all belonged to the MAb 3/1 
negative OLDA subtype, which is 
considered to lack the virulence- 
associated epitope. The non-Sg.1 
isolates (n=37) were analyzed by 
monoclonal subgrouping and 81% 
(n=30) of them were serotyped as Sg.6, 
followed by Sg.8 (n=6) and Sg.10 (n=1). 
The rest of the non-Sg.1 (n= 31) were 
characterized as serogroups 2-14 as 
performed by the agglutination kit (Table 3). 
In general, the study of the population of L. pneumophila in the West Bank showed the 
following patterns; Sg.1 isolates (62.2%) were more frequent than non-Sg.1 isolates 
(37.8%). Among the tested isolates, a higher diversity was observed among the non-
serogroup1 isolates. In this group the majority of isolates were Sg.6 (Table 3). 
3.6 Prevalence and biogeography of L. pneumophila genotypes across the 
West bank 
From the six sampling campaigns from 2012 to 2014, 197 isolates were obtained. 180 
strains were successfully genotyped by MLVA8(12) using 13 loci resulting in 26 different 
genotypes (ID=0.790, 95% CI 0.739-0.841) (Table 4 and 5). 11 genotypes were 
represented by three strains up to a maximum of 74 strains per genotype (Table 4). The 
remaining 15 genotypes were represented by 2 or 1 strain. The 26 genotypes are 
affiliated with the 4 VNTR clonal complexes VACC 1, 2, 5, and 11, indicating the 
relatedness among the genotypes. VACC1, VACC2 and VACC5 were clonal complexes 
previously defined at the MLVA Legionella database. However, VACC11 is described for 
the first time in this study (Figure 12 Figure A1). 17 of the MLVA genotypes are 
considered to be affiliated with 12 different sequence types (ST), meaning that some of 
the MLVA genotypes pertained to the same ST. In the following analyses, the focus will 
be on the genotyped strains; genotyping will be used as a classification scheme for 
further studies of the ecology of L. pneumophila. 
Table 3: Serogroup and monoclonal antibody 
subtyping of 180 environmental L. pneumophila 
isolates from West Bank.   
Serogroup mAb¹ 
subgroup 
L. pneumophila isolates 
   No. Frequency 
(%) 
1 OLDA  10 5.6 
1 NA2  102 56.7 
Total Sg1   112 62.2 
6 Dresden  30 16.7 
8   6 3.3 
10   1 0.6 
(2-14) NA2  31 17.2 
Total non Sg1  68 37.8 
Total   180 100 
¹mAb: monoclonal 
Antibody 
  
2NA: Not analyzed    
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Though sampling was 
achieved in the same 
way for seven hospital 
drinking water sampling 
sites, the yield of 
isolates per site was 
rather variable (Table 
4). It should be noted 
that sampling site D 
spring, summer and 
autumn could only be 
sampled once, while all 
other seven sites were 
sampled twice for these 
seasons (see 
Supplementary 
Material, Table A1).  
When analyzing the 
MLVA-8(12) genotypes, 
the same main clusters 
were observed and only 
minor changes were 
detected. By using the 
combination of 13 loci, a small group of six isolates that belonged to two different 
genotypes separated from the large VACC1 and remained as singletons. These six 
isolates were all Sg.8 strains isolated from AQU in contrast with the rest of the strains 
enclosed in VACC1, which were all Sg.1. They differed from the rest of the isolates 
contained in VACC1 in the number of repeats observed for VNTR markers Lpms31, 
which presented 17 repeats in comparison to 4 or 0 in the rest of the profiles of VACC1, 
and VNTR Lpms33 and Lpms34, which presented both only one repeat in contrast to 4 
and 2 repeats found, respectively, in VACC1.In total, 96.6% of isolates (n=174) were 
clustered in the four VACCs and the rest 3.6% (n=6) were found as singletons. VACC1 
was the largest cluster including 110 isolates (61.2%). VACC11, VACC2 and VACC5 were 
in comparison small clusters counting 31 (17.2%), 19 (10.5%) and 14 (7.7%) isolates 
respectively. Only one Sg.1 isolate (A100) isolated from biofilm in hospital F was as well 
included in VACC2. According to the MLVA genotyping, the West Bank is characterized 
by the presence of few singletons, most of their genotypes were isolated more than 
once. Additionally, the diversity was (ID=0.790, 95% CI 0.739- 0.841) in the West Bank 
although the sampled area extended along the West Bank (Figure 12). 
 
 
 
Table 4. Sampling location and number of isolates obtained from each 
site from six sampling campaigns in 2012-2014.   
Sampling site 
(North to 
South) 
Coordina-
tes  
No. of 
isolates 
Percent 
of total 
isolates 
(%) 
No. of 
geno-
types 
Ratio: 
geno-
types/ 
isolates 
A  Jenin 32°27' N, 
35°17' E 
28 15.6 5 0.19 
B Nablus 32°13' N, 
35°14' E 
32 17.8 5 0.16 
C Nablus 32°13' N, 
35°15' E 
5 2.8 2 0.4 
D  Ramallah 31°53' N, 
35°12' E 
18 10 2 0.11 
Al-Quds 
University/ East 
Jerusalem 
31°45' N, 
35°15' E 
15 8.3 6 0.4 
E East 
Jerusalem 
31°46' N, 
35°14' E 
10 5.6 6 0.6 
F Bethlehem 31°42' N, 
35°11' E 
32 17.8 7 0.22 
G Hebron 31°33' N, 
35° 04' E 
34 18.9 5 0.15 
H Hebron 31°31' N, 
35° 05' E 
6 3.3 4 0.67 
 Total  180 100 26  
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The majority of isolates were 
retrieved from biofilm swabs 
(192 strains in total with 175 
genotyped strains) and only a 
minor fraction from water 
samples (5 strains in total, 3 
from Bethlehem (sampling site 
F), one from Jenin (sampling site 
A) and Hebron (sampling site 
G)). The genotypes isolated from 
water are indicated in table 5; 
these genotypes are among the 
most abundant genotypes in 
general, and of high relevance 
for the respective sampling site. 
For a comparison, the 15 
isolates retrieved from biofilm of 
the Al Quds-University are 
added, and indicated in the 
strain table and the 
biogeographic distribution 
(Table 4, 5 and Figure 13). 
The biogeographic distribution 
of the strains according to their 
MLVA-genotype and clonal 
VNTR complex (VACC) is 
indicated in Figure 13.  On the 
genotype level, Figure 13A 
shows a genotype pattern that 
varies on the regional level. In 
the north of the West Bank, 
genotype 4(17) is highly 
abundant. In the south the 
pattern shows high divergence 
from site to site. For example, 
site G is dominated by genotype 
6(18) that was not retrieved 
from any other site; similarly site 
F showed a high prevalence of 
Gt 10(141) that was endemic for 
this site. Also on the level of the 
clonal complexes the regional variability was well pronounced (Figure 13B). In general, 
there is a high prevalence of VACC1, except for sites E, F and H in the south. Site F 
showed a high prevalence of VACC11, site E for VACC 2 and site H for VACC 5.  
Table 5: MLVA-Genotype composition of isolated L. 
pneumophila strains and their affiliation with VNTR clonal 
complexes (VACC) and sequence types (ST).                                                                                                                               
MLVA-8(12) 
genotype 
VACC No.of 
strains 
Frequenc
y (%) 
Sequence 
Type (ST) 
     
Gt4(17)AQ 1 74 41.1 ST 1 
Gt6(18)w(G) 1 30 16.7 ST 1* 
Gt10(93)w(F) 11 16 8.9 ST 461 
Gt13(72) 2 10 5.6 ST 1326 
Gt9(92) 11 8 4.4 ST 461 
Gt10(141)W(F) 11 6 3.3 ST 461* 
Gt12(84)AQ 1 5 2.8 ST 1358 
Gt16(1)w(A) 5 5 2.8 ST 1438 
Gt40(47) 5 3 1.7 ST 292* 
Gt63(83) 1 3 1.7 NA 
Gt64(74) 2 3 1.7 ST 9* 
Gt13(143) 2 2 1.1 ST 1326e 
Gt8(7) 5 2 1.1 ST 1482 
Gt11(87)AQ 1 1 0.6 ST 1358 
Gt13(106)AQ 2 1 0.6 ST 1326e 
Gt16(3) 5 1 0.6 ST1438e 
Gt16(6) 5 1 0.6 ST1438e 
Gt24(68) 2 1 0.6 ST 93* 
Gt38(109) 2 1 0.6 NA 
Gt4(16) 1 1 0.6 ST 1* 
Gt4(20)AQ 1 1 0.6 ST 1* 
Gt55(94) 11 1 0.6 NA 
Gt6(15) 1 1 0.6 ST 1* 
Gt8(142) 5 1 0.6 ST1482e 
Gt8(23) 5 1 0.6 ST1482e 
Gt84(106)AQ 2 1 0.6 ST 187* 
Total No. 26 4 180 100 12 ST’s 
vs. 23 Gts 
 Legend: NA, not available; *, ST was assessed for strains of the 
same MLVA-8(12) genotype, and not directly for the West Bank 
strains; e, ST was estimated from the MLVA-8 pattern; W, 
genotype retrieved from water, in brackets the site of isolation is 
indicated; AQ, contains strains retrieved from biofilm of the AQU.                                                                         
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Figure 12: Minimum-spanning tree based on MLVA-8(12) profiles of 180 L. pneumophila strains isolated 
from the West Bank.  Each circle in the tree represents a different MLVA-8(12) genotype. The genotype 
number is indicated within or near the circle, which is proportional to the genotype frequencies. Different 
colors in the pie charts refer to the eight sampling locations (see legend). Thickness of the branches 
represents the number of different loci. MLVA clonal complexes (VACC) have been circled. The circles 
representing the Sg6 singletons from Al- Quds University (Gt11 (87) and Gt12(84)) overlap visually within 
the circle that represent Gt4(17) due to the high abundance of this genotype 
In particular, the most frequently isolated genotype was Gt4 (17) (n=74, 41.1%), 
followed by Gt6 (18) (n=30, 16.7%). Both of them corresponded to Sequence Type 1 
(ST1) (39). The following most frequent genotypes were Gt10 (93) (n=16, 8.9%), and Gt9 
(92) (n=8, 4.4%), corresponding to ST461, and Gt13 (72) (n=10, 5.6%), which 
corresponded to ST1326 (Table 5 and Figure A1). 
At the genotype level, only eight out of the 26 MLVA-8(12) genotypes were isolated in 
more than one location. The rest 18 MLVA-8(12) genotypes were isolated exclusively in 
a certain site. Gt4 (17), known to correspond to the highly broad distributed ST1, was 
the only genotype present in all hospitals except in hospital G. Furthermore, it was not 
only present but represented a high fraction of the isolates in several hospitals. Gt4 (17) 
was the most abundant genotype in hospital B (n=22, 68.7%), A (n=20, 71.4%), D (n=15, 
83.4%), and C hospitals (n=4, 80%). At Al-Quds University it accounted for 40% of the 
genotypes (n=6). Gt6(18), which only differed in one repeat in the VNTR Lpms35 and 
also corresponded to ST1, was found exclusively in hospital G. It was the most abundant 
genotype at hospital G (n=30, 90.9%). Genotype Gt10 (93), which corresponded to 
ST461 was found in hospitals C and F, yet, it was isolated only once (n=1, 20%) in 
hospital C and in contrast was the most abundant genotype in hospital F (n=15, 
45.5%).Other genotypes that were found in more than one location, usually only in one 
or two locations, can be observed in (Figure 12 and Table 6). 
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Table 6 (Part 1): MLVA-8(12) genotypes abundance in the West Bank 
Location                           MLVA-8
(12)   
No. 
Genotyp
e (%) 
Sg-MAb                MLVA_C
C 
No. of 
VACCs 
(%) 
Hospital 
A                  
Gt4(17)     20 (71) 1 VACC1   20(71) 
 Gt16(1)     4 (14) 6 
Dresden 
& (2-14)             
VACC5 5(18) 
 Gt13(72)     3 (11) (2-14)                VACC2 3(11) 
 Gt16(6)    1 (4) (2-14)                0 0 
 Total 28(100) 0 0 28(100) 
Hospital 
B                
Gt4(17)     21(66) 1 VACC1   24(75) 
 Gt9(92)     7(22) (2-14)                VACC11  7(22) 
 Gt63(83)    2(6) 1 VACC2  1(3) 
 Gt4(16) 1(3) 1 0 0 
 Gt13(72)    1(3) (2-14)                0 0 
 Total 32(100) 0 0 32(100) 
Hospital 
C                  
Gt4(17)     4(80) 1 VACC1   4(80) 
 Gt10(93)    1(20) (2-14)                VACC11  1(20) 
 Total 5(100) 0 0 5(100) 
Hospital 
D                  
Gt4(17)     15(83) 1 VACC1   15(83) 
 Gt13(72)    3(17) (2-14)                VACC2   3(17) 
 Total 18(100) 0 0 18(100) 
Hospital 
E                 
Gt13(143
)   
2(20) (2-14)  & 
Sg.10              
VACC2   5(50) 
 Gt64(72)    2(20) 6 
Dresden 
& (2-14)             
VACC5   3(30) 
 Gt8(7)     2(20) (2-14)                VACC1   2(20) 
 Gt4(17)    2(20) 1 0 0 
 Gt24(68)    1(10) (2-14)                0 0 
 Gt16(3)     1(10) (2-14)                0 0 
 Total 10(100) 0 0 10(100) 
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In Figure 14, the Venn diagram shows the number of MLVA8(12) genotypes shared 
among the North, Central and Southern West Bank. According to the West Bank 
geographical distribution, 64(35.6%), 43(23.9%) and 73(40.6%) isolates were isolated 
from Northern, Central and Southern West Bank respectively. Nevertheless, the most 
abundant and more broadly distributed genotype were common to the whole West 
Bank, in particular, Gt4(17), which constituted 68.8%, 53.5% and 9.6% of total isolates 
in Northern, Central and Southern WB, respectively. Gt13 (17) was shared between 
Northern and Central West Bank. Gt64 (72) shared between Central and Southern WB. 
Surprisingly, four genotypes [Gt9 (92), Gt10 (93), Gt16 (1) and Gt63 (83)] were shared 
between Northern and Southern WB which are geographically separated. The least 
diversity of the genotypes were in the Northern WB. Whereas, the diversity was slightly 
higher in Southern than Central West Bank. 
Table 6 (part 2): MLVA-8(12) genotypes abundance in the West Bank 
Hospital F           Gt10(93)    14(44) 6 Dresden 
& (2-14)             
VACC11   21(66) 
 Gt10(141)   6(19) 6 Dresden             VACC1   6(19) 
 Gt4(17)    6(19) 1 VACC2 5(16) 
 Gt64(74)    3(9) 6 Dresden             0 0 
 Gt55(94)    1(3) 6 Dresden             0 0 
 Gt64(72)    1(3) 6 Dresden             0 0 
 Gt38(109)   1(3) 1 0 0 
 Total 32(100) 0 0 32(100) 
Hospital 
G                
Gt6(18)     30(88) 1 VACC1   31(91) 
 Gt6(15)     1(3) 1 VACC5   3(9) 
 Gt16(1)     1(3) (2-14)                0 0 
 Gt8(142)    1(3) (2-14)                0 0 
 Gt8(23)     1(3) (2-14) 0 0 
 Total 34(100) 0 0 34(100) 
Hospital 
H                
Gt40(47)    3(50) 6 Dresden             VACC5   3(50) 
 Gt10(93)    1(17) 6 Dresden             VACC11   2(33) 
 Gt9(92) 1(17) (2-14)                VACC1  1(17) 
 Gt63(83)    1(17) 1 0 0 
 Total 6(100) 0 0 6(100) 
AQU* Gt4(17)     6(40) 1 OLDA                VACC1   13(87) 
 Gt12(84)    5(33) 8 VACC2   2(13) 
 Gt4(20)   1(7) 1 OLDA                0 0 
 Gt11(87)    1(7) 8 0 0 
 Gt13(106)   1(7) 6 0 0 
 Gt84(106)   1(7) 6 0 0 
 Total 15(100) 0 0 15(100) 
AQU*: Al-Quds University    
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Figure 14: Venn diagram of the number of MLVA-8(12) 
genotypes shared among distinct geographic areas. The 
size of the circle is proportional to the number of 
genotypes of each area of the West Bank, Palestine. 
The richness, i.e. the number of L. 
pneumophila MLVA genotypes, varied from 2 
to 7 per sampling site, with an average value 
of 4.5 genotypes for the eight sampling sites. 
The ratio of number of genotypes vs. number 
of strains retrieved per sampling site was 
added as an indicator of the “genotype 
diversity” (Table 4), ranging from 0.11 to 0.67 
and on average of 0.30. There was no 
significant correlation (r2 = 0.28) between the 
number of strains and the number of genotypes retrieved per sampling site. Correlation 
analysis revealed a correlation between the average percentage of biofilm swabs 
positive for Legionella culture per sampling site and the “genotype diversity” (Figure 
13C) sites with low Legionella incidence on biofilm swabs showed a high diversity 
compared to a low diversity in case of high Legionella incidence.  
Correlation analyses with the number of genotypes, i.e. the richness, per site vs. the 
abundance of culturable Legionella in biofilm swabs or water or vs. the PCR detection of 
L. pneumophila on biofilm swabs showed rather weak correlations (r2 < 0.4).  No 
obvious correlations occurred between the genotype diversity and the PCR detection of 
L. pneumophila in biofilm swabs (r2 = 0.27) or the detection of culturable Legionella in 
water (r2 = 0.06).  
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Figure 13: Biogeographic distribution of the L. pneumophila strains according to their MLVA-8(12) 
genotype (A) and their clonal complex (VACC) (B). In Figure 13A the respective MLVA-8(12) genotype is 
indicated in the following way: genotype MLVA-8 plus MLVA-12 in brackets, e.g.  the genotype MLVA-
8(12) 4(17) is indicated as “4(17)”. 
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Figure 13C: shows the genotype diversity (number of genotypes / number of strains retrieved per 
sampling site) vs. the average percentage of Legionella positive biofilm swabs (by cultivation) per 
sampling site (n=45, average n=8). 
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A more detailed analysis of the 
population structure at the level of the 
VNTR markers that configure the 
genotypes showed that, overall, balance 
variability in the number of repeats for 
most VNTR markers was observed 
among the isolates (Table 7). This could 
be due to the homogenized habitat and 
location where the isolates have been 
obtained from. Some VNTR markers 
appeared to be less variable and showed 
a reduced number of repeats, as shown 
for markers Lpms3, Lpms17 and Lpms19. 
However, other markers showed a 
greater variability as Lpms31 and 
Lpms35. In general, the same repeats 
prevailed independently of the area 
where the isolates were isolated. Null 
alleles were present at different 
frequencies in distinct VNTR markers. 
Especially high were the frequencies of 
null alleles in Lpms38. Remarkably, a 
new allele of Lpms34 was described 
during this study. The new allele had a 
size of 634 base pairs and was formed of 
four repeats. A total of 31 (17.2%) 
isolates contained this allele. However, 
it was very infrequently found in the 
West Bank. This allele was not described 
before in previous MLVA studies for L. 
pneumophila and therefore should be 
incorporated in the allele assignment 
reference table provided at L. 
pneumophila MLVA database for future 
studies (Table 7).  
 
 
 
 
 
Table 7. VNTR characteristics of the L. 
pneumophila strains isolated from the West Bank  
  West Bank 
VNTR   No. of 
repeats 
HGDI¹ (CI 
95%)  
Null 
alleles 
(%) 
Lpms1  4 0.528 
(0.459-
0.596) 
0 
Lpms3  2 0.461 
(0.420-
0.502) 
0 
Lpms13  5 0.579 
(0.506-
0.652) 
0 
Lpms17  2 0.115 
(0.053-
0.178) 
0 
Lpms19  2 0.022 
(1.000-
0.053) 
1.11 
Lpms31  6 0.576 
(0.513-
0.639) 
1.67 
Lpms33  4 0.575 
(0.506-
0.643) 
0 
Lpms34  4 0.503 
(0.429-
0.577) 
2.22 
Lpms35  6 0.687 
(0.641-
0.733) 
1.67 
Lpms38  3 0.249 
(0.168-
0.330) 
4.44 
Lpms39  3 0.509 
(0.445-
0.574) 
0 
Lpms40  3 0.493 
(0.444-
0.541) 
3.33 
Lpms44  3 0.498 
(0.463-
0.533) 
0 
¹ HGDI: Hunter-Gaston Discrimination Index 
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3.7 Environmental factors correlating with genotype abundance and 
composition 
The variable pattern of genotype prevalence and composition raised the question 
concerning the influencing factors. There was a broad set of physico-chemical 
parameters recorded or obtained from the water authorities of the West Bank (Table 
A1, Supplementary Material). The quantitavely measured parameters that showed 
differences between the sampling sites were used for detailed statistical analysis, i. e. 
PCA and cluster analysis. The selection criterion for the genotypes to be included in 
these analyses was the number of strains available per genotype, i.e. only genotypes 
represented by at least three isolates were included. This selection resulted in ten 
genotypes submitted to PCA and cluster analyses. 
Three groups of genotypes could be separated by PCA and cluster analysis based on 
the environmental parameters, i.e. concentrations of chloride, sulphate, Mg, Ca/Mg-
ratio (“Ratio”), Ca, total dissolved solids (TDS), and turbidity and Legionella plate 
counts (Figure 15).  Cluster analyses formed three groups for the ten genotypes. By 
PCA, eight of the ten genotypes were assigned to three groups, with two genotypes 
(Gt 9(92) and Gt 63(83)) being close the PCA-group B1 comprising Gt 4(17) and Gt 
13(72).  These four genotypes (Gt 9(92), 63(83), 4(17), 13(72) were included in one 
group (cluster group B) by cluster analyses. For further analyses and considerations, 
these four genotypes are treated as members of group B.  
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Figure 15: A) Dendogram showing group average hierarchical clustering of MLVA-8(12) genotypes. B) 
Principal-component analysis (PCA) comparison of MLVA-8(12) genotypes showing the effect of 
biological and physicochemical parameters. Light green ellipses represent the log normal distributions 
of principal component values for genotype groups. Close genotype groups were summarized as 
pertaining to the same niche. The resulting niches are A (green), niche B (red), niche C (blue). Niche A 
and C are consistent with the calculated grouping A and C; group B1 was enlarged to include two more 
genotypes in group B that concomitantly represents niche B.  Legend: Ratio, Ca-Mg ratio; Leg. count, 
Legionella plate counts in water samples. 
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Table 8 provides the specific characteristics of the niches A, B, and C in terms of 
summary of the parameters, their concentrations and distinction per parameter. It 
demonstrates that the group of strains have clearly distinct niches. For more details 
on statistical analyses see Table A2.  
Table 8:  Summary of environmental parameters describing the different niches of L. pneumophila MLVA-
genotypes and their significant differences based on a correlation analysis  
Niche 
design-
ation 
VACC: 
genotypes 
(Gt)  
No. 
isol-
ates 
Statist
ics 
Legion-
ella 
(CFU/l) 
Turb 
(mg/
l) 
Chlori-
de  
(mg/l) 
SO4 
(mg/l) 
TDS 
(mg/l) 
Mg 
(mg/l) 
Ca 
(mg/l) 
Ca/Mg 
ratio 
A VACC11: 
Gt10(93), 
Gt10(141)  
VACC2: 
Gt64(74)         
25 Mean 263 1.3 27.6 13.8 284.3 23.8 80.5 3.4 
           
  SD 235 0.2 6.7 3.8 5.9 4.2 2.9 0.4 
B VACC1: 
Gt4(17), 
Gt63(83)  
VACC2: 
Gt13(72), 
VACC11: 
Gt9(92)     
95 Mean 61 1.3 52 14.9 314.3 34.2 81.8 2.3 
           
  SD 122 0.4 21.1 5.6 91.8 9.2 21.2 0.7 
C VACC1: 
Gt6(18)                                
VACC5: 
Gt16(1), 
Gt40(47) 
38 Mean 41 0.9 62.3 32.7 405.7 31.2 93.8 3 
  SD 79 0.1 4.7 6.2 37.8 2.1 3.8 0.2 
A vs. B   p*  *** NS *** ** ** *** * *** 
A vs. C   p*  *** *** *** *** *** *** *** ** 
B vs.C   p*  NS *** ** *** *** ** *** *** 
Legend: Independent t-test: NS, not significant; *, p≤ 0.05; **, p≤ 0.01; ***, p≤ 
0.001. 
   
 
The environment of these three groups is characterized by the respective parameters 
in summary and assigns distinct niches to the three groups. The characteristisation of 
the three groups by the parameters is shown in Table 8. While a comprehensive and 
stable distinction is shown for the summary of the parameters, also many of the single 
parameters allow a distinction between two or three groups. 
These three groups of genotypes were considered to co-occur in their respective 
environment as described by the above mentioned parameters. The respective 
habitats as described by these environmental parameters for the three groups of 
genotypes could be considered as their “niche”. This means that to each niche three 
to four genotypes were assigned. More genotypes maybe sharing these niches, but 
they were not included in the analysis due to a low strain number. For example, 
genotypes Gt9(92) and Gt63(83) were combined with Gt4(17) and Gt13(72) in niche B, 
because they can be considered to live in a comparable environment. 
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3.8 Relationship between genotype presence and abundance of L. 
pneumophila in water and biofilm  
Since the overall Legionella abundance is critical for environmental issues and human 
health, its relationship with genotype abundance was analysed in more detail. Such a 
relationship was also indicated by the PCA and cluster analyses of the MLVA 
genotypes (Figure 6). Per sampling site, the percentage of culturable L. pneumophila 
positive biofilm samples correlated well with the presence of strains of the clonal 
complex VACC1 (r2 = 0.53), and was improved when adding the locally highly relevant 
strains of VACC11 (r2 = 0.86) (Figure 16A,B). VACC11 alone did not show a good 
correlation with the biofilm (r2 = 0.18), due to their endemic distribution. 
 
Figure 16: Biofilm samples: Correlation of Legionella culture positive biofilm samples was obtained vs. 
the abundance of strains of the clonal complexes VACC1 + VACC11 (n=135, average n=8) (A); for a 
comparison, the correlation vs. VACC1 alone is shown (n=103, average n=8) (B).  
The Legionella plate counts obtained from water samples, correlated best in terms of 
clonal complex with VACC11 (Figure 17). In terms of correlation with genotypes, best 
correlation was obtained with the abundance of the VACC11 genotype Gt 10(141), 
followed by 10(93). As combination, the VACC11-genotypes 10(141) and 10(93) 
showed the best correlation (Figure 17D). However, this observation was strongly 
influenced by the high Legionella counts from site F and the respective genotypes 
present. Indeed, the three isolates retrieved from water samples of site F were 
identified as two strains of the VACC11-genotype 10(93) and one strain of VACC11-
genotype 10(141). Please note that for the calculations based on genotype abundance 
the whole set of isolates consisting of 175 biofilm-derived strains and 5 water-derived 
strains was used. 
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Figure 17:  Water samples: Clonal complex (n=32) (A) and individual genotypes (n=6 and n=16, 
respectively) (B, C) and combination of genotypes (n=22) (D) correlating best with Legionella plate 
counts obtained from water samples.  
3.9 Influence of magnesium concentration on abundance of genotypes 
and clonal complexes 
Figure 18 shows the details on the relationship between the magnesium 
concentration and the relevant clonal complexes and genotypes. For an overview, 
please refer to the correlation matrix (Table 2). There was only a pronounced 
correlation between VACC11 and the magnesium concentration. All other clonal 
complexes including the highly abundant VACC1 did not show a significant correlation 
(Figure 18D). VACC11 showed the highest abundance at low Mg concentrations. The 
occurrence at lower Mg concentrations were even more pronounced for Gt10(93) and 
most pronounced for Gt10(141). There was no obvious pronounced relationship with 
Mg for the highly abundant genotypes. For low abundant genotypes the data did not 
allow an analysis.  
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 Figure 18: Correlation between the Mg concentration and the abundance of the relevant genotypes 
Gt10(93) and Gt 10(141) (n=16, n=6 and n=22, respectively) (A-C, individual and combined) and clonal 
complexes VACC1 (n=103) (D) and VACC11 (n=32) (E) at the respective sampling sites.  
3.10 Comparison of virulence activity of L. pneumophila reference 
strains  
Three L. pneumophila reference strains (Paris, Corby and Philadelphia-1) were tested 
for their virulence effect on A. castellanii, THP-1 macrophages and pore forming 
mediated cytotoxicity in which AA100 wild type L. pneumophila and dotA mutant 
were used as control strains.  
L. pneumophila strain Paris which is Gt4 (17) included in VACC1 a large cluster in the 
West Bank and worldwide showed the highest virulent activity for cytopathogenicity 
of THP-1 macrophages, pore-forming mediated cytotoxicity and Infection with A. 
castellanii. L. pneumophila strain Corby and WTAA100 have nearly the same high 
virulent activity, since WTAA100 is L. pneumophila strain Corby. Also, L. pneumophila 
strain Philadelphia-1 included in VACC2 have the least virulent activity in comparison 
with the previous two L. pneumophila strains. However, the non-virulent dotA mutant 
resulted in less than 15% cell death (Figure 19). 
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Figure 19: The virulent activity of L. pneumophila reference strains during post exponential phase was 
determined by infectivity of A. castellanii and THP-1 macrophages and pore forming mediated 
cytotoxicity of sRBC’s . Each test was done in triplicate. 
One sample t-test was performed to show the difference between the reference 
strains for each test independently. Statistically significant differences were shown for 
Infection with A. castellanii (P≤0.01), cytopathogenicity of THP-1 macrophages 
(P≤0.05) and pore-forming mediated cytotoxicity of sRBCs (P≤0.05).  
3.11 Virulence assessment of L. pneumophila according to MLVA-8(12) 
genotypes and Clonal Complexes 
To investigate whether the genotype affected the virulence of L. pneumophila, 60 
environmental L. pneumophila isolates from the West Bank were grown to the PE 
phase. Five virulence assessment tests were performed; infectivity of A. castellanii and 
cytopathogenicity of THP-1 macrophages at MOI of 10, pore-forming mediated 
cytotoxicity at MOI of 25, heat shock of 60°C for 30min and 100mM sodium chloride 
sensitivity. Data shows statistically significant (ANOVA P<0.001) difference between 
the genotypes for pore forming mediated cytotoxicity (Figure 20). 
Infectivity of A. castellanii, cytopathogenicity of THP-1 macrophages, heat shock and 
sodium chloride sensitivity exhibit no significant difference between L. pneumophila 
genotypes. G4(17) has statistically significant (Independent t-test P≤0.05) in 
comparison with Gt10(141) and Gt40(47) for A. castellani infection assay.Gt64(74) is 
the highest infection of THP-1 macrophages (65%) has statistically significant 
(Independent t-test P≤0.05) in comparison with Gt64(74) and Gt40(47). Gt40(47) has 
the lowest THP-1 infection (35%) in comparison with Gt10(141) (Independent t-test 
P<0.05) (Figure 20). 
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However, Gt4 (17) isolates showed statistically significant (Independent t-test 
P≤0.001, P≤0.01 and P≤0.05) the highest pore forming mediated cytotoxicity (60%) in 
comparison with Gt10 (93),Gt10(141) and Gt64(74), respectively. Moreover, Gt6 (18) 
isolates showed statistically significant (Independent t-test P≤0.01) higher than 
Gt10(93) and Gt10(141) (Fig.2). Furthermore, Gt40(47) showed statistically significant 
(Independent t-test P≤0.01 and P≤0.05) higher than Gt10(93), Gt10(141) and Gt64(74) 
(Figure 20). 
Gt40(47) is sodium chloride labile genotype which has statistically significant 
(Independent t-test P≤0.01 and P≤0.05) in comparison with Gt6(18), Gt10(93), 
Gt10(141) and Gt4(17) respectively. Moreover, Gt40(47)  is heat labile genotype has 
significant difference with Gt10(141) (Independent t-test P≤0.05). Taken together, 
these results demonstrate that there is no clear significant difference between L. 
pneumophila isolates according to the MLVA-8(12) genotypes. Gt4(17) and Gt6(18) 
have high and constant activity (Figure 20). 
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Figure 20: The virulent activity of L. pneumophila genotypes during post exponential phase was 
determined by five different virulence tests; infectivity of A.castellanii and THP-1 macrophages, pore 
forming mediated cytotoxicity of sRBC’s, heat shock at 60°C for 30min and sodium chloride sensitivity. 
Contact-dependent hemolysis is significantly different for the genotypes. Values are  means of triplicate 
samples, and error bars represent standard deviations. The * indicates statistically significant 
differences. 
Regarding the clonal complexes, MLVA-8(12) genotypes in the West Bank are 
clustered together into 4 different clonal complexes. To investigate whether the 
VACCs affected the virulence of L. pneumophila, 60 environmental L. pneumophila 
isolates were grown at post exponential phase. The previously mentioned five 
virulence test were performed. Data shows statistically significant (ANOVA P≤0.001) 
difference between the four VACCs in pore forming mediated cytotoxicity test (Figure 
21). 
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 VACC1 isolates showed statistically significant (Independent t-test P≤0.001) the 
highest pore forming mediated cytotoxicity (53%) in comparison with VACC11 (26%). 
VACC5 isolates showed statistically significant (Independent t-test P≤0.05 and 
P≤0.001) higher pore forming mediated cytotoxicity than VACC2 and VACC 11 
respectively (Figure 21). 
 Moreover, VACC1 isolates showed statistically significant the highest resistant 
percentage for 60°C heat shock for 30min and 100mM NaCl tolerance  (15% and 9% 
respectively) in comparison with VACC5 with (Independent t-test P≤0.05 respectively). 
Also, VACC5 is labile genotype for heat and sodium tolerance (Independent t-test 
P≤0.05 respectively) in comparison with the other genotypes (Figure 21). 
 In addition, VACC2 isolates showed statistically significant (Independent t-test P≤0.05) 
the highest cytopathogenecity activity of THP-1 macrophages (55%) in comparison 
with VACC11 (37%). Taken together, these results demonstrate when the genotypes 
are clustered together in clonal complexes show better significant difference between 
the L. pneumophila isolates. Also, VACC1 and VACC2 are more virulent that VACC5 and 
VACC11 with the exception of VACC5 in pore forming mediated cytotoxicity assay 
(Figure 21). 
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Figure 21: The virulent activity of L. pneumophila clonal complexes during post exponential phase was 
determined by five different virulence tests; infectivity of A.castellanii and THP-1 macrophages, pore 
forming mediated cytotoxicity of sRBC’s, heat shock at 60°C for 30min and sodium chloride sensitivity. 
Virulence assessment tests are significantly different for the four clonal complexes. Values are  means 
of triplicate samples, and error bars represent standard deviations. The *  indicates statistically 
significant differences.  
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3.12 Environmental niche and virulence assessment of L. pneumophila 
isolates 
To investigate whether the environmental niches affected the virulence of L. 
pneumophila, 60 environmental L. pneumophila isolates from the West Bank were 
grown to the PE phase. Five virulence assessment tests were performed; infectivity of 
A. castellanii and cytopathogenicity of THP-1 macrophages at MOI of 10, pore-forming 
mediated cytotoxicity at MOI of 25, heat shock of 60°C for 30min and 100mM sodium 
chloride sensitivity. Data shows statistically significant (ANOVA P≤0.001) difference 
between the genotypes for pore forming mediated cytotoxicity (Figure 22). 
Niche A isolates showed statistically significant (Independent t-test P≤0.001) the 
lowest pore forming mediated cytotoxicity (24%) in comparison with Niche B and 
Niche C.  While the other virulence tests didn’t show any difference between the 
niches. Taken together, environmental niches don’t have a clear effect on L. 
pneumophila virulence  
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Figure 22: The virulent activity of L. pneumophila environmental niches during post exponential phase 
was determined by five different virulence tests; infectivity of A.castellanii and THP-1 macrophages, 
pore forming mediated cytotoxicity of sRBC’s, heat shock at 60°C for 30min and sodium chloride 
sensitivity. Virulence assessment tests are significantly different for the four clonal complexes. Values 
are  means of triplicate samples, and error bars represent standard deviations. The *  indicate 
statistically significant differences.  
3.13 General features of genomes from L. pneumophila isolates 
Twenty-two L. pneumophila genomes were sequenced with approximately 100 X 
coverage using the Illumina Hiseq platform.  A range of 28 to 103 contigs was obtained 
from the Hiseq runs and assembled with Velvet to reduce the gaps between the 
contigs. The genomes of the isolates H3_Gt14(31)_D and A194_Gt40(47)_Ps consisted 
of 3,691,263 bp and 3,467,907 bp, respectively, according to the PacBio sequencing 
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results. Strain H3 is an environmental isolate from the HZI hot water supply. It is 
serogroup 6 Chicago, sequence type 1431 and MLVA genotype Gt14(31). It contained 
genomic islands of a total length of 209,867 bp representing 5.7% of the genome. A 
total of 3386 genes, 3336 Coding DNA Sequence (CDS), 9 rRNA and 43 tRNA genes 
were identified. Strain A194_Gt40(47)_Ps is an environmental isolate from Hebron, 
Palestine. It is serogroup 6 Dresden and MLVA genotype Gt40(47). The total length the 
genomic islands of strain A194_Gt40(47)_Ps was of 156,728bp (4.5%) comprising 3121 
genes, 3071 CDS, 9 rRNA and 43 tRNA genes. Table A3 summarizes the main features 
of all L. pneumophila isolates and their genomes sequenced by the Hiseq and PacBio 
platform in comparison to all reference genomes of L. pneumophila used in this study.  
3.14 SNP analysis of L. pneumophila isolates 
A phylogenomic tree was constructed using single nucleotide polymorphism (SNP) 
analysis of the seventeen reference genomes available from GeneBank and our 38 L. 
pneumophila genome sequenced strains (Table A3). Six main branches or clusters 
were observed in the constructed phylogenomic tree (Figure 23). Branch one includes, 
two clinical isolates from Germany and two environmental isolates from the West 
Bank, Palestine. This branch included five reference L. pneumophila genomes (Lpn-
LPE509, Lpn-Philadelphila1, Lpn-Thunderbay, Lpn-ATCC 43290 and L. pneumophila 
strain Lpn-Lpm7613). Branch two included only isolate A15_Gt12(84)_Ps and the 
reference strains Lpn-Lens and Lpn-Lorraine. The third branch included environmental 
isolates (H29_Gt22(100)_D, H34_Gt22(102)_D and H35_Gt22(102)_D) from the HZI, 
Germany and the New York City outbreak reference genomes (L. pneumophila strain 
Lpn-D7630, Lpn-D7631 and Lpn-D7632) plus an environmental reference strain from 
France (L. pneumophila strain Lpn-HL06041035). As expected, the vast majority of the 
isolates from our collection, either from the West Bank or Germany, clustered in 
branch four. Branch four included the worldwide distributed ST1 represented by 
reference strain Paris which is closely related to our MLVA genotype Gt4(17) including 
the strains A5_Gt4(17)_Ps and A139_Gt4(17)_Ps, Gt6(18) isolates included strains 
A29_Gt6(18)_Ps and A131_Gt6(18)_Ps, exclusively found in Hebron, West Bank and 
the environmental isolate H39_Gt4(17)_D from the HZI, Germany. In branch five a 
group of clinical isolates clustered together with the reference genome of strain 
Pontiac. Finally, the most diverse branch in our collection was branch six named Alcoy. 
Branch six included closely related isolates (all Gt40(47) [L04-545_Cl_Gt40(47)_D, 
A193_Gt40(47)_Ps, A194_Gt40(47)_Ps and A195_Gt40(47)_Ps] from the Warstein 
outbreak occurring in Germany during 2013. The third highly abundant isolates of 
MLVA genotype Gt10(93) [A108_Gt10(93)_Ps, A112_Gt10(93)_Ps, A114_Gt10(93)_Ps 
and A127_Gt10(93)_Ps]  in our collection clustered all together. Also, group of 
environmental isolates from HZI genotyped Gt14(30) and Gt14(31) [H1_Gt14(31)_D, 
H2_Gt14(31)_D, H3_Gt14(31)_D and H23_Gt14(30)_D]. Lastly, a group of clinical 
isolates from Germany [L02-465_Cl_Gt27(133)_D, L06-153_Cl_Gt71(135)_D, L06-
129_Cl_Gt71(135)_D, L04-041_Cl_Gt30(137)_D and L05-341_Cl_Gt8(132)_D] plus an 
environmental isolate [A166_Gt8(142)_Ps], from the West Bank clustered together. 
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This highly diverse cluster six included only two complete reference genomes (L. 
pneumophila strain Alcoy 2300/99 and Corby) (Figure 23).  
 
Figure 23: Phylogenomic tree based on Single Nucleotide Polymorphism (SNP) analysis of 55 L.  
pneumophila genomes. The strains group within six diﬀerent clusters or branches marked in diﬀerent 
colors. As reference for this phylogenomic tree and in order to create the core genome L. pneumophila 
strain A194_Gt40(47)_Ps was used. * indicates the two isolates (A194_Gt40(47)_Ps & H3_Gt14(31)_D) 
which were additionally sequenced using the PacBio platform. 
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By Parsnp analysis we found 
1,955,470 SNPs among the 55 
strains. L. pneumophila strain 
Alcoy 2300/99 was shown to be 
the closest reference strain so far 
with a complete genome available 
in the GenBank database. 
Furthermore, the strain 
A194_Gt40(47)_Ps in the cluster 
six (named branch Alcoy according 
to its best reference genome) was 
shown to be the largest cluster in 
our selection consisting of 
altogether 21 isolates. Indeed, 
strain A194_Gt40(47)_Ps showed 
11,585 SNPs less than performing 
the complete ParSNP analysis with 
L.pneumophila strain Alcoy 
2300/99 as a reference. Thus, the 
best result for our SNP-based 
phylogenomic tree was retrieved 
with strain A194_Gt40(47)_Ps as 
reference and documented in 
Figure 23 and Table 9. The 
greatest diversity was observed 
among isolates associated with 
cluster six, which differed by 69 to 
11,755 SNPs compared to 
L.pneumophila strain A194_Gt40(47)_Ps. Hereby, one sub-lineage, consisting of 
isolates H1_Gt14(31)_D, H2_Gt14(31)_D, H3_Gt14(31)_D and H23_Gt14(30)_D, 
differed by only 5-8 SNPs compared to the strain H3_Gt14(31)_D (Table A4).  
Within cluster one, L. pneumophila strain Thunderbay was most closely related to our 
isolates differing by 3,018 to 6,283 SNPs, respectively. In cluster two, the isolate A15 
was related to L. pneumophila strain Lorraine and differed by 13,180 SNPs. Within 
cluster three, both clinical and environmental strains from the New York City outbreak 
showed differences between 9,764 to 9,831 SNPs. Within the worldwide distributed 
cluster three, L. pneumophila strain OLDA was the most closely related reference 
genome to our isolates of MLVA genotype Gt4(17) and Gt6(18)  differing by 76 to 
11,020 SNPs. Lastly, within cluster five L. pneumophila strain Pontiac had the most 
closely related reference genome differing by 823 to 14,949 SNPs to our isolates 
(Table A4). 
Table 9: Whole-genome SNPs comparison of selected L. 
pneumophila strains in descending order. 
L. pneumophila 
Sequenced 
Genomes 
Core 
genome 
(%) 
SNP 
count 
(bp) 
Genome 
length 
(bp) 
Lpn-Lens 74 3,523,725 3,345,687 
Lpn-Philadelphia 1 73 2,701,132 3,397,754 
Lpn-Lorraine 72 2,659,278 3,467,254 
Lpn-Lpm7613 76 2,630,870 3,261,562 
Lpn-Thunderbay 72 2,617,761 3,455,167 
Lpn-ATCC43290 74 2,616,399 3,359,001 
Lpn-LPE509 72 2,578,310 3,434,224 
Lpn-HL06041035 71 2,398,444 3,492,535 
Lpn-D7632 72 2,314,961 3,435,648 
Lpn-D7631 72 2,314,928 3,436,178 
Lpn-D7630 72 2,314,907 3,444,702 
Lpn-Toronto 70 2,313,226 3,573,898 
Lpn-Pontiac 70 2,223,081 3,545,001 
Lpn-OLDA 71 2,177,492 3,486,108 
Lpn-Paris 71 2,175,712 3,503,610 
Lpn-Corby 70 1,969,316 3,576,470 
H3_Gt14(31)_D 67 1,962,137 3,691,263 
Lpn-Alcoy 71 1,955,470 3,516,334 
A194_Gt40(47)_Ps 72 1,943,885 3,467,904 
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In a detailed bioinformatics analysis, cluster one contained four isolates, three of 
which belong to Gt64(74) and the clinical isolate from Germany L09-313_Cl_Gt84(11 
6)_D was Gt84(16). The two environmental isolates from the West Bank 
[A156_Gt64(74)_Ps and A129_Gt64(74)_Ps] were close to identical in terms of SNPs 
(up to 4 SNPs). However, the clinical isolate L09-313_Cl_Gt84(116)_D was highly 
diverse comprising 6,283 SNPs. Isolates of the MLVA genotypes Gt22(100) and 
Gt22(102) formed a specific sub-lineage but could be still distinguished in most cases. 
For instance, SNP analysis revealed that some Gt22(100) and Gt22(102) isolates 
differed by 67 SNPs. On the other hand, in cluster four sub-lineage the genome 
sequence of isolate A29_Gt6(18)_Ps differed by only 2 SNPs from the environmental 
isolate A131_Gt6(18)_Ps. Interestingly, isolates A29_Gt6(18)_Ps and A131_Gt6(18)_Ps 
were isolated from the hospital G located in Hebron in the Southern West Bank (Table 
A4).  
The MLVA genotype Gt4(17) formed a specific sub-lineage in cluster four, but isolates 
of Gt4(17) from different cities could still be distinguished because they have been 
isolated in different years. For example, the strains A5_Gt4(17)_Ps and 
A139_Gt4(17)_Ps differed by 119 SNPs. However, the strain H39_Gt4(17)_D, also 
being Gt4(17), an environmental isolate from HZI, Germany showed a highly different 
SNPs pattern of 11,020 SNPs.  The branch five contained six clinical isolates from 
Germany. Two of which were Gt75(49), another two were Gt29(27), one was Gt72(66) 
and the last one was Gt69(69). These branch five isolates showed a highly different 
SNP pattern ranging from 823 to 14,949 SNPs among different clinical strains across 
Germany (Table A4).  
In branch six, isolates of Gt40(47) formed MLVA-genotype specific sub-lineages, but 
closely related outbreak associated isolates from Warstein could still be distinguished 
in most cases. For example, SNP analysis revealed that isolates of Gt40(47) associated 
with the Warstein outbreak differed by 595 SNPs. Peltzold et al showed SNPs analysis 
of targeted genes revealed an average of two SNPs per 100bp (131). In the isolates 
from Palestine in hospital H a higher SNP diversity (2,822 SNPs) was identified in 
comparison to the clinical isolate L04-545_Cl_Gt40(47)_D. Similarly, isolates of 
Gt10(93) clustered in one sub-lineage but clearly differed by 541 SNPs. Furthermore, 
the genome sequence of isolate L06-153_Cl_Gt71(135)_D which was Gt71(135) 
differed by only 3 SNPs from isolate L06-129_Cl_Gt71(135)_D (Figure 23 and Table 
A4).  
There is a good concordance between phylogenomic clusters and MLVA-genotypes. 
Cluster one corresponds to Gt64(74). Cluster three included the MLVA genotypes 
Gt22(100) and Gt22(102) which were isolated from the HZI drinking water supply. The 
worldwide present and highly virulent cluster four was inclusive for Gt4(17) and 
Gt6(18). Cluster five corresponds to Gt29(27), Gt69(69), Gt72(66) and Gt75(49). Lastly,  
the highly diverse cluster six included Gt40(47), Gt9(92), Gt10(93), Gt14(40), Gt14(31), 
Gt71(135), Gt8(132), Gt8(142) and Gt30(137) (Table A3). However, genome 
sequencing could distinguish all isolates in this cluster. For instance, SNP analysis 
differentiated between every L. pneumophila strain in the same phylogenomic branch. 
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An alternative way to evaluate variation among the genomes is to study single base 
polymorphism in detail. Therefore, we visualized Parsnp results with the software 
Gingr. High quality SNPs extracted from those positions having SNP changes in the L. 
pneumophila targeted genes. There were four isolates of Gt14(30) and Gt14(31) 
namely H1_Gt14(31)_D, H2_Gt14(31)_D, H3_Gt14(31)_D and H23_Gt14(30)_D, all 
isolated from the hot water supply of the HZI, some isolates had been isolated in 
different years, i. e. 2009 and 2013. These isolates differed by just nine SNPs. We 
identified each individual SNP among these strains (Table 10).  
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Table 10: Nucleotide Polymorphism differences in  cluster six sub-branch of  L. pneumophila isolates from 
the HZI cooling tower relative to the H3_Gt14(31)_D-PacBio reference sequence.   
Nucleotid
e 
Polymorp
hism 
Label 
(locus 
tag) 
L. 
pneumophil
a Isolate 
Gene 
Name 
 Gene Product Function  Length 
(bp)  
Virulence 
Similarity 
(Id) 
A → T H3_0000
6 
H2_Gt14(31
)_D 
SpeA Biosynthetic 
arginine 
decarboxylase  
Intracellular 
Growth 
1,891 NV 
C → T H3_0002
7 
H23_Gt14(3
0)_D 
YhdG_1 Putative 
amino acid 
permease  
Survival in 
vivo 
1,391 NV 
C → T H3_0093
5 
H1_Gt14(31
)_D, 
H2_Gt14(31
)_D and 
H23_Gt14(3
0)_D 
BepC Outer 
membrane 
efflux protein  
Survive inside 
the host cells, 
restores drug 
efflux 
1,724 NV 
T → G H3_0097
8 
H1_Gt14(31
)_D 
mmgC Acyl-CoA 
dehydrogenas
e  
0 1,154 NV 
A → G H3_0165
6 
H23_Gt14(3
0)_D 
0 Putative 
hydrolase 
0 983 NV 
C → T H3_0269
4 
H1_Gt14(31
)_D, 
H2_Gt14(31
)_D and 
H23_Gt14(3
0)_D 
(ankF/leg
A14/ceg3
1) 
Dot/Icm type 
IV secretion 
system 
effector 
(Ankyrin 
repeats) 
Host 
microbes 
interactions, 
Protein-
Protein 
interaction, 
Intracellular 
replication 
2,765 96 
G → T  H3_0270
6 
H23_Gt14(3
0)_D 
0 Aspartyl/Aspar
aginyl beta 
hydrolase 
0 719 NV 
C → T H3_0292
9 
H1_Gt14(31
)_D, 
H2_Gt14(31
)_D and 
H23_Gt14(3
0)_D 
0 Phagosome 
trafficking 
protein DotA 
Bacterial 
replication, 
virulence, 
Intracellular 
growth, 
Evasion of the 
Endocytic 
pathway 
3,119 79 
C → T H3_0312
3 
H23_Gt14(3
0)_D 
0 Hypothetical 
protein 
0 1,289 NV 
NV : Non-Virulence Gene      
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A detailed bioinformatics comparison of nine genes revealed substantial single 
nucleotide polymorphism if the genome of isolate H3 was used a reference genome 
(H3_00006, H3_00027, H3_00935, H3_00978, H3_01656, H3_02694, H3_02706, 
H3_02929 and H3_03123) (Table 10). These nine genes were blasted (Blastp) against 
L. pneumophila strain Philadelphia1 as default reference genome in the Virulence 
Factor Data Base (VFDB) webpage to detect virulence genes. Two virulent genes 
(H3_02694 and H3_02929) were identified with 96% and 79% identity by comparison 
with the Dot/Icm type IV secretion system effector (ankyrin repeats) and the 
phagosome trafficking protein dotA, respectively. These results showed that L. 
pneumophila contained different levels of diversity to be observed in virulence and 
other genes. There are several evolutionary scenarios that will be dealt with in the 
discussion to explain these observed differences.  
3.15 Identification of mobile elements in L. pneumophila Alcoy branch 
A multiple whole genome alignment using Mauve revealed largely syntenic Locally 
Collinear Blocks (LCB) across twenty-one genomes in cluster six, i. e. the Alcoy branch 
(Figure 24). Notably, this cluster contained clinical and environmental strains from two 
geographical regions (West Bank and Germany) that were highly similar except for 
two interesting areas. To investigate the genomic diversity of cluster six, we used the 
Illumina Hiseq genome sequences of all twenty-one isolates and compared them with 
the complete genomes of the reference strains Alcoy 2300/99 and Corby plus the two 
genome sequences of isolate H3_Gt14(31)_D and A194_Gt40(47)_Ps obtained by the 
PacBio platform.  
Genome size and all main genome features between these strains are summarized in 
(Table A3). In this study, we focused on two different areas that were clearly 
identified in H3_Gt14(31)_D, A194_Gt40(47)_Ps and Lpn-Corby strains. Area one was 
a 84 kbp region containing regulatory proteins, antibiotic resistance proteins, genomic 
islands and three tRNAs (Figure 24 and Table 11). This area does not exist in the 
reference genomes of Alcoy 2300/99 and Corby but was clearly present in the isolates 
H1_Gt14(31)_D, H2_Gt14(31)_D, H3_Gt14(31)_D, H23_Gt14(30)_D, 
A193_Gt40(47)_Ps, A194_Gt40(47)_Ps and A195_Gt40(47)_Ps. Also it was present 
partially in the isolates L04-041_Cl_Gt30(137)_D, L05-341_Cl_Gt8(132)_D, L06-
129_Cl_Gt71(135)_D, L06-153_Cl_Gt71(135)_D and A166_Gt8(142)_Ps. The second 
area is with 49 kbp much smaller was present in the Corby genome and the isolates 
H1_Gt14(31)_D, H2_Gt14(31)_D, H3_Gt14(31)_D and H23_Gt14(30)_D (Figure 24). All 
major gene components of area two are summarized in Table 11. Altogether the 
twenty-one isolates in cluster six are highly syntenic. There are few interesting 
exceptions which were identified as mobile elements. 
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Figure 24: Mauve whole-genome alignment of L. pneumophila strains within cluster six. A) Overview, 
a Progressive Mauve was used to compare the complete genomes of the strains Alcoy 2300/99 and 
Corby as well as cluster six isolates. Shown with shared common colors across genomes are pairwise 
LCBs (locally collinear blocks). The program was run using default parameters as described in (122). The 
cluster six organization, as well as the identity and location of the ~84-kb area 1 and the ~49-kb area 2 
elements are shown. B) Magnified in Mauve. 
 
Table 11: Gene content according to  MAUVE aligner in the studied areas. Hypothetical proteins were excluded 
Gene 
Name 
Product Label Length 
(bp)  
Area 1    
 Acetyltransferase (GNAT) family protein A194_02079 437 
dpnM Modification methylase DpnIIA A194_02080 1,412 
dlpA_1 DlpA protein A194_02081 719 
 Phosphotransferase enzyme family protein A194_02082 968 
 aminoglycoside phosphotransferase A194_02083 1,436 
 shikimate kinase A194_02085 779 
 Enterochelin esterase A194_02086 1,415 
abcT3_
4 
ABC transporter, ATP binding protein A194_02088 1,547 
 transcriptional regulator, MerR family, mercury resistance A194_02090 944 
 beta-lactamase AmpS A194_02091 800 
ftsI4_2 cell division protein FtsI/penicillin binding protein 2 A194_02092 1,922 
mecI_2 Methicillin resistance regulatory protein mecI A194_02093 422 
 transcriptional regulator SkgA, mercury resistance A194_02094 749 
 acetyltransferase, GNAT family A194_02097 602 
 reverse transcriptase A194_02098 1,556 
 acetyltransferase, GNAT family A194_02100 482 
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grpB_2 glutamate rich protein GrpB A194_02101 956 
 nucleotidyltransferase PLUS glutamate rich protein GrpB PLUS ribosomal 
protein alanine  acetyltransferase 
A194_02102 794 
 pyridoxamine 5'-phosphate oxidase A194_02104 581 
 phage repressor A194_02105 622 
lvrA_2 Legionella vir region protein A194_02106 872 
lvrC Legionella vir region protein A194_02107 197 
 putative exported protein A194_02108 434 
 Type IV secretory protein VirB4 component A194_02121 2,774 
 TraU protein A194_02122 995 
 membrane protein, Tfp pilus assembly, pilus retraction ATPase PilT A194_02123 1,382 
 conjugative coupling factor TraD A194_02127 2,006 
 Putative HTH-type transcriptional regulator/MT0914 A194_02129 572 
 Avidin family protein A194_02130 413 
 putative secreted esterase A194_02132 1,556 
 Bacterial regulatory proteins, luxR family A194_02133 800 
murE3_
1 
UDP-N-acetylmuramyl tripeptide synthase A194_02134 1,226 
aph_2 spectinomycin phosphotransferase A194_02137 995 
 glyoxylase domain hypothetical protein A194_02138 365 
 short chain dehydrogenase A194_02139 734 
yafP putative N-acetyltransferase YafP A194_02140 1,697 
fni isopentenyl-diphosphate delta-isomerase H3_02136 1,028 
mvaA hydroxymethylglutaryl CoA reductase H3_02137 1,298 
 tRNA-Lys H3_02139 75 
 tRNA-Lys H3_02140 75 
 tRNA-Arg H3_02141 76 
 site specific recombinase H3_02142 1,160 
nucS Endonuclease NucS H3_02143 1,004 
 Acetyltransferase (GNAT) family protein H3_02144 485 
 proline/betaine transport protein like protein H3_02145 1,274 
 putative acetyltransferase H3_02146 512 
 lipolytic enzyme H3_02147 686 
 transcription regulator protein, response regulator containing CheY-like 
receiver domain and HTH  DNA-binding domain 
H3_02148 803 
tylM1 dTDP-3-amino-3,6-dideoxy-alpha-D-glucopyranose N,N-dimethyltransferase H3_02150 824 
 topology modulation protein H3_02152 542 
 aminoglycoside 6'-N-acetyltransferase H3_02154 545 
 acetyltransferase, GNAT family H3_02155 554 
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 transcriptional regulator, MerR family, mercury resistance H3_02156 1,040 
 methyltransferase H3_02157 881 
 Acetyltransferase (GNAT) family protein H3_02158 419 
 recombination protein F H3_02159 1,160 
 Cupin domain protein H3_02160 386 
 O-antigen acetylase H3_02162 1,148 
 serine/threonine protein kinase H3_02163 1,001 
phaB_4 acetyoacetyl CoA reductase H3_02164 782 
 sepiapterin reductase H3_02165 794 
dpnM Modification methylase DpnIIA H3_02165 1,412 
dlpA_1 DlpA protein H3_02168 716 
 Phosphotransferase enzyme family protein H3_02169 968 
 aminoglycoside phosphotransferase H3_02170 1,436 
aroK_2 shikimate kinase H3_02172 779 
mdtK Multidrug resistance protein MdtK H3_02173 1,364 
 transcriptional regulator, LysR family H3_02174 863 
 major facilitator superfamily transporter H3_02175 1,175 
 Peptidase family S41 H3_02176 1,337 
 phage repressor H3_02177 662 
lvrA_2 Legionella vir region protein H3_02178 872 
lvrC_2 Legionella vir region protein H3_02179 197 
 putative exported protein H3_02180 434 
 Type IV secretory protein VirB4 component H3_02193 2,774 
 TraU protein H3_02194 977 
 membrane protein, Tfp pilus assembly, pilus retraction ATPase PilT H3_02195 1,382 
 membrane protein H3_02196 1,568 
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Area 2    
 lipolytic enzyme corby_02494 683 
 transcription regulator protein, response regulator containing CheY-like 
receiver domain and HTH DNA-binding domain 
corby_02495 803 
cadA_2 cadmium translocating P-type ATPase CadA Corby_02499 503 
 cadmium efflux ATPase Corby_02500 1,433 
cadA_3 cadmium translocating P-type ATPase CadA Corby_02502 2,135 
helA_2 cobalt/zinc/cadmium efflux RND transporter, permease protein HelA Corby_02503 3,149 
helB_2 cation efflux system HelB Corby_02504 1,256 
helC_2 cobalt/zinc/cadmium efflux RND transporter, outer membrane protein Corby_02505 1,244 
 reverse transcriptase Corby_02506 1,364 
 reverse transcriptase Corby_02511 1,199 
 transposase IS4 Corby_02512 1,460 
 phage repressor Corby_02513 662 
lvrA_2 Legionella vir region protein Corby_02514 872 
lvrB_2 Legionella vir region protein Corby_02515 383 
lvrC Legionella vir region protein Corby_02516 197 
 putative exported protein Corby_02517 434 
 exported membrane protein Corby_02528 1,313 
 Type IV secretory protein VirB4 component Corby_02530 2,774 
 TraU protein Corby_02531 995 
 membrane protein, Tfp pilus assembly, pilus retraction ATPase PilT Corby_02532 1,382 
 membrane protein Corby_02533 1,568 
 conjugative coupling factor TraD Corby_02536 2,006 
 
3.16 Identification and comparison of genomic islands in L. pneumophila 
isolates  
The different bioinformatics tools for identification of horizontally transferred genes, 
such as IslandPath-DIMOB, SIGI-HMM and IslandPick, are integrated by the 
IslandViewer4 webpage into one output interface. For integrated genomic island 
output, we combined different approaches of IslandViewer4 to identify the major GIs 
in the L. pneumophila isolates.  
In cluster one, the isolates A129 and A156 were aligned against L. pneumophila subsp. 
pneumophila ATCC 43290, due to the fact that the closest isolate reference genome L. 
pneumophila strain Thunderbay does not exist in the IslandViewer4 webpage 
database. This analysis revealed four genomic islands which are not present in isolate 
A156 (Figure 25). Despite, the fact that strains A129 and A156 were in the same sub-
lineage of cluster one (Figure 23) and display a rather similar number of SNPs against 
most other reference genomes in this cluster (Table A4). Isolate A129 contained a 
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total of 294 kbp genomic islands (8.3% of the whole chromosome). However, isolate 
A156 only contained genomic islands of a size of 174 kbp (5.2%).  Isolate A129 
contained the whole genomic content of isolate A156 plus extra-genetic islands 
containing around 40% hypothetical proteins (Table A7). This extra-genetic area in 
isolate A129 could be located extra-chromosomally in a plasmid. 
 
Figure 25: Comparison of Genomic islands in cluster 1 of L. pneumophila strain A129 and A156 aligned 
against reference genome L. pneumophila subsp. pneumophila ATCC 43290. The outer layers, the 
circle shows: (i) nucleotide positions in megabases (M) (black); (ii)Island Viewer-annotated potential 
genomic islands (GI) are labeled accordingly (red); (iii) Extra GIs (marked Green oval); (iv) GI different 
size (Blue arrow). For a summary see Table A5. 
In cluster three, the three environmental isolates from HZI contained 8-10 genomic 
islands (Figure 26). Isolate H35 contained two extra-genomic islands (GI4 and GI10). 
The three isolates shared more than 95% of their genomic island genes (Table A8). 
Table A5 summarizes the number of genomic islands and genomic island genes for all 
isolates.   
 
Figure 26: Comparison of Genomic islands in cluster 3 of L. pneumophila strain H29, H34 and H35 aligned against 
reference genome L. pneumophila strain D-7630. The outer layers, the circle shows: (i) nucleotide positions in 
megabases (M) (black); (ii)Island Viewer-annotated potential genomic islands (GI) are labeled accordingly (red); (iii) 
Extra GIs (marked Green oval); (iv) GI different size (Blue arrow). For a summary see Table A5. 
In cluster four, isolate A139 contained eleven genomic islands whereas isolate A5 
contained ten genomic islands (Figure 27). However, GI11 in isolate A5 was split into 
GI1 and GI11 in isolate A139. Both isolates shared the same genomic islands of a 
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length 226 kbp (6.3%) and 224 kbp (6.3%), respectively (Table A3). On the contrary, 
isolate A29 isolate contained twelve genomic islands and isolate A131 contained 
thirteen genomic islands (Table A5 and Figure 28). Despite the fact that the isolates 
A29 and A131 were in the same sub-lineage, only 2 SNPs were different against the 
reference strains OLDA and Paris (Table A4). Isolate A29 contained 339 kbp (9.3%) of 
genomic islands in contrast to isolate A131 containing 281 kbp (7.9%) of genomic 
islands (Table A3). In cluster five, the isolates L11-209, L09-329, L02-521, L12-317 and 
L10-091 contained 6, 7, 8, 10 and 13 genomic islands respectively (Table A5). The 
clinical isolate L12-317 contained 187 kb (5.3%) genomic islands and the isolates L09-
329 and L02-521 contained 117kb (3.4%) and 118kb (3.4%), respectively (Table A3). 
  
Figure 27: Comparison of Genomic islands in cluster 4 of L. pneumophila strain A5 and A139 aligned 
against reference genome L. pneumophila strain Paris. The outer layers, the circle shows: (i) nucleotide 
positions in megabases (M) (black); (ii)Island Viewer-annotated potential genomic islands (GI) are 
labeled accordingly (red); (iii) Extra GIs (marked Green oval); (iv) GI different size (Blue arrow). For a 
summary see Table A5. 
  
Figure 28: Comparison of Genomic islands in cluster 4 of L. pneumophila strain A29 and A131 aligned 
against reference genome L. pneumophila strain Paris. The outer layers, the circle shows: (i) nucleotide 
positions in megabases (M) (black); (ii)Island Viewer-annotated potential genomic islands (GI) are 
labeled accordingly (red); (iii) Extra GIs (marked Green oval); (iv) GI different size (Blue arrow). For a 
summary see Table A5. 
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In cluster six, the isolates L04-545, A193 and A195 contained eight genomic islands 
(Figure 29). However, isolate A194 contained six genomic islands (Table A5). GI1 and 
GI4 did not exist in isolate A194. GI3 translocated as shown in (Figure 29). 
Interestingly, isolates of Gt40(47) from the West Bank and Germany were closely 
related to isolates from the Warstein outbreak showed a high similarity in the GI gene 
content (Table A9), genomic islands and SNPs pattern which differed by less than 
1500 SNPs if aligned against reference genomes of strain Alcoy 2300/99 and Corby 
(Table A4). These results demonstrated a high similarity between environmental 
isolates from Hebron (West Bank) and the clinical isolate from Germany. Moreover, 
the sub-lineage comprising the isolates A108 and A138 contained seven genomic 
islands. GI4 was not present in isolates A112, A114 and A127 (Figure 30). Isolate A138 
contained 163 kbp (4.8%) of genomic island genes and isolate A127 contained 143kbp 
(4.3%) of genomic island genes. 
 
   
Figure 29: Comparison of Genomic islands in cluster 6 of L. pneumophila strain A193, A194 and L04-
545 (also represents A195 not shown) aligned against reference genome L. pneumophila 2300/99 
Alcoy. The outer layers, the circle shows: (i) nucleotide positions in megabases (M) (black); (ii) Island 
Viewer-annotated potential genomic islands (GI) are labeled accordingly (red); (iii) Extra GIs (marked 
Green oval); (iv) GI different size (Blue arrow); (v) GI translocation (purple arrow). For a summary see 
Table A5. 
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Figure 30: Genomic islands in cluster 6 branch L. pneumophila A108 (also represents A138 not shown) 
and A114 (also representing A112 and A127 not shown) aligned against reference genome L. 
pneumophila 2300/99 Alcoy. The outer layers, the circle shows: (i) nucleotide positions in megabases 
(M) (black); (ii)Island Viewer-annotated potential genomic islands (GI) are labeled accordingly (red); (iii) 
Extra GIs (marked Green oval); (iv) GI different size (Blue arrow). For a summary see Table A5. 
The sub-lineage of the HZI isolates in cluster six showed many differences in GIs. 
Isolate H1 contained ten genomic islands and 253kb (6.9%) genomic island genes 
while isolate H23 contained thirteen genomic islands and 373kb (9.9%) genomic island 
genes (Table A5). Hypothetical proteins formed the major part of the island genes, 
especially in isolate H23 they comprised 45% of the gene sequences. The isolates from 
the hot water supply of the HZI differed by less than 10 SNPs  (Table A4), had the 
same MLVA genotype and clustered closely together in the phylogenomic tree (Figure 
23 and Table A3). However, the HZI isolate sub-lineage has major differences in 
genomic islands.  Finally, clinical isolates in the cluster six sub-lineage contained a 
variety of genomic islands and genomic island genes. For example, isolate L06-129 
contained only five genomic islands while isolate L04-041 contained 14 genomic 
islands. Hypothetical proteins formed the major part ofGI genes for all these isolates 
(Table A5). 
L. pneumophila isolates revealed high genome plasticity by gaining genes from 
genomic islands (GI).  Three different isolates A194_Gt40(47)_Ps, H35_Gt22(102)_D 
and L02-465_Cl_Gt27(133)_D gained genes contributing to   adaptation and 
pathogenicity containing heme proteins, cytochrome C proteins, and hemin binding 
protein. Isolate A194_Gt40(47)_Ps gained 15kb bifunctional hemolysin gene. Clinical 
isolates L10-091_Cl_Gt69(69)_D and L06-129_Cl_Gt71(135)_D gained heat shock 
proteins helping L. pneumophila to improve its virulence by  adapting to high body 
temperature. Also, L06-129_Cl_Gt71(135)_D gained CRISPR-Cas helping the strain to 
improve its  defense mechanisms. Isolate A29_Gt6(18)_Ps contained cold shock 
protein helping it to adapt to cold environments. Strain A112_Gt10(93)_Ps gained 
anaerobic sulfatase-maturating enzyme helpings to adapt to the environment. The 
Gt14(30) and Gt14(31) environmental isolates from HZI sub-lineage gained beta-
lactamase making them antibiotic resistant  The environmental isolates from the West 
Bank A5_Gt4(17)_Ps and A139_Gt4(17)_Ps and environmental isolate from HZI 
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H1_Gt14(31)_D gained bacteriophage helping L. pneumophila to increase  
pathogenicity and adapt faster in the environment to changing conditions (Table 12).  
Table 12: Unique (interesting) genes in L. pneumophila genomic islands as identified by IslandViewer4  
Cluster 
No.- 
Reference 
genome 
L. pneumophila 
Isolate 
Gene ID Locus tag Gene 
Lengt
h (bp) 
Product 
Branch 3- 
D7630 
H34_Gt22(102)
_D 
0 H34_02359 965 major outer membrane protein 
  tufA_2 H34_02301 917 translation elongation factor Tu (EF-Tu) 
  0 H34_02302 341 preprotein translocase subunit SecE 
  nusG H34_02303 548 transcription antitermination protein NusG 
  rplK H34_02304 434 50S ribosomal protein L11 
  rplA H34_02305 695 50S ribosomal protein L1 
  rplJ H34_02306 533 50S ribosomal protein L10 
  rplL H34_02307 380 50S ribosomal protein L7/L12 
  rpoB H34_02308 4,106 DNA-directed RNA polymerase beta subunit 
  rpoC H34_02309 4,247 DNA-directed RNA polymerase subunit beta' 
  rpsL H34_02310 380 30S ribosomal protein S12 
  rpsG H34_02311 527 30S ribosomal protein S7 
  fusA H34_02312 2,084 translation elongation factor G (EF-G) 
 H35_Gt22(102)
_D 
ccmC H35_00671 755 heme exporter protein CcmC 
  ccmD H35_00670 158 heme exporter protein CcmD 
  ccmE H35_00669 431 cytochrome c-type biogenesis protein CcmE 
  ccmF H35_00668 1,952 cytochrome c-type biogenesis protein CcmF 
  ccmG H35_00667 533 cytochrome C biogenesis protein 
  ccmH H35_00666 401 c-type cytochrome biogenesis protein CcmH 
  cycH H35_00665 686 cytochrome c type biogenesis protein CcmH 
Branch 4- 
Paris 
A29_Gt6(18)_P
s 
0 A29_00568 206 cold shock domain family protein 
 A5_Gt4(17)_Ps 0 A5_02183 986 Microvirus H protein (pilot protein) 
  0 A5_02184 1,541 Bacteriophage replication gene A protein 
(GPA) 
  0 A5_02185 260 Phage protein C 
  0 A5_02186 458 Bacteriophage scaffolding protein D 
  0 A5_02187 116 Microvirus J protein 
 A139_Gt4(17)_
Ps 
0 A139_02127 1,025 Bacteriophage replication gene A protein 
(GPA) 
  0 A139_02128 260 Phage protein C 
  0 A139_02129 458 Bacteriophage scaffolding protein D 
  0 A139_02130 116 Microvirus J protein 
  0 A139_02131 1,283 Capsid protein (F protein) 
  0 A139_02132 527 Major spike protein (G protein) 
  0 A139_02133 986 Microvirus H protein (pilot protein) 
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Branch 5- 
Pontiac 
L10-
091_Cl_Gt69(6
9)_D 
hspC2_
1 
L10-091_02122 491 small heat shock protein HspC2 
  0 L10-091_02123 587 heat shock hsp20 
Branch 6- 
Alcoy 
L02-
465_Cl_Gt27(1
33)_D 
0 L02-465_00734 425 hemin binding protein Hbp 
 A194_Gt40(47)
_Ps 
cya A194_00644 15,19
7 
Bifunctional hemolysin/adenylate cyclase 
precursor 
 A112_Gt10(93)
_Ps 
chuR A112_02425 1,475 Anaerobic sulfatase-maturating enzyme 
 H23_Gt14(30)_
D 
ampG H23_01834 1,247 beta lactamase induction signal transducer 
AmpG 
  0 H23_02025 1,361 metallo-beta lactamase family protein 
  0 H23_01996 1,424 Bacteriophage replication gene A protein 
(GPA) 
  0 H23_01997 260 Phage protein C 
  0 H23_01998 458 Bacteriophage scaffolding protein D 
  0 H23_01999 116 Microvirus J protein 
  0 H23_02000 1,283 Capsid protein (F protein) 
  0 H23_02001 527 Major spike protein (G protein) 
  0 H23_02002 986 Microvirus H protein (pilot protein) 
 H1_Gt14(31)_D ampG H1_02766 1,247 beta lactamase induction signal transducer 
AmpG 
  0 H1_00952 1,361 metallo-beta lactamase family protein 
  0 H1_02730 416 Bacteriophage scaffolding protein D 
  0 H1_02731 116 Microvirus J protein 
  0 H1_02732 1,283 Capsid protein (F protein) 
  0 H1_02733 527 Major spike protein (G protein) 
  0 H1_02734 986 Microvirus H protein (pilot protein) 
  0 H1_02735 1,541 Bacteriophage replication gene A protein 
(GPA) 
 H2_Gt14(31)_D 0 H2_02312 1,361 metallo-beta lactamase family protein 
 H3_Gt14(31)_D 0 H3_03288 1,361 metallo-beta lactamase family protein 
 L06-
129_Cl_Gt71(1
35)_D 
htpX_3 L06-129_01854 965 heat shock protein, protease HtpX 
  0 L06-129_01853 470 Phosphate-starvation-inducible E 
  trxA3_2 L06-129_01852 440 thioredoxin 
  0 L06-129_01848 569 small HspC2 heat shock protein 
  cas1 L06-129_01845 968 CRISPR-associated endonuclease Cas1 
  cas3 L06-129_01844 3,395 CRISPR-associated nuclease/helicase Cas3 
subtype I-F/YPEST 
  csy1 L06-129_01843 1,265 CRISPR-associated protein Csy1 
  htpX_3 L06-129_01854 965 heat shock protein, protease HtpX 
  0 L06-129_01853 470 Phosphate-starvation-inducible E 
  0 L06-129_01848 569 small HspC2 heat shock protein 
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Overall, it becomes clear that our L. pneumophila isolates revealed high genome 
plasticity and adaptation to their environments and pathogenicity  by acquisition and 
loss of genes and genomic islands taken together in the composition of all genomes 
and up to nine percent of the genome content comprising horizontally transferred 
genes (87).  
3.17 Identification of pore-forming genes mediating cytotoxicity in L. 
pneumophila isolates  
Central to the pore-forming mediated cytotoxicity of L. pneumophila are the Dot/Icm 
loci, which taken together directly assemble to a type IV secretion system (T4SS) (132, 
133). Also, the toxin rtxA has an important role in the pore-mediated cytotoxicity (111, 
134, 135). Although all L. pneumophila strains examined until today contain the 
complete Dot/Icm loci, sequence variations among the Dot/Icm genes among 
different L. pneumophila strains have been reported (132, 136).  
Eleven Dot/Icm T4SS genes (icmT (72, 73), icmS (137), icmR (137), icmQ (137), 
icmL/dotI (112), icmK/dotH (112), icmE/dotG (112), icmC/dotE (112), dotB (112), dotA 
(112) and icmW (137)) and rtxA gene (135) are responsible for the pore-forming 
mediated cytotoxicity of L. pneumophila. Furthermore, three genes [legiolysin (lly) 
(138), alternative sigma factor RpoS (ProA) (136) and phospholipase (plaB) (139)] have 
hemolytic activity but do not display virulence effects on Red Blood Cells (RBCs)  by L. 
pneumophila. Therefore, these three hemolytic but non-virulent genes were not 
studied.  Dot/Icm T4SS pore-forming mediated cytotoxicity and rtxA genes were 
identified by a BLASTp search against the VFDB using L. pneumophila strain 
Philadelphia1 as default reference genome for the thirty-eight isolates which had 
been genome sequenced (Table A6). 
Table A6 shows 75% to 100% similarity between the pore-forming mediated 
cytotoxicity genes. The icmT gene shared 82% similarity for all strains among twelve 
VFDB-annotated genes identified from L. pneumophila strains. The IcmS gene was 
shared by all strains (100%) except for cluster three (99%). For the IcmR gene the 
blastp similarity varied (from 91 to 97%) for all the strains. The IcmQ gene had a 100% 
similarity in clusters one, two and six plus a 99% similarity for clusters three, four and 
five. The IcmL/DotI genes shared 84% similarity for all strains on the average. The 
IcmR/DotH, IcmE/DotG, IcmC/DotE, dotB, dotA and IcmW gene shared (79-84%), (87-
91%), (99-100%), (99-100%), (78-93%) and (98-100%) similarity for all strains, 
respectively. Also, the rtxA gene shared (75% to 85%) similarity for all L. pneumophila 
strains (Figure 31). 
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Figure 31:  Percentages of the differences of the fifty-five L. pneumophila strains genome sequenced 
in the pore-forming mediated cytotoxicity virulence genes as identified by BLASTp search against the 
VFDB using L. pneumophila strain Philadelphia1 as default reference genome. 
Taken together, this detailed analysis suggests that the twelve genes studied out of 
more than 200  of the Dot/Icm components of L. pneumophila are representing a large 
repertoire of effectors which are necessary for virulence (140). In general, all L. 
pneumophila strains shared the same Dot/Icm T4SS with less than 25% structural 
differences at the protein level.  
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4. Discussion 
This is the first extensive study, which addresses the prevalence of Legionella spp in 
hospitals water systems in the West Bank.  We set out to identify the levels of 
Legionella contamination in West Bank hospitals water supplies testing water samples 
and biofilms using both cultivation dependent and cultivation independent techniques 
targeting Legionella from genus level to clonal level for L. pneumophila using the 
MLVA-8(12) typing method. 
4.1 Legionella abundance in water and biofilm  
Culturable L. pneumophila were surprisingly low in water of the eight sampling sites in 
the West Bank. In only three of the eight sampling sites, Legionella were detected at 
all, and at only one site (F), L. pneumophila was detected more frequently in summer 
and autumn at a maximum value of 500 CFU/l.  Hot water followed this trend and did 
not show higher concentrations than cold water. Using L. pneumophila specific PCR, L. 
pneumophila was detected at all sampling sites except site E. PCR detection was thus 
more sensitive with a broad range of site specific variability from 0 to 100% of water 
samples being positive on average per site. PCR-based detection was consistent with 
cultivation in a way that all cultivation positive samples were PCR positive.  In biofilm, 
culturable L. pneumophila was detected at all sites, but with high sampling site specific 
variability.  The incidence rate of culturable L. pneumophila in biofilm ranged from 3 to 
30%. L. pneumophila specific PCR was positive on average for 40 to 93% of the biofilm 
samples per site. 
Culture based detection was always lower compared to L. pneumophila specific PCR 
detection in bulk water, but culture based data were consistent with PCR based data, 
i.e. PCR based detection was always positive when cultivation was successful. This 
higher sensitivity of the PCR compared to cultivation was valid for water and biofilm. 
Culture based detection in biofilm was far more successful than in water. Culturable L. 
pneumophila was only detected in water when about 50% of the biofilm samples of 
the respective site and sampling were positive. The abundance of L. pneumophila by 
culture and PCR did not show a regional pattern. This was most obvious for the two 
sampling sites in Nablus (B, C) and Hebron (G, H), that differed by an order of 
magnitude.  Compared to an annual study in a close climatic region, i.e. a water 
network at an university campus (Oranim) close to Haifa, much higher Legionella 
counts in drinking water were observed (49). The level of culturable Legionella in 
water at Oranim campus was in the range of 10 to 5800 CFU/l, with more than 60% of 
Legionella positive water samples. The prevalence of L. pneumophila in culture-based 
studies is in accordance with studies (50, 141) in Israel and Greece. Also, the 
prevalence of L. pneumophila in other studies was low (21.6% and 22%) in Kuwait and 
Tunisia respectively (52, 54).   On the other hand, the prevalence of L. pneumophila 
was high (40%) in Jordan (142). Also in this study, samples with culturable L. 
pneumophila usually were obtained from the vicinity of culture positive biofilm 
samples.  
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A main cause of poor water quality is the build-up of biofilm in water distribution 
systems and tanks. Legionella are often considered as pioneers in creating biofilm in 
water distribution systems (100); with increasing biofilm formation the elimination of 
Legionella becomes difficult due to L. pneumophila tolerance to harsh physical and 
chemical conditions, including temperature and chlorination. Two buildings in hospital 
D water system; are relatively new wards established in 2010.  However, Legionella 
was found in those two wards. A reasonable explanation is the problem in the control 
of water temperature which is maintained around 50°C, a suitable environment for 
the survival of Legionella within the hospital’s water system. To prevent the 
accumulation of biofilm, a factor known to be associated with outbreaks of LD, water 
systems should be cleaned and maintained regularly including showerheads, shower 
hoses, faucets and main storage tanks.  
The water reservoir of hospital C, E and H were analyzed for Legionella spp, and were 
found to be uncontaminated in most of water collections during the 2.3 years, 
whereas the swab from the distribution systems of the hospitals grew Legionella. 
Biofilms are found in every drinking water distribution system attached to the surface 
where they harbor many potentially pathogenic bacteria which are not isolated from 
the bulk water but are in the biofilms. The biofilm community is protected against 
adverse environmental conditions including disinfection (143-145).  
4.2 Seasonal dynamics of L. pneumophila 
Seasonal dynamics of L. pneumophila abundance showed a different pattern for water 
and biofilm. Abundance in water had a maximum in summer, and thus followed the 
temperature regime over the year. Abundance in biofilm increased from spring to 
summer and from summer to autumn indicating a maximum of L. pneumophila 
prevalence in biofilm in autumn. These seasonal patterns of water and biofilm were 
obtained by culture based analyses and by L. pneumophila specific PCR. In biofilm, the 
ratio of culturable L. pneumophila did approximately double from spring to autumn. 
From a seasonal perspective, there was no correlation between L. pneumophila 
abundance in water and biofilm due to their different seasonal maxima (146). In the 
water network at a campus close to Haifa, the highest fraction of Legionella positive 
samples (71%) were observed in spring and summer for both water and biofilm (49).   
4.3 Influence of physico-chemical and bacteriological factors on 
Legionella abundance 
In order to determine factors that influence the prevalence of  L. pneumophila at the 
different sampling sites a broad set of physico-chemical and bacteriological 
parameters was analysed with respect to their relationship with Legionella abundance 
in water and biofilm of the eight sampling sites. In addition, the abundance of relevant 
L. pneumophila MLVA genotypes was included in this correlation analysis.  
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In terms of physico-chemical parameters only the magnesium concentration showed a 
significant negative correlation with Legionella abundance in water and biofilm that 
was observed by cultivation and PCR. Magnesium showed a very close negative 
correlation with the Ca/Mg ratio but was not correlated with the calcium 
concentration. Also, the calcium concentration did not correlate with Legionella 
abundance. Due to this Ca-Mg relationship, Legionella abundance showed a positive 
correlation with the Ca/Mg ratio. Therefore, we hypothesize that either Mg, the 
Ca/Mg ratio or a factor closely related to Mg had an influence on Legionella 
abundance in the drinking water of the West Bank. 
In terms of bacteriological factors, there was no correlation of Legionella abundance 
in water and biofilm with heterotrophic plate counts, but with the prevalence of 
specific genotypes and their clonal complexes. The effect of heterotrophic plate 
counts (HPC) and physico-chemical parameters of water, on the presence and count of 
Legionella has been intensively studied in the past years. Nevertheless, some studies 
showed positive or contradicting association between Legionella counts with chlorine, 
temperature and HPC (49, 99, 147, 148).  However, the magnesium concentration also 
showed a negative correlation with these specific genotypes and clonal complexes of 
L. pneumophila as it did on Legionella abundance.    
The magnesium concentrations for all sampling sites were rather high ranging from 22 
to 42 mg/l. High magnesium concentrations were observed in a hydrological study of 
spring and ground water in the West Bank with especially high values in the Eastern 
part of the West Bank (149). To the best of our knowledge, no study on Legionella 
abundance in drinking water is available that deals with drinking water with 
magnesium concentrations of this level.  
4.4 L. pneumophila serogroups in the West Bank and comparison with 
worldwide view 
 L. pneumophila is the most pathogenic of Legionella spp, causing up to 90% of the 
cases of legionellosis (43, 44). Unfortunately, there are no previous data about 
legionellosis cases in the West Bank. According to the current epidemiological data 
available from the world, different L. pneumophila serogroups cause legionellosis. 
Overall, the great majority of strains isolated from the area under study in the West 
Bank were characterized as Sg.1 (62.3%). This fact followed the tendency already 
reported by other studies that have described Sg1 as the most frequently detected 
environmental isolate in different geographic regions (150-152). Besides the high 
prevalence of Sg1, other serogroups were isolated, where the fraction of non-Sg1 
isolates went up to (37.7%). Sg6 was particularly abundant (16.7%). Sg8 and Sg10 
were as well isolated, although in smaller proportions (3.3% and 0.7%, respectively). 
The results obtained here were highly concordant with two studies about the 
distribution of L. pneumophila serogroups in man-made water systems not related to 
human disease (152, 153). L. pneumophila Sg1 was the most frequently isolated 
serogroup followed by Sg6 in France and the UK, where they found as commonly 
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Sg10. Sg.6 was the serogroup responsible for cases of LD after Sg1, according to the 
European surveillance data (154) (Table 3). 
4.5 Biogeography of L. pneumophila genotype prevalence and their 
shaping force 
MultiLocus Variable number of tandem Repeats Analysis (MLVA) was the method of 
choice in this study to evaluate the diversity and population structure of the large set 
of 180 L. pneumophila isolates in the West Bank due to its rapidity, cost, high 
reproducibility and discriminatory power (38, 39). Groundwater mostly is the origin of 
water supply in the West Bank (3). Interestingly, in the West Bank each hospital 
presented particular genotypes (Figure 12 and Table 6). Among the common 
genotypes, Gt4 (17) and Gt6 (18), the most frequent and more broadly distributed 
genotypes in each area belong to ST1 (Table 5 and Figure A1). Furthermore, ST1 is the 
most prevalent sequence type in the West Bank, and is the most dominant sequence 
type worldwide (152, 155-157). The high abundance of ST1 in the environment has 
been reported in several studies. In Japan, the majority of environmental isolates 
(29%) were ST1 (158) as well as in South Korea, where ST1 was distributed across all 
sampled facilities and regions and accounted for 48.1% of the isolates (159). ST1 was 
the most abundant sequence type among environmental isolates in Canada and it was 
found ubiquitously across the country (157). In a study conducted across the United 
States, ST1 was the most frequent sequence type among both clinical sporadic and 
environmental isolates, accounting for 25% and 49% of the total number of isolates 
respectively (156). In Europe, ST1 has also been reported as the most predominant 
sequence type among environmental isolates in Germany (88), England and Wales 
(152), Portugal(160) and Spain (161). 
At the clonal level, the 180 L. pneumophila isolates were grouped according to their 
MLVA genotypes into four MLVA clonal complexes or VACCs (VACC1, VACC2, VACC5 
and VACC11). VACC11 is defined for the first time by this study and it was formed 
exclusively by a group of 31 strains isolated from several hospitals. The population 
structure of L. pneumophila in the West Bank was characterized by the presence of a 
large cluster (VACC1, which included the “Paris” reference strain or ST1) that enclosed 
closely related Sg1 strains isolated from all of the sampling locations. VACC2, which 
included the “Philadelphia-1” reference strain.  This pattern was consistent with 
previous studies (39). In the study by Visca et al., the population structure of a set of L. 
pneumophila strains with different origins from the European Union Legionella (EUL) 
collection was investigated by MLVA-8 genotyping. The majority of the strains (86%) 
were grouped into clonal complexes, of which VACC1 was the largest cluster followed 
by VACC2. The same pattern was observed among environmental strains isolated from 
water supply systems, cooling towers and hot springs in China (162). The majority of 
the isolates (89%) were enclosed in a large clonal complex formed by ST1 and single 
locus variants of this sequence type, which can be assigned to VACC1 (Figure 12 and 
Figure A1). 
86 
 
A large set of 26 MLVA genotypes was retrieved from 180 L. pneumophila isolates with 
most isolates obtained from biofilm due to the low abundance of culturable Legionella 
strains in the bulk water. Only five strains were obtained from water: three from site F 
where the highest Legionella counts occurred in water, i.e. genotypes 10 (93) and 10 
(141) belonging to VACC11; one from site A: Gt 16(1), VACC5; and one from site G: Gt 
6(18), VACC1. The four genotypes obtained from water were represented by 5 to 30 
isolates, and were frequently isolated from biofilm. The highest number of 74 strains 
was obtained for Gt 4(17) that was highly abundant in biofilm samples from the north 
of the West Bank, but was not obtained from water samples (97). 
23 of the genotypes could be matched with 12 sequence types (Table 4) indicating 
that both genotyping methods revealed a high sub-species diversity of L. pneumophila 
isolates in the West Bank. The prevalence of the genotypes in the West Bank showed 
a site specific regional diversity. In the north of the West Bank a pronounced 
prevalence of Gt4(17) was observed. In the south, the genotype composition was 
more distinct from site to site and had endemic genotypes. Site G in the South was 
dominated by Gt6(18) that was endemic for this site, as was Gt10 (141) for site F.  
As an index of genotype diversity per sampling site the ratio of the number of 
genotypes to the number of strains retrieved from the respective site was used. A 
correlation analysis showed that sites where high numbers of strains were isolated 
had a low genotype diversity compared to sites with low isolate numbers. Only from 
sites with low genotype diversity, isolates were obtained from water. This may 
indicate that higher numbers of L. pneumophila in the bulk water reduce the diversity 
in biofilm, or, that high L. pneumophila counts in water are often due to a rather 
restricted number of genotypes or even a single genotype.   
4.6 Environmental drivers of genotype consortia or do L. pneumophila 
genotypes have specific niching preferences?  
MLVA-genotypes with more than three representatives were analysed by average 
hierarchical cluster analysis and PCA with respect to their co-occurrence and 
positioning in the frame of bacteriological and physico-chemical parameters. Both 
statistical analyses showed the same three groupings of genotypes. Three to four 
genotypes formed one group. The environmental parameters and their statistical 
distinctness describing the niche of each group are given in Table 8.  
The highest culturable Legionella abundance in water was associated with group A, 
comprising two VACC11-genotypes (Gt10(93), Gt10(141)) and one VACC2-genotype 
(Gt64(74)). This group was also characterized by low chloride and low magnesium 
concentrations compared to the other two groups. Group B comprised four 
genotypes, two of VACC1, the highly abundant Gt4(17) and Gt63(83), one genotype of 
VACC2 (Gt 13(72)) and one of VACC11 (Gt 9(93)). This group was distinct from group B 
and C with respect to most parameters, but was with most parameters in between the 
other two groups. Group B had the highest average Mg concentration at a high 
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variability. This may indicate that these genotypes are most tolerant to Mg. Group C 
comprised the VACC1-genotype Gt6(18), and the VACC5-genotypes Gt 16(1) and 
Gt40(47) that had a high prevalence in Hebron in the South of the West Bank. The 
environmental parameters of this group were characterized by high sulphate, 
chloride, calcium concentrations and a resulting high content of TDS.      
4.7 Relevance of the observed genotypes for human health and 
environmental issues in the West Bank and worldwide 
Only one previous study reported about the epidemiology of L. pneumophila in the 
West Bank hospitals water (57). In this current study, the systematic sampling of both 
water and biofilm carried out during 2.3 years in the West Bank lead to a large 
collection of 180 environmental L. pneumophila isolates that could bring new insights 
into the molecular epidemiology and genetic diversity of L. pneumophila in the West 
Bank. The studies, which focused on the genetic diversity of L. pneumophila in the 
environment, are not very common (161, 163) compared to those based on clinical 
isolates (153, 156, 164). The studies including environmental samples have been 
usually realized with the aim of establishing epidemiological links between clinical 
isolates and their presumed environmental sources, usually during legionellosis 
outbreaks (85, 93). However, since Legionella infections originate directly from the 
environment and do not occur by human-to-human transmission, the study of the 
genetic diversity and the distributions of L. pneumophila strains using this large set of 
environmental isolates could be relevant in public health control strategies in future 
epidemiological studies. 
The genotypes isolated from the West Bank can be considered to be of environmental 
and human health relevance. As shown by Visca et al. (2011) and Sobral et al. (2011) 
(39, 85) MLVA genotype is well comparable to sequence based typing. In most cases, 
strains of a specific MLVA genotype have the same sequence type (ST). The applied 
MLVA using 13 loci can be considered to have a higher resolution than sequence 
based typing  (85), meaning that several MLVA genotypes can be contained in one 
sequence type.  
The most abundant genotype in the West Bank was Gt 4(17). This genotype comprises 
the pathogenic L. pneumophila strain Paris, belongs to sequence type 1 and serogroup 
1 (40, 101).  Gt 4(17) is distributed globally in anthropogenic freshwater systems (87). 
This strain is relevant as clinical isolate, and was occasionally related to outbreaks of 
LD (49, 162).  More specifically, for the West Bank, some of the highly abundant 
genotypes can be considered to be of special health relevance. PCR-based direct 
analysis of the sequence types in respiratory specimens of pneumonia patients, 
revealed that genotypes belonging to ST1 and ST461 were present in half of the L. 
pneumophila positive specimens (165). We assume that the highly abundant 
representatives of these sequence types are the relevant pathogenic genotypes, 
means Gt4 (17) may be relevant for the detected ST1 infections, and the highly 
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abundant genotypes in the South of the West Bank , Gt 9 and 10 may be responsible 
for the ST461 infections (88). 
The highly abundant genotypes Gt 4(17) and Gt 6(18) in the West Bank were also of 
high relevance in drinking water distribution systems and clinical isolates in Israel (18, 
49, 86). Interestingly, none of the other genotypes in the West Bank were detected so 
far in Israel. In contrast to observations at the West Bank, genotypes Gt 4(17) and Gt 
6(18) had a high abundance in the water and the biofilm in a campus drinking water 
distribution network in Northern Israel. The study comprised an annual cycle. The 
presence of Gt4 was associated with average Legionella counts in water of 2500 CFU/l 
at an average water temperature of 20.6°C. The presence of Gt6 was associated with 
average Legionella counts in water of 240 CFU/l at an average water temperature of 
27.9°C. In the West Bank, Gt4(17) was only detected in biofilm in samples with no 
detection of culturable Legionella in bulk water; Gt6(18) was once isolated from 
water, at a single event of detectable Legionella in water in summer during a two 
annual cycles.   
Rodriguez-Martinez et al. (2015) concluded that the presence of Gt4 could be 
considered as an indicator of high Legionella presence in drinking water, and 
suggested Gt4 as indicator genotype. Based on the observations in the West Bank 
where Gt4 was very frequently observed in biofilms in the Northern part without co-
occurrence of high Legionella counts in water, we suggest that the presence in biofilm 
might not be an indicator for high Legionella counts in water (49). Due to the 
worldwide occurrence of Gt4 and the observations in Israel, we suggest that Gt4 may 
be regarded as an indicator of high Legionella abundance when showing up in the 
water phase. Furthermore, the presence of GT4 in biofilm might be considered as 
warning that, if conditions change, a “Legionella bloom” may be at risk.  
4.8 In vitro-viulence traits of L. pneumophila genotypes 
Little is known about the L. pneumophila in the West Bank in general and the virulence 
of these bacteria in particular. The understanding of L. pneumophila pathogenicity has 
been achieved mostly by the study of clinical isolates. Nevertheless, the analysis of the 
pathogenicity of environmental isolates is essential since environmental strains are 
considered the primary source of outbreaks as well as nosocomial and community 
acquired LD. In general, the degree of virulence of the of L. pneumophila strains is 
determined by studying various traits such as cytopathogenicity and infectivity within 
A. castellanii and THP-1 macrophages. Other approaches, as induction of pore-
formation mediated cytotoxicity of the host and appearance of specific serogroup are 
also commonly used (110). Until now, none of these traits is decisive. Moreover, 
specific strains are thought to be particularly pathogenic since they are frequently 
found among clinical isolates, although it is still not clear which specific factors 
promote their pathogenicity. The assessment of the virulence of L. pneumophila 
strains is very supportive in order to understand the epidemiology of these bacteria.  
Therefore, to complement the genotyping results and better understand its 
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epidemiological significance, the virulence of representative MLVA genotypes and the 
virulence at clonal level were assessed for the genotypes. sixty environmental L. 
pneumophila isolates from the most abundant genotypes were tested for five 
different virulence assessment tests; infectivity of A. castellanii, cytopathogenicity of 
THP-1 macrophages, pore-forming mediated cytotoxicity, heat shock at 60°C for 
30min and sodium chloride sensitivity. 
Pore-forming mediated cytotoxicity and bacterial egress from the host cell upon 
termination of intracellular replication (69, 73) is one phase proposed of 
Acanthamoeba and macrophages killing by L. pneumophila. In this study, infectivity of 
A. castellanii and THP-1 macrophages and pore-forming mediated cytotoxicity of 
sRBC’s were examined with intracellular replication in cells and presence of the 
Dot/Icm system to elucidate the virulence traits for different L. pneumophila 
genotypes and VACCs. Also, comparison between the WT AA100 and dotA mutant 
cultures were performed as control in three assays of virulence. The virulence of dotA 
mutant L. pneumophila was less than 15% for the three virulence tests. While, WT 
AA100 has high (60%) virulence activity for the tests. Moreover, L. pneumophila strain 
Paris and L. pneumophila strain Corby has higher virulence activity in comparison with 
L. pneumophila strain Philadelphia-1. Significant difference were shown for infection 
with A. castellanii (P≤0.01), THP-1 macrophages (P≤0.05) and pore forming mediated 
cytotoxicity of sRBC’s (P≤0.05) (Figure 19).  
The classification of the L. pneumophila strains used in this study into two main 
clusters provides important signs to the pathogenic features of L. pneumophila in the 
West Bank. Cluster one comprised the most abundant genotypes in the West Bank. 
The second cluster comprised the VACC in the West Bank.   In this study, the infectivity 
assay either for A. castellanii or THP-1 macrophages had the same virulence 
distribution for the genotypes and clonal complexes. Gt6(18) which is also serogroup 1 
and exclusively found in hospital G in Southern West Bank is the most virulent 
genotype. Also, VACC2 is the most virulent clonal complex (Figure 20 and Figure 21). 
The virulence of L. pneumophila strains was tested by contact dependent pore 
formation mediated cytotoxicity of sRBC’s. The Dot/Icm system is central for 
pathogenesis of L. pneumophila. Significant difference was clearly observed between 
L. pneumophila genotypes. L. pneumophila Gt4(17) showed the highest virulence 
activity (60%) which is Sg.1 corresponding to ST1. These results are in accordance with 
Kirby et al study (166) which indicates L. pneumophila Sg.1 as a highly virulent strain 
and ST1 is the most common Worldwide (Figure 7). Gt6(18) which is also Sg.1 and ST1 
hemolysed sRBC’s to (46%). Both genotypes [Gt4(17) and Gt6(18)]  belong to VACC1. It 
is the most abundant clonal complex in the WB and worldwide and has the highest 
hemolytic activity (53%). L. pneumophila Gt12(84) shows high hemolytic activity (57%) 
which is Sg.8 corresponding to ST1358. For instance, ST1358 was among the most 
frequently isolated sequence types across Spain (167) and it is one of the virulent 
sequence types detected in a hotel outbreak in Calpe (Spain) affecting 44 patients 
including six deaths (94). Whereas, Gt9(92), Gt10(93) and Gt10(141) showed the low 
hemolytic activity (36%, 26% and 26% respectively) which corresponds to the VACC11. 
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VACC11 is the clonal complex identified for the first time in this study (Figure 20 and 
Figure 21) and has the least clonal complex hemolytic activity (29%). The three least 
hemolytic activity genotypes [Gt10(93), Gt10(141) and Gt64(74)] are site related in 
hospital F (Figure 20 and Figure 21). Also, L. pneumophila str. Paris and L. 
pneumophila str. Corby have the highest virulence activity (75% and 61% respectively). 
They also belong to VACC1. VACC2 has hemolytic activity of (41%) and the hemolytic 
activity of the L. pneumophila str. Pheladelphia-1 was (34%) belongs also to VACC2 
(Figure 21). 
A pore forming mediated cytotoxicity of L. pneumophila is associated with L. 
pneumophila virulence. As when MOI increase, L. pneumophila insert a pore which 
leads to osmotic lysis and replication death (112). Normally, L. pneumophila insert 
pores into its phagosomal membrane to block fusion with the lysosomal network 
(166). Instead, the cytotoxin could facilitate the lysis of the host membranes by L. 
pneumophila (67). Pore forming cytotoxicity plays an important role in the 
cytopathogenicity and cytotoxicity of L. pneumophila isolates since all the isolates 
have virulent activity. In fact, this is not only factor responsible for the virulence in L. 
pneumophila. Feeley et al observed that Legionella were sensitive to sodium ions. So, 
potassium hydroxide is recommended to adjust the pH of BCYE (168). The genetic 
studies showed that Dot/Icm loci is the most important loci responsible for sodium 
tolerance (169). Also, ompS gene is negatively regulated by inhibitory level of sodium 
chloride (170). The heating of water to temperatures of 60°C or more is widely used to 
reduce total bacterial numbers and inactivate the number of pathogens like Legionella 
(17, 171). 
As shown in (Figure 20) no significant difference was present between L. pneumophila 
genotypes. Gt4(17) tolerated sodium chloride (12%) more than the other genotypes. 
However, Gt64(74) was the most resistant to 60°C heat shock test. Both Gt(4(17) and 
Gt6(18) belong to VACC1. As shown in (Figure 21) significant difference (P≤0.05) was 
shown between VACC1 and VACC5 in sodium tolerance test. Also VACC1 is 
significantly resistant to 60°C heat than VACC5 (P≤0.05). As shown in (Figure 22) 
environmental niches don’t have clear effect on L. pneumophila virulence activity. In 
general L. pneumophila responds to amino acid depletion by switching from a 
replicative phase to a virulent form, a state characterized by cytotoxicity assays and 
sodium sensitivity (67). 
4.9 Comparison of taxonomic resolution of MLVA genotyping and SNP 
analysis 
In the present study, we sequenced and compared the genomes of thirty-eight L. 
pneumophila isolates covering different serogroups, MLVA-8(12) genotypes, isolation 
sources (clinical and environmental) from the West Bank and Germany. The majority 
of previous studies have used WGS to study genomics of L. pneumophila and to 
discriminate outbreak strains of L. pneumophila retrospectively or during the outbreak 
(89, 172). Moran-Gilad el al (172) studied outbreak isolates using core genome multi-
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locus sequence typing (cgMLST) and observed that cgMLST has a high enough 
resolution to identify L. pneumophila outbreak strains (172). Another study compared 
whole genome SNP analysis with sequence based typing (SBT) for genotyping L. 
pneumophila and they found a comparable relationship between genome SNPs and 
SBT (89). Qin et al defined the minimum core genome (MCG) and demonstrated that 
MCG typing enabled differentiating L. pneumophila strain into groups having major 
differences in virulence and phenotypic features (95).  
Actually, a threshold for the number of SNPs necessary to identify outbreak-
associated L. pneumophila strains still has to be established. For example, more than 
200 SNPs have been reported in phylogenetically closely related L. pneumophila 
outbreak strains (93, 173). Mercante et al (174) showed that up to 20 core SNPs were 
identified in comparison of Philadelphia clade L. pneumophila isolates. In the present 
study, up to 120 SNPs were identified in the same MLVA-8(12) genotype from the 
same sub-lineage in a phylogenomic cluster. In particular, the environmental isolates 
A156_Gt64(74)_Ps and A129_Gt64(74)_Ps Gt64(74) from a biofilm of hospital F in the 
Bethlehem area were identical for all reference genomes except for L. pneumophila 
strain Lens and L. pneumophila strain LPE509 differed by only one and four SNPs, 
respectively. The environmental isolates H29_Gt22(100)_D, H34_Gt22(102)_D and 
H35_Gt22(102)_D from the HZI differed by less than 70 SNPs. A sub-lineage of cluster 
six for the clinical isolates L06-153_Cl_Gt71(135)_D and L06-129_Cl_Gt71(135)_D 
from Brandenburg, Germany differed by only three SNPs against all reference 
genomes used in this study. On the other hand, the cluster four sub-lineage of Gt4(17) 
contained four strains (two reference genomes from the strains Paris and OLDA from 
France and USA, respectively and two environmental isolates A5_Gt4(17)_Ps and 
A139_Gt4(17)_Ps from Jerusalem and Nablus, West Bank) differed by less than 260 
SNPs against all reference genomes in this study. These results are in concordance 
with Khodr et al (101). They sequenced six ST1 genomes (four clinical and 
environmental isolates from a hospital and the other two were unrelated) and 
observed that geographically unrelated isolates differed by more than 1,500 SNPs. In 
comparison our hospital isolates differed by up to 20 SNPs between two strains. 
Several previous studies showed that L. pneumophila strains have the same genotype 
(either SBT or MLVA) isolated from the same area have less SNP differences than 
strains isolated from different areas. This demonstrates that the geographical origin is 
as important as the genotype (Figure 23 and Table A4).  
Morozova et al (175) showed that the Dot/Icm genes are highly conserved in L. 
pneumophila strains. After whole genome sequencing (WGS) technology was available 
on the market, Gomez-Valero et al (140, 176) confirmed the previous study showing 
high conservation (98%) among orthologs of the reference strains Corby, Paris, 
Philadelphia and Lens with few exceptions in the dotA gene. The dotA gene is an 
essential gene for virulence activity of L. pneumophila strains since it encodes an 
integral membrane protein with eight domains. This explains why a dotA mutant of L. 
pneumophila strain Corby is being used as a negative control for all virulence assays 
(177). Costa et al (178) analyzed 300 dotA gene sequences from L. pneumophila 
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strains and demonstrated that pathogenic L. pneumophila strains belong to a subset 
of the genotypes existing in the environment. Khodr et al (101) explained the high 
variation of the dotA gene of L. pneumophila by indicating that this gene is a target for 
host speciation and adaptive evolution to different hosts and environments. Dumenil 
et al (179) showed that IcmR is a regulator gene for the IcmQ gene that possesses 
pore-forming activity. In addition, Gomez-Valero et al (180) demonstrated that dotB, 
IcmS and IcmW are highly conserved genes. These facts are in accordance with our 
results (Table A6 and Figure 31) showing that IcmR (91-96%), IcmS and dotB (99-
100%) and IcmQ (98-100%) were highly conserved gene while dotA had only a 78% to 
93% gene similarity for our L. pneumophila strains. Overall, the Dot/Icm system is a 
highly conserved and complex molecular system.  
4.10 Evolutionary scenarios explaining levels of diversity observed in 
virulence and other genes 
L. pneumophila shows large genome plasticity and possesses a highly dynamic 
accessory genome due to its peculiar evolutionary conditions as an internal parasite, 
its substantial horizontal gene transfer (HGT) and the presence of mobile genetic 
elements (92). Mobile genetic elements together with bacteriophages and plasmids 
are called integrative conjugative elements (181). Most of L. pneumophila mobile 
genetic elements are integrative conjugative elements encoding different T4SS which 
mainly consist of the L. pneumophila vir homologues regions (Lvh-region), the Trb/Tra 
family of conjugative elements and other genomic islands associated with the T4SS 
gene family. The Lvh-region consists of eleven genes encoding a T4SS and are located 
on DNA islands with high CG content (140, 182). The Lvh T4ASS is not present in L. 
pneumophila strain Corby, but a similar T4ASS is integrated in this site (tmRNA) and a 
second genomic island carrying a T4ASS is integrated in the tRNA gene, a site not 
occupied by a mobile genetic element in the strains Paris, Lens or Philadelphia (182).  
In addition to HGT, gene duplication contributes to the evolution of bacterial genomes 
(101). It is one of the main driving forces of genetic diversity, adaptation to specific 
environments and speciation. Four paralogues genes (sdeA, sdeB, sdeC and sdeE) are 
on example of gene duplication in the expanded Dot/Icm effector repertoire (40, 183). 
Khodr el al (101) summarized the distribution of integrative conjugative element and 
essential duplication genes present in L. pneumophila strain. These genomic elements 
could be observed in our study in the isolates A129_Gt64(74)_Ps, A156_Gt64(74)_Ps, 
H29_Gt22(100)_D, H34_Gt22(102)_D, H35_Gt22(102)_D, A193_Gt40(47)_Ps, 
A195_Gt40(47)_Ps and L04-545_Cl_Gt40(47)_D (Appendices A7-A9). In this study, 
most of the T4SS mobile genetic elements or duplication genes do not express a 
strong virulence phenotype. 
According to David et al (87) a certain local microevolution could be observed if 
isolates from the same site have been obtained at different times. Such a case of 
micro-evolution could have occurred in the set of isolates obtained from the HZI hot 
water supply. Strain H23_Gt14(30)_D of Gt14(30) has had more time to diversify by 
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genetic drift since it was isolated in 2013 in contrast to the isolates H1_Gt14(31)_D, 
H2_Gt14(31)_D, and H3_Gt14(31)_D obtained in 2009. It is also possible that L. 
pneumophila strain was subjected to different selection pressures during its life in the 
hot water supply system. If this is the case then a likely explanation is the harsh 
conditions in the hot water selected for changes in the metabolism of the isolates 
making them able to adapt to this environment (184). This selection process could 
make L. pneumophila more virulent because it adapted better to high temperature 
occurring in the human body. Differentiating between these putative evolutionary 
scenarios will be difficult and will require a greater understanding of the effect of 
diversity within hot water samples and isolates from this environment (Table 10). To 
this end, further genomic and metagenomics studies are needed using these materials 
collected during this time. 
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6. Appendices 
 
 
 
 
  
 
 
 
 
 106 
 
 Figure A1 UPGMA inferred from the clustering analysis of the MLVA-8(12) profiles of 180 L. pneumophila 
strains isolated from water and biofilm samples taken from the Al-Quds University campus and from 
eight hospitals along the West Bank. MLVA clusters (VACC) of three or more genotypes were defined 
using a cutoff of 60% of similarity and are shown with colors done by (97). 
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Collecti
on No.
Water 
Type
Physiochem parameter
 Hospital A 
(Jenin)
 Hospital B 
(Nablus) 
  Hospital C 
(Nablus)
 Hospital D 
(Ramallah)
  Hospital E 
(Jerusalem) 
 Hospital F 
(Bethlehem) 
Hospital G 
(Hebron)  
  Hospital H 
(Hebron) 
HPC (CFU/L) 37°C 1.40E+03 1.60E+03 2.56E+02 7.33E+04 1.50E+03 2.50E+04 1.53E+04 2.50E+03
HPC (CFU/L) 22°C 1.30E+03 1.67E+03 1.93E+02 3.33E+04 8.30E+02 2.30E+04 3.30E+03 2.00E+03
Leg.count (CFU/L) 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
Temprature °C 25 23.2 25.5 22.5 24 26.2 24.2 21.3
pH 7.6 7.8 8 7.6 7.82 7.8 7.6 7.8
Conductivity µS/cm 650 720 780 650 761 650 780 998
Total iron (Feᶧ³/Feᶧ²) mg/l 2 2 2 2 2 2 2 2
 chlorine Sensitive (Cl2) mg/l 5 0.5 0.5 0.1 0.1 0.5 0.1 0.1
Nitrate (NO3¯) mg/l 10 25 25 10 10 10 10 10
Nitrite (NO2¯) mg/l 0 0 0 0 0 0 0 0
Ammonia (NH3) mg/l 0.5 0.5 0.5 0.5 0 0.5 0.5 0.5
Copper (Cuᶧ/ᶧ²) mg/l 0 0 0 0 0 0 0 0
Phosphate (PO4³¯) mg/l 0 0 0 0 0 0 0 0
Zinc (Zn) mg/l 2 2 2 2 0 2 2 2
Turb (mg/l) 1.2 1.8 1.4 1.1
HCO3 (mg/l) 242 178 206 234
Chlorides CL (mg/l) 78 36 50 25
SO4 (mg/l) 21 15 20 19
Hardness (mg/l) 312 228 274 263
TDS (mg/l) 371 283 334 285
Flouride (mg/l) 0.2 0.2 0.2 0.2
Magnesium (mg/l) 34.0 39.5 38.0 39.5 35.5 25.0 32.0 33.5
Calcium (mg/l) 99.5 81.0 82.0 82.5 81.5 83.5 92.5 92.0
Ca/Mg ratio 2.9 2.1 2.2 2.1 2.3 3.3 2.9 2.7
% swab positive Com 100 100 100 100 100 100 100 100
% swab positive Lgsp 80 80 20 60 40 80 60 60
% swab positive L1 60 60 20 60 40 80 60 40
% swab positive Culture CIA 
subset 
0 60 0 20 0 60 20 40
%  positive Lpn PCR water 100 0 0 0 0 100 100 0
% Total positive CIA 
(L.pneumophila)  (W+B)
66.7 42.9 16.7 42.9 28.6 85.7 71.4 33.3
% positive swabs (culture 
Based)
0 20 0 0 0 20 5 10
% VACC1 0.0 9.4 0.0 0.0 0.0 0.0 2.9 33.3
% VACC2 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0
% VACC5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
% VACC11 0.0 3.1 0.0 0.0 0.0 6.3 0.0 0.0
% Gt4(17) 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0
% Gt6(18) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
% Gt10(93) 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0
% Gt13(72) 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0
% Gt9(92) 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0
 % Gt10(141) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
% Gt12(84) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
% Gt16(1) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
% Gt40(47) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
% Gt63(83) 0.0 3.1 0.0 0.0 0.0 0.0 0.0 33.3
% Gt64(74) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
HPC (CFU/L) 37°C NA 0.00E+00 NA NA 7.60E+02 9.34E+03 2.70E+04 NA
HPC (CFU/L) 22°C NA 0.00E+00 NA NA 6.33E+02 8.30E+03 4.30E+04 NA
Leg.count (CFU/L) NA 0.00E+00 NA NA 0.00E+00 0.00E+00 0.00E+00 NA
Temprature °C NA 70.9 NA NA 47.4 44.8 42.7 NA
pH NA 7.6 NA NA 7.9 7.8 7.6 NA
Conductivity µS/cm NA 701 NA NA 781 630 799 NA
Table A1 (Part 2): Detailed data collection on sampling per site and sampling campaign 
0.2 0.2
Hot 
Water
14 30
296 273
320 410
2nd 
(Mar-
May 
2013)
Cold 
Water
1.6 1.1
180 197
55 58
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Collecti
on No.
Water 
Type
Physiochem parameter
 Hospital A 
(Jenin)
 Hospital B 
(Nablus) 
  Hospital C 
(Nablus)
 Hospital D 
(Ramallah)
  Hospital E 
(Jerusalem) 
 Hospital F 
(Bethlehem) 
Hospital G 
(Hebron)  
  Hospital H 
(Hebron) 
HPC (CFU/L) 37°C 3.70E+04 4.60E+04 8.50E+03 2.47E+05 1.50E+04 1.50E+05 3.70E+04 4.50E+04
HPC (CFU/L) 22°C 1.00E+04 2.13E+04 8.00E+03 2.11E+05 8.30E+03 1.03E+05 3.00E+04 2.00E+04
Leg.count (CFU/L) 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 4.67E+02 0.00E+00 0.00E+00
Temprature °C 26.6 25.5 26.2 25.3 33.6 27 22 23.1
pH 8 7.9 8 7.6 7.6 7.6 7.6 7.8
Conductivity µS/cm 628 720 743 650 734 620 780 898
Total iron (Feᶧ³/Feᶧ²) mg/l 2 2 2 2 2 2 2 2
 chlorine Sensitive (Cl2) mg/l 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
Nitrate (NO3¯) mg/l 10 10 25 10 0 10 10 10
Nitrite (NO2¯) mg/l 0 0 0 0 0 0 0 0
Ammonia (NH3) mg/l 0.5 0.5 0.5 0.5 0.5 0 0.5 0.5
Copper (Cuᶧ/ᶧ²) mg/l 0 0 0 0 0 0 0 0
Phosphate (PO4³¯) mg/l 0 0 0 0 0 0 0 0
Zinc (Zn) mg/l 0 0 0 0 0 0 0 0
Turb (mg/l) 1.3 2.0 1.6 1.4
HCO3 (mg/l) 243 175 202 217
Chlorides CL (mg/l) 89 34 52 23
SO4 (mg/l) 26 16 19 14
Hardness (mg/l) 270 207 261 264
TDS (mg/l) 325 301 319 285
Flouride (mg/l) NA NA 0.2 0.17
Magnesium (mg/l) 35 40 38 39 36 22 30 31
Calcium (mg/l) 96 84 85 81 81 80 94 94
Ca/Mg ratio 2.74 2.10 2.24 2.08 2.25 3.64 3.13 3.03
% swab positive Com 100 100 100 100 100 100 100 100
% swab positive Lgsp 80 60 40 60 40 100 100 80
% swab positive L1 80 60 20 60 20 100 100 60
% swab positive Culture CIA 
subset 
0 20 0 20 0 100 0 0
%  positive Lpn PCR water 100 50 0 50 0 100 100 0
% Total positive CIA 
(L.pneumophila ) (W+B)
83.3 57.1 16.7 57.1 14.3 100.0 100.0 50.0
% positive swabs (culture 
Based)
10 10 0 5 0 60 0 0
% VACC1 0.00 6.25 0.00 5.56 0.00 3.13 0.00 0.00
% VACC2 0.00 0.00 0.00 0.00 0.00 3.13 0.00 0.00
% VACC5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
% VACC11 0.00 0.00 0.00 0.00 0.00 21.88 0.00 0.00
% Gt4(17) 0.00 6.25 0.00 5.56 0.00 3.13 0.00 0.00
% Gt6(18) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
% Gt10(93) 0.00 0.00 0.00 0.00 0.00 12.50 0.00 0.00
% Gt13(72) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
% Gt9(92) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
 % Gt10(141) 0.00 0.00 0.00 0.00 0.00 6.25 0.00 0.00
% Gt12(84) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
% Gt16(1) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
% Gt40(47) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
% Gt63(83) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
% Gt64(74) 0.00 0.00 0.00 0.00 0.00 3.13 0.00 0.00
HPC (CFU/L) 37°C NA 0.00E+00 NA 6.08E+05 7.70E+03 6.56E+05 2.70E+04 NA
HPC (CFU/L) 22°C NA 0.00E+00 NA 6.10E+05 6.33E+03 2.00E+05 4.30E+04 NA
Leg.count (CFU/L) NA 0.00E+00 NA 0.00E+00 0.00E+00 5.08E+02 0.00E+00 NA
Temprature °C NA 55.6 NA 43.2 49.7 40.3 42.7 NA
pH NA 8 NA 7.7 7.6 7.8 7.6 NA
Conductivity µS/cm NA 758 NA 678 786 697 799 NA
Table A1 (Part 3): Detailed data collection on sampling per site and sampling campaign 
329 356
0.17 0.2
Hot 
Water
53 60
16 26
320 246
3rd 
(Jun-
Aug 
2013)
Cold 
Water
1.8 1.3
183 192
 
 110 
 
Collecti
on No.
Water 
Type
Physiochem parameter
 Hospital A 
(Jenin)
 Hospital B 
(Nablus) 
  Hospital C 
(Nablus)
 Hospital D 
(Ramallah)
  Hospital E 
(Jerusalem) 
 Hospital F 
(Bethlehem) 
Hospital G 
(Hebron)  
  Hospital H 
(Hebron) 
HPC (CFU/L) 37°C 6.60E+03 5.00E+03 6.50E+03 NA 1.60E+03 5.33E+03 8.33E+03 1.35E+04
HPC (CFU/L) 22°C 3.30E+03 2.33E+03 4.00E+03 NA 1.00E+03 1.10E+03 6.60E+03 1.60E+03
Leg.count (CFU/L) 0.00E+00 0.00E+00 0.00E+00 NA 0.00E+00 0.00E+00 0.00E+00 0.00E+00
Temprature °C 21.6 26.2 21.4 NA 23.1 21.2 19.1 20.5
pH 7.7 8.2 7.97 NA 8 7.98 8.1 7.9
Conductivity µS/cm 860 560 653 NA 595 421 447 578
Total iron (Feᶧ³/Feᶧ²) mg/l 2 0 2 NA 0 2 0 0
 chlorine Sensitive (Cl2) mg/l 0.5 0.5 0.5 NA 0.1 0.5 10 0.5
Nitrate (NO3¯) mg/l 10 0 0 NA 0 10 10 10
Nitrite (NO2¯) mg/l 0 0 0 NA 0 0 0 0
Ammonia (NH3) mg/l 0.5 0.5 0.5 NA 0 0.5 0 0
Copper (Cuᶧ/ᶧ²) mg/l 0 0 0 NA 0 0 0 0
Phosphate (PO4³¯) mg/l 0 0 0 NA 0 0 0 0
Zinc (Zn) mg/l 0 0 0 NA 0 0 2 2
Turb (mg/l) 1.3 NA 1.4 1.4
HCO3 (mg/l) 230 NA 197 219
Chlorides CL (mg/l) 99 NA 56 26
SO4 (mg/l) 25 NA 20 12
Hardness (mg/l) 269 NA 260 260
TDS (mg/l) 358 NA 325 283
Flouride (mg/l) 0.2 NA 0.2 0.2
Magnesium (mg/l) 34.0 38.5 38.0 NA 33.5 21.0 29.0 31.5
Calcium (mg/l) 96.5 84.5 83.5 NA 82.0 78.5 91.5 93.5
Ca/Mg ratio 2.8 2.2 2.2 NA 2.4 3.7 3.2 3.0
% swab positive Com 100 100 100 NA 100 100 100 100
% swab positive Lgsp 60 80 40 NA 80 80 100 80
% swab positive L1 40 80 20 NA 80 80 100 60
% swab positive Culture CIA 
subset 
0 80 0 NA 60 60 100 0
%  positive Lpn PCR water 100 0 0 NA 0 100 100 0
% Total positive CIA 
(L.pneumophila ) (W+B)
50.0 57.1 16.7 NA 57.1 85.7 100.0 50.0
% positive swabs (culture 
Based)
0 30 0 NA 15 15 30 0
% VACC1 0.0 12.5 0.0 NA 20.0 0.0 17.6 0.0
% VACC2 0.0 0.0 0.0 NA 10.0 3.1 0.0 0.0
% VACC5 0.0 0.0 0.0 NA 0.0 0.0 0.0 0.0
% VACC11 0.0 3.1 0.0 NA 0.0 6.3 0.0 0.0
% Gt4(17) 0.0 12.5 0.0 NA 0.0 0.0 0.0 0.0
% Gt6(18) 0.0 0.0 0.0 NA 0.0 0.0 17.6 0.0
% Gt10(93) 0.0 0.0 0.0 NA 0.0 6.3 0.0 0.0
% Gt13(72) 0.0 0.0 0.0 NA 0.0 0.0 0.0 0.0
% Gt9(92) 0.0 3.1 0.0 NA 0.0 0.0 0.0 0.0
 % Gt10(141) 0.0 0.0 0.0 NA 0.0 0.0 0.0 0.0
% Gt12(84) 0.0 0.0 0.0 NA 0.0 0.0 0.0 0.0
% Gt16(1) 0.0 0.0 0.0 NA 0.0 0.0 0.0 0.0
% Gt40(47) 0.0 0.0 0.0 NA 0.0 0.0 0.0 0.0
% Gt63(83) 0.0 0.0 0.0 NA 0.0 0.0 0.0 0.0
% Gt64(74) 0.0 0.0 0.0 NA 0.0 3.1 0.0 0.0
HPC (CFU/l) 37C NA 4.70E+04 NA NA 8.70E+04 1.30E+04 1.00E+03 NA
HPC (CFU/l) 22C NA 1.73E+04 NA NA 1.16E+03 1.30E+03 3.16E+03 NA
Leg.count (CFU/L) NA 0.00E+00 NA NA 0.00E+00 0.00E+00 0.00E+00 NA
Temprature °C NA 38.8 NA NA 39.8 41.8 47.6 NA
pH NA 8.0 NA NA 7.9 7.9 8.1 NA
Conductivity µS/cm NA 680 NA NA 754 473 367 NA
Table A1 (Part 4): Detailed data collection on sampling per site and sampling campaign 
Hot 
Water
308 254
327 371
0.2 0.2
4th 
(Mar-
May 
2014)
Cold 
Water
1.6 1.0
181 198
51 63
14 32
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Collecti
on No.
Water 
Type
Physiochem parameter
 Hospital A 
(Jenin)
 Hospital B 
(Nablus) 
  Hospital C 
(Nablus)
 Hospital D 
(Ramallah)
  Hospital E 
(Jerusalem) 
 Hospital F 
(Bethlehem) 
Hospital G 
(Hebron)  
  Hospital H 
(Hebron) 
HPC (CFU/l) 37°C 3.00E+04 5.03E+04 5.40E+04 NA 2.00E+04 2.07E+04 4.00E+04 6.30E+04
HPC (CFU/l) 22°C 1.60E+03 3.76E+04 5.30E+04 NA 6.60E+02 1.83E+04 1.90E+04 2.20E+04
Leg.count (CFU/L) 0.00E+00 0.00E+00 0.00E+00 NA 0.00E+00 4.21E+02 0.00E+00 0.00E+00
Temprature °C 23.6 26.2 21.4 NA 29.1 27.5 25 20.1
pH 7.7 8.2 8.0 NA 8.4 7.7 8.1 7.7
Conductivity µS/cm 984 560 653 NA 737 615 681 607
Total iron (Feᶧ³/Feᶧ²) mg/l 2 0 2 NA 0 2 0 0
 chlorine Sensitive (Cl2) mg/l 1 0.5 0.5 NA 0.1 0.5 1 0.5
Nitrate (NO3¯) mg/l 10 0 0 NA 0 10 10 10
Nitrite (NO2¯) mg/l 0 0 0 NA 0 0 0 0
Ammonia (NH3) mg/l 0.5 0.5 0.5 NA 0 0.5 0 0
Copper (Cuᶧ/ᶧ²) mg/l 0 0 0 NA 0 0 0 0
Phosphate (PO4³¯) mg/l 0 0 0 NA 0 0 0 0
Zinc (Zn) mg/l 0 0 0 NA 0 0 2 0
Turb (mg/l) 1.3 NA 1.2 1.3
HCO3 (mg/l) 217.4 NA 192.7 220.6
Chlorides CL (mg/l) 108.0 NA 59.3 29.6
SO4 (mg/l) 24.3 NA 20.2 11.3
Hardness (mg/l) 266.8 NA 258.6 256.5
TDS (mg/l) 390.7 NA 331.8 281.2
Flouride (mg/l) 0.2 NA 0.2 0.2
Magnesium (mg/l) 34.0 38.0 38.0 NA 33.0 21.0 29.0 32.0
Calcium (mg/l) 94.0 85.0 82.0 NA 83.0 78.0 91.0 95.0
Ca/Mg ratio 2.8 2.2 2.2 NA 2.5 3.7 3.1 3.0
% swab positive Com 100 100 100 NA 100 100 100 100
% swab positive Lgsp 80 80 80 NA 60 100 100 80
% swab positive L1 60 60 80 NA 60 100 100 80
% swab positive Culture CIA 
subset 
0 20 40 NA 0 60 40 0
%  positive Lpn PCR water 0 100 100 NA 0 100 100 100
% Total positive CIA 
(L.pneumophila ) (W+B)
50 71.42857 83.333333 NA 42.857143 100 100 83.3333333
% positive swabs (culture 
Based)
0 15 0 NA 0 65 35 0
% VACC1 0.0 3.1 0.0 NA 0.0 6.3 17.6 0.0
% VACC2 0.0 0.0 0.0 NA 0.0 3.1 0.0 0.0
% VACC5 0.0 0.0 0.0 NA 0.0 0.0 2.9 0.0
% VACC11 0.0 0.0 0.0 NA 0.0 18.8 0.0 0.0
% Gt4(17) 0.0 3.1 0.0 NA 0.0 6.3 0.0 0.0
% Gt6(18) 0.0 0.0 0.0 NA 0.0 0.0 17.6 0.0
% Gt10(93) 0.0 0.0 0.0 NA 0.0 6.3 0.0 0.0
% Gt13(72) 0.0 0.0 0.0 NA 0.0 0.0 0.0 0.0
% Gt9(92) 0.0 0.0 0.0 NA 0.0 0.0 0.0 0.0
 % Gt10(141) 0.0 0.0 0.0 NA 0.0 12.5 0.0 0.0
% Gt12(84) 0.0 0.0 0.0 NA 0.0 0.0 0.0 0.0
% Gt16(1) 0.0 0.0 0.0 NA 0.0 0.0 0.0 0.0
% Gt40(47) 0.00 0.00 0.00 NA 0.00 0.0 0.00 0.00
% Gt63(83) 0.00 0.00 0.00 NA 0.00 0.0 0.00 0.00
% Gt64(74) 0.00 0.00 0.00 NA 0.00 3.1 0.00 0.00
HPC (CFU/L) 37°C NA 6.70E+04 NA NA 4.40E+03 3.70E+04 2.47E+04 NA
HPC (CFU/L) 22°C NA 3.37E+04 NA NA 2.00E+03 4.60E+03 2.80E+04 NA
Leg.count (CFU/L) NA 0.00E+00 NA NA 0.00E+00 0.00E+00 0.00E+00 NA
Temprature °C NA 38.8 NA NA 54.2 37.3 33.7 NA
pH NA 8.0 NA NA 7.6 8.1 8.1 NA
Conductivity µS/cm NA 680 NA NA 708 615 661 NA
Table A1 (Part 5): Detailed data collection on sampling per site and sampling campaign 
0.2 0.2
Hot 
Water
12.8 37.5
297.0 262.0
325.0 387.0
5th 
(Jun-
Aug 
2014)
Cold 
Water
1.4 0.7
179.4 205.0
48.2 66.0
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Collecti
on No.
Water 
Type
Physiochem parameter
 Hospital A 
(Jenin)
 Hospital B 
(Nablus) 
  Hospital C 
(Nablus)
 Hospital D 
(Ramallah)
  Hospital E 
(Jerusalem) 
 Hospital F 
(Bethlehem) 
Hospital G 
(Hebron)  
  Hospital H 
(Hebron) 
HPC (CFU/L) 37°C 1.33E+04 1.00E+04 1.67E+04 NA 1.00E+04 4.00E+04 1.33E+04 3.30E+03
HPC (CFU/L) 22°C 8.40E+03 1.67E+04 1.20E+04 NA 3.30E+04 4.40E+04 1.10E+04 2.70E+03
Leg.count (CFU/L) 0.00E+00 0.00E+00 0.00E+00 NA 0.00E+00 0.00E+00 0.00E+00 0.00E+00
Temprature °C 20.3 23.8 23.7 NA 19.8 20.8 30.7 29.9
pH 7.6 8.2 8.0 NA 7.8 8.0 8.2 8.1
Conductivity µS/cm 913 560 653 NA 595 421 400 542
Total iron (Feᶧ³/Feᶧ²) mg/l 2 0 2 NA 0 2 0 0
 chlorine Sensitive (Cl2) mg/l 0.5 0.5 0.5 NA 0.1 0.5 10 0.5
Nitrate (NO3¯) mg/l 0 0 0 NA 0 10 10 10
Nitrite (NO2¯) mg/l 0 0 0 NA 0 0 0 0
Ammonia (NH3) mg/l 0 0.5 0.5 NA 0 0.5 0 0
Copper (Cuᶧ/ᶧ²) mg/l 0 0 0 NA 0 0 0 0
Phosphate (PO4³¯) mg/l 0 0 0 NA 0 0 0 0
Zinc (Zn) mg/l 0 0 0 NA 0 0 2 2
Turb (mg/l) 1.3 NA 1.3 1.3
HCO3 (mg/l) 224 NA 206 220
Chlorides CL (mg/l) 103 NA 61 28
SO4 (mg/l) 25 NA 21 12
Hardness (mg/l) 268 NA 272 258
TDS (mg/l) 374 NA 340 282
Flouride (mg/l) 0.2 NA 0.2 0.2
Magnesium (mg/l) 31 37 38 NA 34 29 30 32
Calcium (mg/l) 88 79 82 NA 75 84 96 95
Ca/Mg ratio 2.84 2.14 2.16 NA 2.21 2.90 3.20 2.97
swab % positive Com 100 100 100 NA 100 100 100 100
swab % positive Lgsp 100 80 60 NA 60 100 100 60
swab % positive L1 100 60 60 NA 60 80 100 40
swab% positive Culture CIA 
subset 
100 60 40 NA 40 60 100 40
%  positive Lpn PCR water 0 0 0 NA 0 100 100 0
% Total positive CIA 
(L.pneumophila ) (W+B)
83.3 42.9 50.0 NA 42.9 85.7 100.0 33.3
% positive swabs (culture 
Based)
30 15 10 NA 10 15 50 15
% VACC1 21.4 3.1 40.0 NA 0.0 3.1 26.5 0.0
% VACC2 0.0 0.0 0.0 NA 20.0 0.0 0.0 0.0
% VACC5 0.0 0.0 0.0 NA 0.0 0.0 0.0 50.0
% VACC11 0.0 6.3 0.0 NA 0.0 9.4 0.0 0.0
% Gt4(17) 21.4 3.1 40.0 NA 0.0 3.1 0.0 0.0
% Gt6(18) 0.0 0.0 0.0 NA 0.0 0.0 26.5 0.0
% Gt10(93) 0.0 0.0 0.0 NA 0.0 9.4 0.0 0.0
% Gt13(72) 0.0 0.0 0.0 NA 0.0 0.0 0.0 0.0
% Gt9(92) 0.0 6.3 0.0 NA 0.0 0.0 0.0 0.0
 % Gt10(141) 0.0 0.0 0.0 NA 0.0 0.0 0.0 0.0
% Gt12(84) 0.0 0.0 0.0 NA 0.0 0.0 0.0 0.0
% Gt16(1) 0.0 0.0 0.0 NA 0.0 0.0 0.0 0.0
% Gt40(47) 0.0 0.0 0.0 NA 0.0 0.0 0.0 50.0
% Gt63(83) 0.0 0.0 0.0 NA 0.0 0.0 0.0 0.0
% Gt64(74) 0.0 0.0 0.0 NA 0.0 0.0 0.0 0.0
HPC (CFU/L) 37°C NA 1.67E+04 NA NA 2.06E+03 3.70E+04 3.33E+04 NA
HPC (CFU/L) 22°C NA 1.33E+04 NA NA 3.30E+03 4.60E+03 1.47E+04 NA
Leg.count (CFU/L) NA 0.00E+00 NA NA 0.00E+00 0.00E+00 0.00E+00 NA
Temprature °C NA 36.3 NA NA 44.8 44.3 30.7 NA
pH NA 8.0 NA NA 8 7.9 8.5 NA
Conductivity µS/cm NA 680 NA NA 754 672 400 NA
Table A1 (Part 6): Detailed data collection on sampling per site and sampling campaign 
326 379
Hot 
Water
49 65
14 35
303 258
6th 
(Oct-
Dec 
2014)
Cold 
Water
1.5 0.9
180 202
0.2 0.2
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Parameter Genotype Gt4(17) Gt6(18) Gt10(93) Gt13(72) Gt9(92) Gt10(141) Gt16(1) Gt40(47) Gt64(74) Gt63(83)
Gt4(17)
Gt6(18) NS
Gt10(93) * *
Gt13(72) NS NS NS
Gt9(92) *** *** ** NS
Gt10(141) *** *** ** *** ***
Gt16(1) *** *** NS ** *** ***
Gt40(47) *** *** ** NS *** *** ***
Gt64(74) ** NS NS NS NS NS NS NS
Gt63(83) *** *** ** NS *** *** *** NS NS
Gt4(17)
Gt6(18) ***
Gt10(93) * ***
Gt13(72) NS *** NS
Gt9(92) NS *** * NS
Gt10(141) * *** NS NS NS
Gt16(1) *** *** * ** ** ***
Gt40(47) *** NS ** *** ** *** *
Gt64(74) NS *** NS NS NS NS ** **
Gt63(83) NS NS NS NS NS NS NS NS NS
Gt4(17)
Gt6(18) *
Gt10(93) *** ***
Gt13(72) NS NS **
Gt9(92) NS ** *** NS
Gt10(141) ** *** NS ** ***
Gt16(1) NS * *** NS *** ***
Gt40(47) *** ** *** NS *** *** NS
Gt64(74) * *** NS * *** NS *** ***
Gt63(83) NS NS *** NS NS *** NS NS **
Gt4(17)
Gt6(18) ***
Gt10(93) NS ***
Gt13(72) NS *** *
Gt9(92) NS *** NS NS
Gt10(141) ** *** NS *** *
Gt16(1) * *** ** NS NS ***
Gt40(47) *** ** NS ** * *** NS
Gt64(74) NS *** ** ** NS NS * *
Gt63(83) NS ** NS NS NS ** NS NS NS
Gt4(17)
Gt6(18) ***
Gt10(93) ** ***
Gt13(72) NS * NS
Gt9(92) NS ** *** NS
Gt10(141) *** *** * NS **
Gt16(1) *** NS *** ** ** ***
Gt40(47) *** ** *** NS NS *** *
Gt64(74) NS *** NS NS NS NS *** **
Gt63(83) NS NS NS NS NS * * NS *
Gt4(17)
Gt6(18) ***
Gt10(93) *** ***
Gt13(72) NS * ***
Gt9(92) * *** *** NS
Gt10(141) *** *** NS *** ***
Gt16(1) * ** *** ** *** ***
Gt40(47) *** NS * * *** *** *
Gt64(74) ** *** NS ** *** NS *** **
Gt63(83) NS ** *** NS NS * NS NS **
Gt4(17)
Gt6(18) ***
Gt10(93) * ***
Gt13(72) NS NS NS
Gt9(92) NS *** NS *
Gt10(141) * *** * ** NS
Gt16(1) ** * *** * *** ***
Gt40(47) *** *** *** NS *** *** NS
Gt64(74) NS *** NS NS NS NS *** ***
Gt63(83) NS NS * NS * NS NS NS NS
Gt4(17)
Gt6(18) ***
Gt10(93) *** *
Gt13(72) NS * ***
Gt9(92) NS *** *** *
Gt10(141) *** *** ** *** ***
Gt16(1) *** NS * NS *** ***
Gt40(47) *** *** *** NS *** *** NS
Gt64(74) *** *** NS ** *** NS *** *
Gt63(83) NS ** * NS NS *** * NS **
Mg (mg/l)
Ca (mg/l)
Ca/Mg 
ratio
Legend: Independent t-test *: P<0.05 , **:P<0.01 , ***:P<0.001 , NA: Not Avaliable and NS: Non significant. Group A: Green, group 
B: Red and group C: Blue. Significant marks highlighted light green: for genotypes from different groups and red: for genotypes 
Table A2: Genotype niches summary matrix gentype by genotype. 
Leg.count 
(CFU/L) in 
water
Turb 
(mg/l)
Chloride 
Cl (mg/l)
SO4 
(mg/l)
TDS 
(mg/l)
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Table A3: Main features of L. pneumophila isolates and reference strains used in the study.        
Strain 
designation 
Reference 
No: 
Sg (mAb)¹ ST² MLVA-
8(12)³ 
VACC³ Site of 
Isolation  
Year of 
Isolation 
Source of 
isolation 
Genome 
Size (bp) 
No. of 
Genes 
Genomic 
Islands 
(bp)  
Geno
mic 
Island
s (%) 
CDS* Con
tigs 
Reason for selection 
Lpn-LPE509 CP003886 NA NA NA NA Shanghai, 
China 
2013 Hospital water 3,434,224 3,105 NA NA 3,055 1 Already published 
Lpn-
Philadelphia
1 
NC_002942 1 
Philadelphia        
ST36 Gt 64 
(74)    
VACC2   Philadelphia, 
USA 
1974 Clinical sample 3,397,754 2,943 180,555 5.3 3,023 1 Type strain- well 
characterized/ cause 
Philadelphia 
outbreak/ Already 
published 
Lpn-
Thunderbay 
 CP003730 Sg.6 ST18
7 
NA NA Thunderbay, 
Canada 
Unknow
n 
Clinical sample 3,455,167 2,998 NA NA 3,116 1 Already published 
Lpn-
ATCC43290 
CP003192.1 Sg.12 ST18
7 
NA NA USA 1987 Clinical sample 3,359,001 2,926 NA NA 2,993 1 Already published 
Lpn-
lpm7613 
NZ_LT59865
7, 
NZ_LT59865
8 
NA NA NA NA NA 2000 Clinical sample 3,261,562 2,944 NA NA 2,894 1 Already published 
Lpn-Lens GCA_000048
665.1 
Sg.1 ST15 NA NA France 2004 Clinical sample 3,345,687 3,004 180,986 5.4 2,956 1 Caused a big outbreak 
in France/ already 
published 
Lpn-Lorraine  FQ958210 Sg.1 ST47 NA NA France 2004 Clinical sample 3,467,254 3,069 0 0 3,130 1 In top six strains that 
cause disease/ already 
published 
Lpn-
HL06041035 
FQ958211.1 NA NA NA NA France 2006 Hospital water 3,492,535 3,184 NA NA 3,113 1 Already published 
Lpn-D7631 CP015343 Sg.1 ST73
1 
NA NA NYC, USA 2012 Environmental 
sample 
3,436,178 3,090 NA NA 3,040 1 Already published 
Lpn-D7630 CP015344 Sg.1 ST731 NA NA NYC, USA 2012 Clinical sample 3,444,702 3,097 NA NA 3,047 1 Already published 
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Lpn-D7632 CP015342 Sg.1 ST73
1 
NA NA NYC, USA 2012 Clinical sample 3,435,648 3,087 NA NA 3,037 1 Already published 
Lpn-Paris CIP107629 1 
Philadelphia        
ST1 Gt 4 (17)     VACC1 Paris, France 2004 Clinical sample 3,503,610 3,224 163,637 4.7 3,101 1 Worldwide 
distributed/ already 
published/ manually 
annonated  
Lpn-OLDA CP016030 1 OLDA ST1 NA NA USA 1947 Frozen cell 
culture 
3,486,108 3,144 0 0 3,094 1 already published 
Lpn-Pontiac CP016029 1 OLDA NA NA NA Michigan, 
USA  
1968 Sporadic LD case 3,545,001 3,224 NA NA 3,174 1 Already published 
Lpn-Toronto CP012019.1 NA NA NA NA Toronto, 
Canada 
2005 Clinical sample 3,573,898 3,269 NA NA 3,187 1 Already published 
Lpn-Alcoy 
2300/99 
CP001828 Sg.1 ST57
8 
NA NA Alcoy, Spain 1999 Clinical sample 3,516,334 3,190 157,442 4.5 NA 1 Caused big outbreak 
in Spain/ already 
published/ manually 
annotated 
Lpn-Corby CP000675 1 Knoxville           ST16
85 or 
ST51 
Gt 86 
(97)    
NA UK 1985 Clinical sample 3,576,470 3,204 217,089 6.1 NA 1 already 
published/manually 
annotated 
A156_Gt64(
74)_Ps 
0 6 Dresden             ST74 Gt 64 
(74)    
VACC2   Beit Jala, 
Palestine 
2013 Hopital 
environmental 
swab 
3,366,323 3,049 174,331 5.2 3008 40 Thunderbay branch 
A129_Gt64(
74)_Ps 
0 6 Dresden             ST74 Gt 64 
(74)    
VACC2   Beit Jala, 
Palestine 
2012 Hopital 
environmental 
swab 
3,527,232 3,206 293,904 8.3 3166 56 Thunderbay branch 
A15_Gt12(8
4)_Ps 
0 Sg.8 ST 
1358 
Gt 12 
(84)    
NA Jerusalem, 
Palestine 
2012 Hopital 
environmental 
swab 
3,495,260 3,088 180,013 5.2 3,053 127 Lorraine brach 
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A139_Gt4(1
7)_Ps 
0 Sg.1 ST1 Gt 4 (17)     VACC1 Nablus, 
Palestine 
2012 Hopital 
environmental 
swab 
3,579,958 3,242 223,851 6.3 3,205 78 Worldwide present 
and highest 
abundance in our 
collections 
A5_Gt4(17)_
Ps 
0 1 OLDA ST1 Gt 4 (17)     VACC1 Jerusalem, 
Palestine 
2012 Hopital 
environmental 
swab 
3,586,669 3,249 225,997 6.3 3,211 80 Worldwide present 
and highest 
abundance in our 
collections 
A29_Gt6(18)
_Ps 
0 Sg.1 ST1 Gt 6 (18)     VACC1 Hebron, 
Palestine 
2012 Hopital 
environmental 
swab 
3,626,550 3,289 339,005 9.3 3,251 68 Dominant in southern 
West Bank 
A131_Gt6(1
8)_Ps 
0 Sg.1 ST1 Gt 6 (18)     VACC1 Hebron, 
Palestine 
2012 Hopital 
environmental 
swab 
3,548,746 3,206 281,219 7.9 3,169 67 Dominant in southern 
West Bank 
A193_Gt40(
47)_Ps 
0 6 Dresden             ST34
5  
Gt 40 
(47)    
VACC5   Hebron, 
Palestine 
2014 Hopital 
environmental 
swab 
3,446,379 3,098 185,152 5.4 3,056 33 Alcoy branch, close to 
Warstein outbreak 
A194_Gt40(
47)_Ps 
0 6 Dresden             ST34
5  
Gt 40 
(47)    
VACC5   Hebron, 
Palestine 
2014 Hopital 
environmental 
swab 
3,467,907 3,121 156,728 4.5 3,071 1 Alcoy branch, close to 
Warstein outbreak 
A195_Gt40(
47)_Ps 
0 6 Dresden             ST34
5  
Gt 40 
(47)    
VACC5   Hebron, 
Palestine 
2014 Hopital 
environmental 
swab 
3,440,802 3,095 167,241 4.9 3,051 42 Alcoy branch, close to 
Warstein outbreak 
A138_Gt9(9
2)_Ps 
0 6 Dresden             ST46
1 
Gt 9 (92)     VACC11  Nablus, 
Palestine 
2014 Hopital 
environmental 
swab 
3,363,143 3,038 162,571 4.8 2,996 40 Alcoy branch 
A112_Gt10(
93)_Ps 
0 6 Dresden             ST46
1 
Gt 10 
(93)    
VACC11  Beit Jala, 
Palestine 
2013 Hopital 
environmental 
swab 
3,362,286 3,030 147,968 4.4 2,990 42 Highly abundant 
genotype 
A114_Gt10(
93)_Ps 
0 6 Dresden             ST46
1 
Gt 10 
(93)    
VACC11  Beit Jala, 
Palestine 
2013 Hospital hot 
water sample 
3,362,313 3,033 159,647 4.7 2,989 41 Highly abundant 
genotype 
 117 
 
A127_Gt10(
93)_Ps 
0 6 Dresden             ST46
1 
Gt 10 
(93)    
VACC11  Beit Jala, 
Palestine 
2013 Hopital 
environmental 
swab 
3,363,025 3,037 142,978 4.3 2,993 38 Highly abundant 
genotype 
A108_Gt10(
93)_Ps 
0 6 Dresden             St46
1 
Gt 10 
(93)    
VACC11  Beit Jala, 
Palestine 
2013 Hopital 
environmental 
swab 
3,291,620 2,949 153,342 4.7 2,907 38 Highly abundant 
genotype 
A166_Gt8(1
42)_Ps 
0 Sg.(2-14)                ST14
82 
Gt 8 
(142)    
VACC5   Hebron, 
Palestine 
2014 Hopital 
environmental 
swab 
3,353,128 3,014 204,232 6.1 2,974 28 Alcoy branch 
H34_Gt22(1
02)_D 
0 Sg.10 NA Gt 22 
(102)   
 Braunschwei
g, Germany 
2013 Environmental 
sample 
3,403,136 3,049 160,329 4.7 3,016 64 D7630 branch 
H29_Gt22(1
00)_D 
0 4 Portland            NA Gt 22 
(100)   
VACC2 Braunschwei
g, Germany 
2013 Environmental 
sample 
3,403,391 3,061 144,415 4.2 3,017 68 D7630 branch 
H35_Gt22(1
02)_D 
0 Sg.1 NA Gt 22 
(102)   
VACC5 Braunschwei
g, Germany 
2013 Environmental 
sample 
3,402,267 3,049 166,533 4.9 3,013 64 D7630 branch 
H39_Gt4(17)
_D 
0 4 Portland            NA Gt 4 (17)     NA Braunschwei
g, Germany 
2014 Environmental 
sample 
3,592,274 3,245 226,268 6.3 3,202 78 Worldwide present 
and highest 
abundance in our 
collections 
H3_Gt14(31)
_D 
0 6 Chicago             ST14
31 
Gt 14 
(31)    
VACC2 Braunschwei
g, Germany 
2009 Environmental 
sample 
3,691,263 3,386 209,867 5.7 3,336 2 Alcoy branch 
H23_Gt14(3
0)_D 
0 6 Chicago             ST14
31 
Gt 14 
(30)    
VACC2 Braunschwei
g, Germany 
2013 Environmental 
sample 
3,783,853 3,482 372,750 9.9 3,444 130 Alcoy branch 
H1_Gt14(31)
_D 
0 6 Chicago             ST14
31 
Gt 14 
(31)    
VACC2 Braunschwei
g, Germany 
2009 Environmental 
sample 
3,654,038 3,355 253,073 6.9 3,312 69 Alcoy branch 
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H2_Gt14(31)
_D 
0 6 Chicago             ST14
31 
Gt 14 
(31)    
VACC2 Braunschwei
g, Germany 
2009 Environmental 
sample 
3,650,216 3,347 238,649 6.5 3,310 64 Alcoy branch 
L09-
313_Cl_Gt84
(116)_D 
0 Sg.3 ST93 Gt 84 
(116)   
VACC13 Freiburg, 
Germany 
2009 Clinical sample 3,398,240 3,068 160,181 4.7 3,027 58 Thunderbay branch 
L01-
443_Cl_Gt64
(74)_D 
0 1 Knoxville           ST9 Gt 64 
(74)    
VACC13 Herford, 
Germany 
2001 Clinical sample 3,477,581 3,142 225,639 6.5 3,099 103 Thunderbay branch 
L10-
091_Cl_Gt69
(69)_D 
0 1 
Philadelphia        
ST43
5 
Gt 69 
(69)    
VACC2 Erlangen, 
Germany 
2010 Clinical sample 3,687,459 3,373 187,440 5.1 3,330 97 Pontiac Branch 
L12-
317_Cl_Gt72
(66)_D 
0 1 Knoxville           ST44
4 
Gt 72 
(66)    
VACC2 Lorrach, 
Germany                            
2012 Clinical sample 3,516,737 3,170 186,733 5.3 3,133 74 Pontiac Branch 
L11-
209_Cl_Gt29
(27)_D 
0 1 Knoxville           ST62 Gt 29 
(27)    
VACC2 Hannover, 
Germany 
2011 Clinical sample 3,461,996 3,130 96,408 2.8 3,085 65 Pontiac Branch 
L10-
023_Cl_Gt75
(49)_D 
0 1 Knoxville           ST62 Gt 75 
(49)    
VACC2 Ulm, 
Germany 
2010 Clinical sample 3,641,882 3,427 NA NA 3,377 1 Pontiac Branch 
L09-
329_Cl_Gt75
(49)_D 
0 1 
Philadelphia        
ST62 Gt 75 
(49)    
VACC2 Trier, 
Germany                              
2009 Clinical sample 3,445,544 3,108 117,416 3.4 3,068 76 Pontiac Branch 
L02-
521_Cl_Gt29
(27)_D 
0 1 
Philadelphia        
ST62 Gt 29 
(27)    
VACC2 Bad 
Langensalza, 
Germany                    
2002 Clinical sample 3,478,585 3,161 118,405 3.4 3,117 72 Pontiac Branch 
L02-
465_Cl_Gt27
(133)_D 
0 1 Benidorm            ST42
5 
Gt 
27(133)    
VACC1 Berlin, 
Germany 
2002 Clinical sample 3,500,734 3,173 214,498 6.1 3,135 52 Alcoy branch 
L04-
545_Cl_Gt40
(47)_D 
0 6 Dresden             ST29
2 
Gt 40 
(47)    
VACC2 Heide-West, 
Germany 
2004 Clinical sample 3,358,959 3,006 160,642 4.8 2,964 34 Alcoy branch, close to 
Warstein outbreak 
 119 
 
L06-
153_Cl_Gt71
(135)_D 
0 1 OLDA ST16
9 
Gt 71 
(135)   
VACC18 Brandenbur
g , Germany                       
2006 Clinical sample 3,405,980 3,074 NA NA 3,030 39 Alcoy branch 
L06-
129_Cl_Gt71
(135)_D 
0 1 OLDA ST16
9 
Gt 71 
(135)   
VACC18 Brandenbur
g , Germany                       
2006 Clinical sample 3,406,112 3,075 172,495 5.1 3,031 40 Alcoy branch 
L04-
041_Cl_Gt30
(137)_D 
0 Sg.3 ST87 Gt 30 
(137)   
NA Kassel, 
Germany 
2004 Clinical sample 3,522,671 3,206 258,174 7.3 3,165 50 Alcoy branch 
L05-
341_Cl_Gt8(
132)_D 
0 6 Chicago             ST81 Gt 8 
(132)    
VACC16 Darmstadt, 
Germany 
2005 Clinical sample 3,410,856 3,071 219,558 6.4 3,035 31 Alcoy branch 
¹ Serogruop (monoclonal antibody) ² Sequence Type ³ Multi-Locus of Variable Number of Tandem Repeats 
Analysis using 13 loci 
³´ VNTR-Analysis -Clonal Complex * Coding DNA Sequence  
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Table A4:  Whole-genome SNP comparison of L. pneumophila isolates and reference 
strains. 
           
L. pneumophila 
Isolates 
Lpn-
LPE50
9 
Lpn-
Phildel
phia1 
Lpn-
Thund
erbay 
Lpn-
ATCC4
3290 
Lpn-
lpm76
13 
Lpn-
Lens 
Lpn-
Lorraine 
Lpn-
HL060
41035 
Lpn-
D7631 
Lpn-
D7630 
Lpn-
D7632 
Lpn-
Paris 
Lpn-
OLDA 
Lpn-
Pontiac 
Lpn-
Toronto 
Lpn-
Alcoy 
Lpn-
Corby 
A194-
Gt40(4
7)-Ps 
H3-
Gt14(
31)-D 
Lpn-LPE509 0 7,893 6,607 4,432 5,681 61,660 52,372 55,729 51,231 51,231 51,232 54,130 54,189 54,867 57,050 56,175 56,022 56,954 56,967 
Lpn-Phildelphia1 7,949 0 7,173 6,931 8,114 60,513 52,197 57,012 54,113 54,113 54,114 56,508 56,567 57,130 58,655 59,954 59,707 59,815 59,716 
L09-
313_Cl_Gt84(11
6)_D 
7,497 6,725 3,463 3,736 4,614 60,800 52,184 58,590 52,244 52,244 52,245 59,151 59,210 57,112 58,850 56,022 56,099 56,924 57,071 
L01-
443_Cl_Gt64(74
)_D 
9,711 8,315 6,283 6,589 7,259 60,203 52,162 58,289 52,019 52,019 52,020 59,314 59,373 57,215 59,036 56,337 56,576 57,346 57,053 
Lpn-Thunderbay 6,645 7,122 0 2,376 3,271 60,903 52,499 57,766 50,688 50,688 50,689 58,421 58,480 57,208 58,841 56,525 56,277 57,458 57,151 
Lpn-ATCC43290 4,471 6,876 2,376 0 1,663 61,037 52,710 57,620 50,680 50,680 50,681 58,102 58,161 56,886 58,502 56,719 56,690 57,633 57,324 
Lpn-lpm7613 5,727 8,062 3,270 1,665 0 60,217 52,715 57,852 51,426 51,426 51,427 58,455 58,518 57,005 58,682 56,692 56,664 57,919 57,438 
A156_Gt64(74)_
Ps 
6,255 5,700 3,018 3,288 4,185 61,079 52,328 58,651 50,720 50,720 50,721 59,348 59,407 57,387 58,767 55,986 55,492 57,772 56,644 
A129_Gt64(74)_
Ps 
6,251 5,700 3,018 3,288 4,185 61,078 52,328 58,651 50,720 50,720 50,721 59,348 59,407 57,387 58,767 55,986 55,492 57,772 56,644 
Lpn-Lens 62,174 60,985 61,462 61,608 60,755 0 55,607 68,139 66,603 66,603 66,604 67,884 67,917 62,288 63,962 70,708 71,182 70,922 70,076 
Lpn-Lorraine 52,252 52,094 52,408 52,634 52,624 54,968 0 50,857 52,019 52,019 52,020 46,520 46,547 40,566 44,745 53,380 53,848 53,596 53,236 
A15_Gt12(84)_P
s 
53,544 52,817 52,966 53,275 53,208 52,506 13,180 53,553 54,043 54,043 54,044 50,895 50,922 48,035 49,236 55,931 56,527 56,183 55,605 
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Lpn-
HL06041035 
55,334 56,644 57,431 57,284 57,502 66,966 50,330 0 28,898 28,898 28,899 32,907 32,968 39,435 40,855 47,898 48,866 48,578 45,746 
Lpn-D7631 50,817 53,705 50,323 50,325 51,070 65,514 51,655 29,003 0 0 1 43,822 43,887 46,214 46,966 45,673 46,299 46,044 44,305 
Lpn-D7630 50,817 53,705 50,323 50,325 51,070 65,514 51,655 29,003 0 0 1 43,822 43,887 46,214 46,966 45,673 46,299 46,044 44,305 
Lpn-D7632 50,818 53,706 50,324 50,326 51,071 65,515 51,656 29,004 1 1 0 43,823 43,888 46,215 46,967 45,674 46,300 46,045 44,306 
H34_Gt22(102)_
D 
53,856 58,095 54,717 54,848 54,850 66,807 51,795 25,429 9,793 9,793 9,794 43,034 43,095 44,852 45,631 43,272 43,761 44,291 41,670 
H29_Gt22(100)_
D 
53,855 58,066 54,688 54,819 54,821 66,778 51,766 25,400 9,764 9,764 9,765 43,005 43,066 44,823 45,602 43,243 43,732 44,262 41,641 
H35_Gt22(102)_
D 
53,855 58,132 54,750 54,885 54,887 66,844 51,832 25,466 9,831 9,831 9,832 43,071 43,132 44,889 45,669 43,310 43,799 44,329 41,708 
H39_Gt4(17)_D 55,366 57,545 57,882 57,756 57,893 62,815 47,911 36,501 44,709 44,709 44,710 11,084 11,020 32,760 32,365 46,510 46,595 46,619 46,258 
A139_Gt4(17)_P
s 
53,876 56,316 58,267 57,951 58,294 66,870 46,172 33,110 43,893 43,893 43,894 260 195 28,098 29,498 46,344 46,958 46,574 46,185 
Lpn-Paris 53,754 56,173 58,128 57,812 58,155 66,767 46,068 32,935 43,744 43,744 43,745 0 90 28,057 29,457 46,188 46,802 46,417 46,033 
A5_Gt4(17)_Ps 53,881 56,289 58,244 57,928 58,271 66,851 46,147 33,054 43,863 43,863 43,864 147 76 28,080 29,480 46,305 46,919 46,534 46,150 
Lpn-OLDA 53,817 56,232 58,187 57,871 58,214 66,794 46,092 32,997 43,807 43,807 43,808 89 0 28,026 29,424 46,247 46,861 46,476 46,092 
A29_Gt6(18)_Ps 53,003 56,351 57,396 57,080 57,411 66,653 46,114 32,784 42,711 42,711 42,712 1,753 1,688 28,114 29,416 45,065 45,636 45,379 44,982 
A131_Gt6(18)_P
s 
53,001 56,347 57,392 57,076 57,407 66,651 46,112 32,782 42,709 42,709 42,710 1,751 1,686 28,112 29,414 45,061 45,632 45,375 44,978 
L10-
091_Cl_Gt69(69
)_D 
54,313 56,966 57,043 56,697 56,892 64,690 42,654 38,454 44,541 44,541 44,542 24,407 24,377 14,358 15,657 45,825 45,796 46,448 46,077 
L12-
317_Cl_Gt72(66
)_D 
54,279 56,915 56,951 56,621 56,801 64,191 42,018 38,499 44,954 44,954 44,955 25,422 25,392 14,949 16,587 45,264 45,257 46,004 45,589 
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L11-
209_Cl_Gt29(27
)_D 
54,688 56,911 56,569 56,259 56,280 60,112 40,762 40,236 46,186 46,186 46,187 28,696 28,667 2,704 17,498 47,311 47,981 47,912 47,050 
L10-
023_Cl_Gt75(49
)_D 
54,483 56,779 56,797 56,483 56,586 61,117 40,207 39,537 46,013 46,013 46,014 27,898 27,869 823 16,393 46,774 47,339 47,539 46,453 
L09-
329_Cl_Gt75(49
)_D 
54,327 56,492 56,579 56,342 56,445 59,975 40,316 40,251 46,761 46,761 46,762 29,248 29,219 2,329 17,797 47,545 47,965 48,201 47,333 
Lpn-Pontiac 54,350 56,657 56,744 56,430 56,533 61,016 39,951 39,432 45,999 45,999 46,000 27,956 27,927 0 16,484 46,973 47,501 47,597 46,747 
L02-
521_Cl_Gt29(27
)_D 
54,215 56,521 56,608 56,294 56,397 60,051 40,083 40,073 46,572 46,572 46,573 29,082 29,053 2,030 17,670 47,787 48,273 48,363 47,595 
Lpn-Toronto 56,626 58,242 58,470 58,127 58,294 62,885 44,296 40,967 46,900 46,900 46,901 29,477 29,446 16,653 0 46,576 47,001 47,176 46,853 
L02-
465_Cl_Gt27(13
3)_D 
56,947 59,635 57,486 57,654 57,718 67,881 51,844 43,966 39,939 39,938 39,939 43,405 43,466 45,846 46,267 19,764 20,122 19,031 21,146 
L04-
545_Cl_Gt40(47
)_D 
56,226 59,148 56,602 56,796 57,088 69,342 52,781 48,072 46,337 46,336 46,337 45,808 45,869 47,918 46,700 11,776 12,448 2,822 15,112 
A193_Gt40(47)_
Ps 
56,790 59,399 57,082 57,269 57,542 69,601 53,182 48,816 46,127 46,126 46,127 46,656 46,717 48,220 47,519 13,008 14,269 595 16,883 
A194_Gt40(47)_
Ps 
55,980 58,832 56,516 56,703 56,976 69,038 52,613 48,246 45,547 45,546 45,547 46,086 46,147 47,651 46,952 12,623 13,696 0 16,319 
A195_Gt40(47)_
Ps 
56,044 58,896 56,580 56,767 57,040 69,101 52,677 48,309 45,612 45,611 45,612 46,150 46,211 47,715 47,016 12,686 13,759 69 16,383 
A138_Gt9(92)_P
s 
55,387 58,320 56,257 56,577 56,771 69,093 52,304 47,447 46,595 46,594 46,595 45,200 45,262 47,414 47,230 11,674 12,977 9,235 15,497 
A112_Gt10(93)_
Ps 
55,391 58,287 56,228 56,579 56,773 69,035 52,119 47,331 46,562 46,561 46,562 45,023 45,085 47,006 46,832 12,080 13,387 9,737 15,668 
 123 
 
A114_Gt10(93)_
Ps 
55,397 58,293 56,234 56,585 56,779 69,041 52,125 47,337 46,568 46,567 46,568 45,029 45,091 47,012 46,838 12,086 13,393 9,743 15,674 
A127_Gt10(93)_
Ps 
55,398 58,324 56,265 56,616 56,810 69,073 52,157 47,369 46,600 46,599 46,600 45,061 45,123 47,044 46,870 12,119 13,426 9,776 15,707 
A108_Gt10(93)_
Ps 
55,400 58,296 56,237 56,588 56,782 69,044 52,128 47,340 46,571 46,570 46,571 45,032 45,094 47,015 46,841 12,089 13,396 9,746 15,677 
H3_Gt14(31)_D 55,599 58,312 55,793 55,969 56,073 67,765 51,960 45,184 43,502 43,501 43,502 45,499 45,560 46,694 46,414 12,709 13,932 15,997 0 
H23_Gt14(30)_
D 
55,605 58,318 55,799 55,975 56,079 67,771 51,966 45,190 43,508 43,507 43,508 45,505 45,566 46,700 46,420 12,715 13,938 16,003 8 
H1_Gt14(31)_D 55,602 58,315 55,796 55,972 56,076 67,768 51,963 45,187 43,505 43,504 43,505 45,502 45,563 46,697 46,417 12,712 13,935 16,000 5 
H2_Gt14(31)_D 55,602 58,315 55,796 55,972 56,076 67,768 51,963 45,187 43,505 43,504 43,505 45,502 45,563 46,697 46,417 12,712 13,935 16,000 5 
Lpn-Alcoy 55,191 58,936 55,551 55,754 55,715 68,796 52,373 47,589 45,173 45,172 45,173 45,889 45,950 47,059 46,349 0 8,536 12,575 12,992 
Lpn-Corby 54,760 58,420 55,226 55,457 55,428 69,105 52,667 48,358 45,614 45,613 45,614 46,311 46,372 47,418 46,605 8,569 0 13,669 14,240 
L06-
153_Cl_Gt71(13
5)_D 
56,435 60,030 56,786 57,052 57,085 70,197 53,883 49,343 46,579 46,578 46,579 46,688 46,749 48,436 47,569 11,960 12,203 11,755 15,637 
L06-
129_Cl_Gt71(13
5)_D 
56,432 60,027 56,783 57,049 57,082 70,194 53,880 49,340 46,576 46,575 46,576 46,685 46,746 48,433 47,566 11,957 12,200 11,752 15,634 
A166_Gt8(142)_
Ps 
56,734 59,717 57,005 57,273 57,506 69,648 53,331 48,134 44,949 44,948 44,950 45,390 45,451 47,608 46,775 13,650 13,572 11,522 16,010 
L04-
041_Cl_Gt30(13
7)_D 
55,304 58,994 55,498 55,768 55,990 68,718 52,568 45,987 42,328 42,327 42,328 45,102 45,163 46,619 46,345 14,500 14,015 13,889 15,584 
L05-
341_Cl_Gt8(132
)_D 
56,279 59,240 56,383 56,663 56,758 69,406 52,920 47,086 45,076 45,075 45,076 45,359 45,418 47,058 46,395 13,146 13,809 11,468 14,975 
A color represents relative number of SNPs differences. Each branch has specific color code as given in Figure 1. Bold and Underlined = 
Least No. of SNPs 
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Table A5: Summary of Genome Islands of L.pneumophila of the selected strains. 
Cluster Isolate No of GI GI GI length 
(bp) 
No of 
Genes 
Total No. 
of Genes 
in GI 
ATCC4329
0 Branch 1 
L09-
313_Cl_Gt
84(116)_D 
8 1 6,666 7 162 
2 6,819 10 
3 16,241 19 
4 17,924 21 
5 64,086 64 
6 16,989 16 
7 12,159 17 
8 17,497 8 
 L01-
443_Cl_Gt
64(74)_D 
11 1 25,819 33 214 
 2 12,159 17 
 3 6,666 7 
 4 8,619 10 
 5 14,609 16 
 6 11,582 15 
 7 16,992 16 
 8 53,658 60 
 9 13,729 8 
 10 9,075 10 
 11 52,731 22 
 A156_Gt6
4(74)_Ps 
9 1 6,666 7 189 
 2 8,619 10 
 3 16,241 19 
 4 16,856 20 
 5 64,062 64 
 6 16,989 16 
 7 21,177 24 
 8 11,562 12 
 9 12,159 17 
 A129_Gt6
4(74)_Ps 
13 1 6,666 7 282 
 2 8,619 10 
 3 16,241 19 
 4 16,856 20 
 5 64,062 64 
 6 16,989 16 
 7 18,290 22 
 8 11,562 12 
 9 5,373 8 
 10 48,997 23 
 11 12,225 13 
   12 59,011 58  
   13 9,013 10  
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Lorraine 
Branch 2 
A15_Gt12(
84)_Ps 
11 1 8,007 8 169 
2 13,279 15 
3 12,162 10 
4 13,368 18 
5 11,447 14 
6 13,771 12 
7 24,364 24 
8 7,312 8 
9 13,264 18 
10 8,860 11 
11 54,179 31 
D7630 
Branch 3 
H34_Gt22(
102)_D 
8 1 8,009 8 152 
2 16,952 19 
3 7,152 8 
4 27,517 24 
5 32,779 36 
6 16,619 13 
7 21,177 24 
8 30,124 20 
H29_Gt22(
100)_D 
8 1 8,009 8 142 
2 16,952 19 
3 7,152 8 
4 27,517 24 
5 37,893 39 
6 16,619 13 
7 21,177 24 
8 9,146 7 
H35_Gt22(
102)_D 
10 1 8,009 8 150 
2 16,952 19 
3 7,152 8 
4 7,769 9 
5 25,463 19 
6 37,843 39 
7 16,619 13 
8 21,177 24 
 9 9147 7 
 10 16,402 4 
Paris 
Branch 4 
H39_Gt4(1
7)_D 
11 1 8372 8 174 
2 4699 7 
3 12,218 10 
4 11,507 12 
5 46,869 46 
6 6656 7 
7 5238 7 
 8 43,618 37 
  9 59,039 11  
  10 8497 2  
  11 19,555 27  
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Paris 
Branch 4 
A139_Gt4(
17)_Ps 
11 1 8372 8 224 
2 4699 7 
3 13,220 14 
4 22,127 23 
5 5310 7 
6 43,012 37 
7 6954 11 
8 46,869 46 
9 6656 7 
10 50,258 54 
11 16,374 10 
A5_Gt4(17
)_Ps 
10 1 4699 7 215 
2 12,039 11 
3 22,127 23 
4 5310 7 
5 43,012 37 
6 6954 11 
7 46,869 46 
8 6656 7 
9 49,633 53 
10 28,689 13 
A29_Gt6(1
8)_Ps 
12 1 8372 8 309 
2 4699 7 
3 12,064 11 
4 22,127 23 
5 27,526 24 
6 30,804 35 
7 42,942 37 
8 6954 11 
9 74,559 79 
10 6656 7 
11 51,378 55 
12 50,924 12 
A131_Gt6(
18)_Ps 
13 1 8372 8 268 
2 4699 7 
 3 12,041 11 
 4 22,127 23 
 5 27,526 24 
 6 30,804 35 
 7 8807 8 
 8 42,942 37 
 9 6954 11 
 10 20,474 17 
 11 64,866 73 
  12 6656 7 
   13 24,951 7  
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Pontiac 
Branch 5 
L10-
091_Cl_Gt
69(69)_D 
13 1 5520 8 175 
2 12,846 11 
3 8997 7 
4 6739 11 
5 26,673 37 
6 9527 13 
7 8836 9 
8 20,964 21 
9 15,724 24 
10 8519 11 
11 8920 7 
12 6656 7 
13 47,519 9 
L12-
317_Cl_Gt
72(66)_D 
10 1 32,465 28 176 
2 12,224 9 
3 12,170 10 
4 64,066 64 
5 19,685 20 
6 6014 7 
7 13,114 15 
8 11,419 9 
9 8920 7 
10 6656 7 
L11-
209_Cl_Gt
29(27)_D 
6 1 17,154 18 94 
2 12,846 11 
3 27,009 29 
4 15,752 11 
5 16,990 18 
6 6657 7 
L09-
329_Cl_Gt
75(49)_D 
7 1 6657 7 116 
2 46,585 41 
3 6867 11 
4 12,857 11 
 5 8577 7 
 6 5511 7 
 7 30,362 32 
 L02-
521_Cl_Gt
29(27)_D 
8 1 13,937 17 108 
 2 6867 11 
 3 9929 8 
 4 6890 7 
 5 8721 8 
 6 39,879 42 
 7 6657 7 
 8 25,525 8 
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Alcoy 
Branch 6 
L02-
465_Cl_Gt
27(133)_D 
13 1 4180 7 215 
2 9993 8 
3 9620 8 
4 5031 7 
5 27,758 24 
6 65,316 71 
7 8431 9 
8 21,716 29 
9 5477 7 
10 14,122 13 
11 17,732 20 
12 6667 7 
13 18,455 5 
L04-
545_Cl_Gt
40(47)_D 
8 1 6667 7 144 
2 20,340 30 
3 16,142 16 
4 7119 7 
5 55,223 30 
6 28,334 25 
7 9085 9 
8 17,732 20 
A193_Gt4
0(47)_Ps 
8 1 6667 7 161 
2 19,317 27 
3 17,424 17 
4 7119 7 
5 68,131 36 
6 28,258 25 
7 19,749 19 
8 18,487 23 
A194_Gt4
0(47)_Ps 
6 1 15,197 1 108 
2 17,424 16 
3 68,995 35 
4 28,295 27 
 5 9085 9 
 6 17,732 20 
 A195_Gt4
0(47)_Ps 
8 1 6667 7 146 
 2 19,317 27 
 3 16,142 15 
 4 7119 7 
 5 26,090 33 
 6 28,334 25 
 7 9085 9 
 8 18,487 23 
 A138_Gt9(
92)_Ps 
7 1 6667 7 127 
 2 37,408 46 
 3 59,978 34 
 4 8980 7 
 5 8429 8 
 6 17,721 20 
 7 23,388 5 
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Alcoy 
Branch 6 
A112_Gt1
0(93)_Ps 
6 1 17,721 20 120 
2 6667 7 
3 37,408 46 
4 58,777 32 
5 8429 8 
6 18,966 7 
A114_Gt1
0(93)_Ps 
6 1 6667 7 122 
2 37,408 46 
3 58,777 32 
4 8429 8 
5 17,721 20 
6 30,645 9 
A127_Gt1
0(93)_Ps 
6 1 6667 7 127 
2 42,945 56 
3 58,777 32 
4 8429 8 
5 17,721 20 
6 8439 4 
A108_Gt1
0(93)_Ps 
7 1 6667 7 134 
2 42,991 55 
3 58,782 32 
4 7941 8 
5 8429 8 
6 17,721 20 
7 10,811 4 
H1_Gt14(3
1)_D 
10 1 6668 7 226 
2 13,062 16 
3 5996 10 
4 15,575 17 
5 60,003 35 
6 64,648 67 
7 32,103 31 
8 8437 8 
9 19,754 21 
 10 26,827 14 
 H2_Gt14(3
1)_D 
11 1 13,062 16 211 
 2 5996 10 
 3 15,575 17 
 4 60,053 35 
 5 45,783 49 
 6 9077 11 
 7 32,103 31 
 8 8437 8 
 9 19,811 21 
 10 6668 7 
   11 22,084 6  
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Alcoy 
Branch 6 
H3_Gt14(3
1)_D 
12 1 23,425 25 198 
2 13,062 16 
3 5996 10 
4 12,559 17 
5 6615 11 
6 65,118 36 
7 10,222 9 
8 27,708 30 
9 9978 13 
10 10,560 8 
11 14,861 13 
12 9763 10 
H23_Gt14(
30)_D 
13 1 13,062 16 315 
2 5996 10 
3 15,575 17 
4 5964 7 
5 21,994 34 
6 64,640 36 
7 45,836 47 
8 12,096 13 
9 40,813 43 
10 8437 8 
11 19,772 21 
12 6668 7 
13 111,897 56 
L06-
153_Cl_Gt
71(135)_D 
NA NA NA NA NA 
L06-
129_Cl_Gt
71(135)_D 
5 1 63,906 65 167 
2 54,896 59 
3 18,290 22 
4 27,397 11 
5 8006 10 
A166_Gt8(
142)_Ps 
11 1 6667 7 188 
 2 13,958 17  
  3 14,858 14  
  4 9620 8  
  5 15,564 12  
  6 21,177 24  
  7 60,115 33  
  8 21,716 29  
  9 12,520 13  
  10 10,305 11  
  11 17,732 20  
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Alcoy 
Branch 6 
L04-
041_Cl_Gt
30(137)_D 
14 1 6667 7 245 
2 10,111 9 
3 9620 8 
4 27,517 24 
5 31,931 36 
6 7390 10 
7 7228 10 
8 21,177 24 
9 14,752 12 
10 61,045 34 
11 15,724 24 
12 12,529 13 
13 14,751 14 
 14 17,732 20 
 L05-
341_Cl_Gt
8(132)_D 
11 1 6667 7 205 
  2 24,616 22  
  3 11,536 9  
  4 9620 8  
  5 18,192 24  
  6 21,177 24  
  7 60,169 33  
  8 21,716 29  
  9 12,532 13  
   10 15,601 16  
   11 17,732 20  
NA: Not Available      
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Table A6 (Part 1): Percentage of nucleotide identity of orthologous pore-forming activity genes with respect to the BLASTp search against the VFDB using L. pneumophila strain 
Philadelphia1 as default reference genome  
L. 
pneumoph
ila isolate 
Secretion system 
 Dot/Icm type IVB secretion system 
 icmT   icmS   icmR   icmQ   
 Locus Id Length 
(bp) 
Locus Id Length 
(bp) 
Locus Id Length 
(bp) 
Locus Id Length 
(bp) 
Lpn-Corby LPC_2902 82% 260 LPC_2901 100% 344 LPC_2900 95% 362 LPC_2899 100% 575 
Lpn-Alcoy 
2300/99 
Alcoy_004
88 
82% 260 Alcoy_048
9 
100% 344 Alcoy_004
90 
95% 362 Alcoy_004
91 
100% 575 
L02-
465_Cl_Gt
27(133)_D 
L02_465-
D-
cl_01280 
82% 260 L02_465-
D-
cl_01281 
100% 344 L02_465-
D-
cl_01282 
95% 362 L02_465-
D-
cl_01284 
100% 575 
L04-
545_Cl_Gt
40(47)_D 
L04_545_0
0300 
82% 260 L04_545_0
0301 
100% 344 L04_545_0
0302 
95% 362 L04_545_0
0303 
100% 575 
A193_Gt4
0(47)_Ps 
A193_003
15 
82% 260 A193_003
14 
100% 344 A193_003
13 
95% 362 A193_003
12 
100% 575 
A194_Gt4
0(47)_Ps 
A194_004
42 
82% 260 A194_004
43 
100% 344 A194_004
44 
95% 362 A194_004
45 
100% 575 
A195_Gt4
0(47)_Ps 
A195_012
39 
82% 260 A195_012
38 
100% 344 A195_012
37 
95% 362 A195_012
36 
100% 575 
A138_Gt9(
92)_Ps 
A138_012
48 
82% 260 A138_012
47 
100% 344 A138_012
46 
95% 362 A138_012
45 
100% 575 
A112_Gt1
0(93)_Ps 
A112_012
39 
82% 260 A112_012
40 
100% 344 A112_012
41 
95% 362 A112_012
42 
100% 575 
A114_Gt1
0(93)_Ps 
A114_014
59 
82% 260 A114_014
58 
100% 344 A114_014
57 
95% 362 A114_014
56 
100% 575 
A127_Gt1
0(93)_Ps 
A127_002
29 
82% 260 A127_002
30 
100% 344 A127_002
31 
95% 362 A127_002
32 
100% 575 
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A108_Gt1
0(93)_Ps 
A108_002
45 
82% 260 A108_002
46 
100% 344 A108_002
47 
95% 362 A108_002
48 
100% 575 
H3_Gt14(3
1)_D 
H3_00490 82% 260 H3_00491 100% 344 H3_00492 95% 362 H3_00493 100% 575 
H23_Gt14(
30)_D 
H23_0267
6 
82% 260 H23_0267
7 
100% 344 H23_0267
8 
95% 362 H23_0267
9 
100% 575 
H1_Gt14(3
1)_D 
H1_01840 82% 260 H1_01841 100% 344 H1_01842 95% 362 H1_01843 100% 575 
H2_Gt14(3
1)_D 
H2_03184 82% 260 H2_03185 100% 344 H2_03186 95% 362 H2_03187 100% 575 
L06-
153_Cl_Gt
71(135)_D 
L06_153_0
2963 
82% 260 L06_153_0
2962 
100% 344 L06_153_0
2961 
95% 362 L06_153_0
2960 
100% 575 
L06-
129_Cl_Gt
71(135)_D 
L06_129_0
1414 
82% 260 L06_129_0
1413 
100% 344 L06_129_0
1412 
95% 362 L06_129_0
1411 
100% 575 
A166_Gt8(
142)_Ps 
A166_004
56 
82% 260 A166_004
57 
100% 344 A166_004
58 
95% 362 A166_004
59 
100% 575 
L04-
041_Cl_Gt
30(137)_D 
L04_041_0
3094 
82% 260 L04_041_0
3093 
100% 344 L04_041_0
3092 
95% 362 L04_041_0
3091 
100% 575 
L05-
341_Cl_Gt
8(132)_D 
L05_341_0
2188 
82% 260 L05_341_0
2189 
100% 344 L05_341_0
2190 
95% 362 L05_341_0
2191 
100% 575 
Lpn-
Pontiac 
Pontiac_0
0497 
82% 260 Pontiac_0
0498 
100% 344 Pontiac_0
0499 
96% 362 Pontiac_0
0500 
99% 575 
L10-
091_Cl_Gt
69(69)_D 
L10_091_0
1392 
82% 260 L10_091_0
1393 
100% 344 L10_091_0
1394 
96% 362 L10_091_0
1395 
99% 575 
L12-
317_Cl_Gt
72(66)_D 
L12_317_0
2108 
82% 260 L12_317_0
2107 
100% 344 L12_317_0
2106 
96% 362 L12_317_0
2105 
99% 575 
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L11-
209_Cl_Gt
29(27)_D 
L11_209_0
0706 
82% 260 L11_209_0
0705 
100% 344 L11_209_0
0704 
96% 362 L11_209_0
0703 
99% 575 
L10-
023_Cl_Gt
75(49)_D 
L10_023_0
0511 
82% 260 L10_023_0
0512 
100% 344 L10_023_0
0513 
96% 362 L10_023_0
0514 
99% 575 
L09-
329_Cl_Gt
75(49)_D 
L09_329_0
0128 
82% 260 L09_329_0
0127 
100% 344 L09_329_0
0126 
96% 362 L09_329_0
0125 
99% 575 
L02-
521_Cl_Gt
29(27)_D 
L02_521_0
0369 
82% 260 L02_521_0
0368 
100% 344 L02_521_0
0367 
96% 362 L02_521_0
0366 
99% 575 
Lpn-Paris Paris_0051
3 
82% 260 Paris_0051
4 
100% 344 Paris_0051
5 
96% 362 Paris_0051
6 
99% 575 
H39_Gt4(1
7)_D 
H39_0024
1 
82% 260 H39_0024
2 
100% 344 H39_0024
3 
96% 362 H39_0024
4 
99% 575 
A139_Gt4(
17)_Ps 
A139_017
48 
82% 260 A139_017
49 
100% 344 A139_017
50 
96% 362 A139_017
51 
99% 575 
A5_Gt4(17
)_Ps 
A5_01374 82% 260 A5_01373 100% 344 A5_01372 96% 362 A5_01371 99% 575 
A29_Gt6(1
8)_Ps 
A29_0146
9 
82% 260 A29_0147
0 
100% 344 A29_0147
1 
96% 362 A29_0147
2 
99% 575 
A131_Gt6(
18)_Ps 
A131_018
19 
82% 260 A131_018
18 
100% 344 A131_018
17 
96% 362 A131_018
16 
99% 575 
Lpn-D7630 Lpn_D763
1_00446 
82% 260 lpn_D7631
_00447 
99% 344 Lpn_D763
0_00448 
97% 362 lpn_D7630
_00449 
99% 575 
H34_Gt22(
102)_D 
H34_0193
3 
82% 260 H34_0193
4 
99% 344 H34_0193
5 
97% 362 H34_0193
6 
99% 575 
H29_Gt22(
100)_D 
H29_0080
5 
82% 260 H29_0080
4 
99% 344 H29_0080
3 
97% 362 H29_0080
2 
99% 575 
H35_Gt22(
102)_D 
H35_0074
8 
82% 260 H35_0074
7 
99% 344 H35_0074
6 
97% 362 H35_0074
5 
99% 575 
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Lpn-
Lorraine 
Lorriane_0
0478 
82% 260 Lorriane_0
0479 
100% 344 Lorriane_0
0480 
97% 362 Lorriane_0
0481 
100% 575 
A15_Gt12(
84)_Ps 
A15_0083
4 
82% 260 A15_0083
3 
100% 344 A15_0083
2 
97% 362 A15_0083
1 
100% 575 
Lpn-
Thunderba
y 
Thunderba
y_00431 
82% 260 Thunderba
y_00432 
100% 344 Thunderba
y_00433 
91% 362 Thunderba
y_00434 
100% 575 
L09-
313_Cl_Gt
84(116)_D 
L09_313_0
1086 
82% 260 L09_313_0
1087 
100% 344 L09_313_0
1088 
91% 362 L09_313_0
1089 
100% 575 
L01-
443_Cl_Gt
64(74)_D 
L01_443_0
1651 
82% 260 L01_443_0
1650 
100% 344 L01_443_0
1649 
91% 362 L01_443_0
1648 
100% 575 
A156_Gt6
4(74)_Ps 
A156_016
87 
82% 260 A156_016
88 
100% 344 A156_016
89 
91% 362 A156_016
90 
100% 575 
A129_Gt6
4(74)_Ps 
A129_013
77 
82% 260 A129_013
78 
100% 344 A129_013
79 
91% 362 A129_013
80 
100% 575 
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Table A6 (Part 2): Percentage of nucleotide identity of orthologous pore-forming activity genes with respect to the BLASTp search against the VFDB using L. 
pneumophila strain Philadelphia1 as default reference genome 
L. 
pneumoph
ila isolate 
Secretion system           
 Dot/Icm type IVB secretion system          
 icmL/dotI   icmK/dotH   icmE/dotG   icmC/dotE   
 Locus Id Length 
(bp) 
Locus Id Length 
(bp) 
Locus Id Length 
(bp) 
Id Id Length 
(bp) 
Lpn-Corby LPC_2894 84% 638 LPC_2893 84% 1,082 LPC_2892 88.00% 3,146 LPC_2890 91.00% 341 
Lpn-Alcoy 
2300/99 
Alcoy_004
96 
84% 638 Alcoy_004
97 
84% 1,085 Alcoy_004
98 
88.00% 3,146 Alcoy_005
00 
99.00% 584 
L02-
465_Cl_Gt
27(133)_D 
L02_465-
D-
cl_01288 
84% 638 L02_465-
D-
cl_01289 
84% 1,085 L02_465-
D-
cl_01290 
88.00% 3,146 L02_465-
D-
cl_01292 
99.00% 584 
L04-
545_Cl_Gt
40(47)_D 
L04_545_0
0308 
84% 638 L04_545_0
0309 
84% 1,085 L04_545_0
0310 
88.00% 3,146 L04_545_0
0312 
99.00% 584 
A193_Gt4
0(47)_Ps 
A193_003
07 
84% 638 A193_003
06 
84% 1,085 A193_003
05 
88.00% 3,146 A193_003
02 
99.00% 584 
A194_Gt4
0(47)_Ps 
A194_004
50 
84% 638 A194_004
51 
84% 1,085 A194_004
52 
88.00% 3,146 A194_004
54 
99.00% 584 
A195_Gt4
0(47)_Ps 
A195_012
31 
84% 638 A195_012
30 
84% 1,085 A195_012
29 
88.00% 3,146 A195_012
27 
99.00% 584 
A138_Gt9(
92)_Ps 
A138_012
40 
84% 638 A138_012
39 
83% 1,085 A138_012
38 
88.00% 3,146 A138_012
36 
99.00% 548 
A112_Gt1
0(93)_Ps 
A112_012
47 
84% 638 A112_012
48 
83% 1,085 A112_012
49 
88.00% 3,146 A112_012
51 
99.00% 548 
A114_Gt1
0(93)_Ps 
A114_014
51 
84% 638 A114_014
50 
83% 1,085 A114_014
49 
88.00% 3,146 A114_014
47 
99.00% 548 
A127_Gt1
0(93)_Ps 
A127_002
37 
84% 638 A127_002
38 
83% 1,085 A127_002
39 
88.00% 3,146 A127_002
41 
99.00% 548 
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A108_Gt1
0(93)_Ps 
A108_002
53 
84% 638 A108_002
54 
83% 1,085 A108_002
55 
88.00% 3,146 A108_002
57 
99.00% 548 
H3_Gt14(3
1)_D 
H3_00498 84% 638 H3_00499 83% 1,085 H3_00500 87.00% 3,146 H3_00502 99.00% 548 
H23_Gt14(
30)_D 
H23_0268
4 
84% 638 H23_0268
5 
83% 1,085 H23_0268
6 
87.00% 3,146 H23_0268
8 
99.00% 584 
H1_Gt14(3
1)_D 
H1_01848 84% 638 H1_01849 83% 1,085 H1_01850 87.00% 3,146 H1_01852 99.00% 584 
H2_Gt14(3
1)_D 
H2_03192 84% 638 H2_03193 83% 1,085 H2_03194 87.00% 3,146 H2_03196 99.00% 584 
L06-
153_Cl_Gt
71(135)_D 
L06_153_0
2955 
84% 638 L06_153_0
2954 
84% 1,085 L06_153_0
2953 
88.00% 3,146 L06_153_0
2951 
99.00% 584 
L06-
129_Cl_Gt
71(135)_D 
L06_129_0
1406 
84% 638 L06_129_0
1405 
84% 1,085 L06_129_0
1404 
88.00% 3,146 L06_129_0
1402 
99.00% 584 
A166_Gt8(
142)_Ps 
A166_004
64 
84% 638 A166_004
65 
84% 1,085 A166_004
66 
89.00% 3,146 A166_004
69 
99.00% 584 
L04-
041_Cl_Gt
30(137)_D 
L04_041_0
3086 
84% 638 L04_041_0
3085 
84% 1,085 L04_041_0
3084 
88.00% 3,146 L04_041_0
3082 
99.00% 584 
L05-
341_Cl_Gt
8(132)_D 
L05_341_0
2196 
84% 638 L05_341_0
2197 
84% 1,085 L05_341_0
2198 
88.00% 3,146 L05_341_0
2200 
99.00% 584 
Lpn-
Pontiac 
Pontiac_0
0505 
84% 638 Pontiac_0
0506 
82% 1,085 Pontiac_0
0507 
88.00% 3,146 Pontiac_0
0509 
100.00% 584 
L10-
091_Cl_Gt
69(69)_D 
L10_091_0
1400 
84% 638 L10_091_0
1401 
82% 1,085 L10_091_0
1402 
88.00% 3,146 L10_091_0
1404 
100.00% 584 
L12-
317_Cl_Gt
72(66)_D 
L12_317_0
2100 
84% 638 L12_317_0
2099 
82% 1,085 L12_317_0
2098 
88.00% 3,146 L12_317_0
2096 
100.00% 584 
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L11-
209_Cl_Gt
29(27)_D 
L11_209_0
0698 
84% 638 L11_209_0
0697 
82% 1,085 L11_209_0
0696 
88.00% 3,146 L11_209_0
0694 
100.00% 584 
L10-
023_Cl_Gt
75(49)_D 
L10_023_0
0519 
84% 638 L10_023_0
0520 
82% 1,085 L10_023_0
0521 
88.00% 3,146 L10_023_0
0523 
100.00% 584 
L09-
329_Cl_Gt
75(49)_D 
L09_329_0
0120 
84% 638 L09_329_0
0119 
82% 1,085 L09_329_0
0118 
88.00% 3,146 L09_329_0
0116 
100.00% 584 
L02-
521_Cl_Gt
29(27)_D 
L02_521_0
0361 
84% 638 L02_521_0
0360 
82% 1,085 L02_521_0
0359 
88.00% 3,146 L02_521_0
0357 
100.00% 584 
Lpn-Paris Paris_0052
1 
84% 638 Paris_0052
2 
82% 1,085 Paris_0052
3 
89.00% 3,146 Paris_0052
5 
100.00% 584 
H39_Gt4(1
7)_D 
H39_0024
9 
84% 638 H39_0025
0 
82% 1,085 H39_0025
1 
89.00% 3,146 H39_0025
3 
100.00% 584 
A139_Gt4(
17)_Ps 
A139_017
56 
84% 638 A139_017
57 
82% 1,082 A139_017
58 
89.00% 3,146 A139_017
60 
100.00% 584 
A5_Gt4(17
)_Ps 
A5_01366 84% 638 A5_01365 82% 1,082 A5_01364 89.00% 3,146 A5_01362 100.00% 584 
A29_Gt6(1
8)_Ps 
A29_0147
7 
84% 638 A29_0147
8 
82% 1,082 A29_0147
9 
89.00% 3,146 A29_0148
1 
100.00% 584 
A131_Gt6(
18)_Ps 
A131_018
11 
84% 638 A131_018
10 
82% 1,082 A131_018
09 
89.00% 3,146 A131_018
07 
100.00% 584 
Lpn-D7630 lpn_D7630
_00454 
84% 638 lpn_D7630
_00455 
82% 1,085 lpn_D7630
_00456 
87.00% 3,146 lpn_D7630
_00458 
99.00% 584 
H34_Gt22(
102)_D 
H34_0194
1 
84% 638 H34_0194
2 
82% 1,085 H34_0194
3 
87.00% 3,146 H34_0194
5 
99.00% 584 
H29_Gt22(
100)_D 
H29_0079
7 
84% 638 H29_0079
6 
82% 1,085 H29_0079
5 
87.00% 3,146 H29_0079
3 
99.00% 584 
H35_Gt22(
102)_D 
H35_0074
0 
84% 638 H35_0073
9 
82% 1,085 H35_0073
8 
87.00% 3,146 H35_0073
6 
99.00% 584 
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Lpn-
Lorraine 
Lorriane_0
0486 
84% 638 Lorriane_0
0487 
82% 1,085 Lorriane_0
0488 
87.00% 3,146 Lorriane_0
0490 
100.00% 584 
A15_Gt12(
84)_Ps 
A15_0082
6 
84% 638 A15_0082
5 
82% 1,082 A15_0082
4 
87.00% 3,146 A15_0082
2 
100.00% 584 
Lpn-
Thunderba
y 
Thunderba
y_00439 
84% 638 Thunderba
y_00440 
79% 1,085 Thunderba
y_00441 
91.00% 3,146 Thunderba
y_00443 
100.00% 584 
L09-
313_Cl_Gt
84(116)_D 
L09_313_0
1094 
84% 638 L09_313_0
1095 
79% 1,085 L09_313_0
1096 
91.00% 3,146 L09_313_0
1098 
100.00% 584 
L01-
443_Cl_Gt
64(74)_D 
L01_443_0
1643 
84% 638 L01_443_0
1642 
79% 1,085 L01_443_0
1641 
91.00% 3,146 L01_443_0
1639 
100.00% 584 
A156_Gt6
4(74)_Ps 
A156_016
95 
84% 638 A156_016
96 
79% 1,085 A156_016
97 
91.00% 3,146 A156_016
99 
100.00% 584 
A129_Gt6
4(74)_Ps 
A129_013
85 
84% 638 A129_013
86 
79% 1,085 A129_013
87 
91.00% 3,146 A129_013
89 
100.00% 584 
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Table A6 (Part 3): Percentage of nucleotide identity of orthologous pore-forming activity genes with respect to the BLASTp search against the VFDB using L. 
pneumophila strain Philadelphia1 as default reference genome 
L. 
pneumoph
ila isolate 
Secretion system        Toxin   
 Dot/Icm type IVB secretion system       RtxA   
 dotB   dotA   icmW   rtxA   
 Locus Id Length 
(bp) 
Locus Id Length 
(bp) 
Locus Id Length 
(bp) 
Locus Id Length 
(bp) 
Lpn-Corby LPC_0461 100.00% 1,109 LPC_0450 85.00% 3,062 LPC_0448 98.00% 455 LPC_2649 85.00% 18,869 
Lpn-Alcoy 
2300/99 
Alcoy_028
16 
100.00% 1,133 Alcoy_028
26 
81.00% 3,059 Alcoy_028
28 
98.00% 455 Alcoy_007
32 
85.00% 14,009 
L02-
465_Cl_Gt
27(133)_D 
L02_465-
D-
cl_02396 
100.00% 1,133 L02_465-
D-
cl_02386 
81.00% 3,107 L02_465-
D-
cl_02384 
99.00% 455 L02_465_0
0601 
85.00% 3,854 
L04-
545_Cl_Gt
40(47)_D 
L04_545_0
2079 
100.00% 1,133 L04_545_0
2089 
81.00% 3,119 L04_545_0
2091 
98.00% 455 L04_545_0
1005 
84.00% 3,827 
A193_Gt4
0(47)_Ps 
A193_022
94 
100.00% 1,133 A193_023
04 
78.00% 3,119 A193_023
06 
98.00% 455 A193_025
96 
84.00% 3,827 
A194_Gt4
0(47)_Ps 
A194_027
75 
100.00% 1,133 A194_027
85 
78.00% 3,119 A194_027
87 
98.00% 455 A194_006
44 
84.00% 15,197 
A195_Gt4
0(47)_Ps 
A195_030
02 
100.00% 1,133 A195_030
12 
78.00% 3,119 A195_030
14 
98.00% 455 A195_013
55 
84.00% 4,331 
A138_Gt9(
92)_Ps 
A138_027
11 
100.00% 1,133 A138_027
01 
78.00% 3,119 A138_026
99 
98.00% 455 A138_000
37 
75.00% 4,877 
A112_Gt1
0(93)_Ps 
A112_019
60 
100.00% 1,133 A112_019
70 
78.00% 3,119 A112_019
72 
98.00% 455 A112_013
65 
75.00% 4,877 
A114_Gt1
0(93)_Ps 
A114_028
00 
100.00% 1,133 A114_028
10 
78.00% 3,119 A114_028
12 
98.00% 455 A114_016
66 
75.00% 4,877 
A127_Gt1
0(93)_Ps 
A127_020
15 
100.00% 1,133 A127_020
05 
78.00% 3,119 A127_020
03 
98.00% 455 A127_000
73 
75.00% 5,360 
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A108_Gt1
0(93)_Ps 
A108_026
16 
100.00% 1,133 A108_026
26 
78.00% 3,119 A108_026
28 
98.00% 455 A108_027
33 
75.00% 4,877 
H3_Gt14(3
1)_D 
H3_02919 100.00% 1,133 H3_02929 79.00% 3,119 H3_02931 98.00% 455 H3_00731 86.00% 14,000 
H23_Gt14(
30)_D 
H23_0007
3 
100.00% 1,133 H23_0006
3 
78.00% 3,119 H23_0006
1 
98.00% 455 H23_0199
3 
86.00% 4,892 
H1_Gt14(3
1)_D 
H1_01583 100.00% 1,133 H1_01573 78.00% 3,119 H1_01571 98.00% 455 H1_02924 86.00% 4,892 
H2_Gt14(3
1)_D 
H2_01436 100.00% 1,133 H2_01446 78.00% 3,119 H2_01448 98.00% 455 H2_03057 86.00% 4,892 
L06-
153_Cl_Gt
71(135)_D 
L06_153_0
2441 
100.00% 1,133 L06_153_0
2451 
80.00% 3,059 L06_153_0
2453 
98.00% 455 L06_153_0
0001 
85.00% 3,854 
L06-
129_Cl_Gt
71(135)_D 
L06_129_0
2607 
100.00% 1,133 L06_129_0
2617 
80.00% 3,059 L06_129_0
2619 
98.00% 455 L06_129_0
0121 
85.00% 3,854 
A166_Gt8(
142)_Ps 
A166_029
37 
100.00% 1,133 A166_029
47 
80.00% 3,059 A166_029
49 
98.00% 455 A166_014
63 
84.00% 3,827 
L04-
041_Cl_Gt
30(137)_D 
L04_041_0
1669 
100.00% 1,133 L04_041_0
1679 
80.00% 3,059 L04_041_0
1681 
98.00% 455 L04_041_0
1996 
85.00% 3,875 
L05-
341_Cl_Gt
8(132)_D 
L05_341_0
2472 
100.00% 1,133 L05_341_0
2462 
80.00% 3,059 L05_341_0
2460 
98.00% 455 L05_341_0
2062 
84.00% 3,881 
Lpn-
Pontiac 
Pontiac_0
2875 
100.00% 1,133 Pontiac_0
2886 
88.00% 890 Pontiac_0
2888 
99.00% 455 Pontiac_0
0698 
80.00% 24,137 
L10-
091_Cl_Gt
69(69)_D 
L10_091_0
1582 
100.00% 1,133 L10_091_0
1593 
81.00% 3,107 L10_091_0
1595 
99.00% 455 L10_091_0
0688 
75.00% 4,421 
L12-
317_Cl_Gt
72(66)_D 
L12_317_0
0927 
100.00% 1,133 L12_317_0
0938 
81.00% 3,107 L12_317_0
0940 
99.00% 455 L12_317_0
1355 
75.00% 4,421 
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L11-
209_Cl_Gt
29(27)_D 
L11_209_0
3041 
100.00% 1,133 L11_209_0
3031 
81.00% 3,107 L11_209_0
3029 
99.00% 455 L11_209_0
1543 
80.00% 4,508 
L10-
023_Cl_Gt
75(49)_D 
L10_023_0
3069 
100.00% 1,133 L10_023_0
3079 
81.00% 3,107 L10_023_0
3081 
99.00% 455 L10_023_0
0715 
80.00% 7,496 
L09-
329_Cl_Gt
75(49)_D 
L09_329_0
2691 
100.00% 1,133 L09_329_0
2681 
81.00% 3,107 L09_329_0
2679 
99.00% 455 L09_329_0
1602 
80.00% 4,508 
L02-
521_Cl_Gt
29(27)_D 
L02_521_0
2549 
100.00% 1,133 L02_521_0
2559 
81.00% 3,107 L02_521_0
2561 
99.00% 455 L02_521_0
1083 
80.00% 4,508 
Lpn-Paris Paris_0279
3 
99.00% 1,133 Paris_0280
3 
81.00% 3,107 Paris_0280
5 
99.00% 455 Paris_0071
5 
83.00% 23,039 
H39_Gt4(1
7)_D 
H39_0315
9 
100.00% 1,133 H39_0316
9 
81.00% 3,107 H39_0317
1 
99.00% 455 H39_0120
9 
83.00% 5,012 
A139_Gt4(
17)_Ps 
A139_029
71 
99.00% 1,133 A139_029
81 
81.00% 3,107 A139_029
83 
99.00% 455 A139_011
18 
83.00% 5,012 
A5_Gt4(17
)_Ps 
A5_02597 99.00% 1,133 A5_02587 81.00% 3,107 A5_02585 99.00% 455 A5_03010 83.00% 5,012 
A29_Gt6(1
8)_Ps 
A29_0296
7 
99.00% 1,133 A29_0295
7 
81.00% 3,107 A29_0295
5 
99.00% 455 A29_0194
2 
83.00% 5,012 
A131_Gt6(
18)_Ps 
A131_031
34 
99.00% 1,133 A131_031
44 
81.00% 3,107 A131_031
46 
99.00% 455 A131_013
68 
83.00% 5,012 
Lpn-D7630 lpn_D7630
_02761 
100.00% 1,133 lpn_D7630
_02772 
81.00% 3,104 lpn_D7630
_02774 
99.00% 455 lpn_D7630
_00651 
85.00% 22,649 
H34_Gt22(
102)_D 
H34_0234
7 
100.00% 1,133 H34_0098
3 
81.00% 3,104 H34_0098
1 
99.00% 455 H34_0022
1 
85.00% 4,415 
H29_Gt22(
100)_D 
H29_0232
9 
100.00% 1,133 H29_0201
6 
81.00% 3,104 H29_0201
8 
99.00% 455 H29_0044
9 
85.00% 4,415 
H35_Gt22(
102)_D 
H35_0290
6 
100.00% 1,133 H35_0242
5 
81.00% 3,104 H35_0242
3 
99.00% 455 H35_0198
6 
85.00% 4,415 
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Lpn-
Lorraine 
Lorriane_0
2816 
100.00% 1,133 Lorriane_0
2827 
81.00% 3,095 Lorriane_0
2829 
99.00% 455 Lorriane_0
0680 
85.00% 12,950 
A15_Gt12(
84)_Ps 
A15_0102
7 
100.00% 1,133 A15_0101
5 
81.00% 3,095 A15_0101
3 
99.00% 455 A15_0266
5 
77.00% 4,475 
Lpn-
Thunderba
y 
Thunderba
y_02811 
100.00% 1,133 Thunderba
y_02821 
93.00% 3,146 Thunderba
y_02823 
100.00% 455 Thunderba
y_00633 
85.00% 6,989 
L09-
313_Cl_Gt
84(116)_D 
L09_313_0
1999 
100.00% 1,133 L09_313_0
1989 
93.00% 3,146 L09_313_0
1987 
100.00% 455 L09_313_0
0347 
85.00% 3,854 
L01-
443_Cl_Gt
64(74)_D 
L01_443_0
1451 
100.00% 1,133 L01_443_0
1461 
93.00% 3,146 L01_443_0
1463 
100.00% 455 L01_443_0
1090 
85.00% 4,850 
A156_Gt6
4(74)_Ps 
A156_021
17 
100.00% 1,133 A156_021
07 
93.00% 3,146 A156_021
05 
100.00% 455 A156_024
30 
85.00% 3,875 
A129_Gt6
4(74)_Ps 
A129_011
86 
100.00% 1,133 A129_011
76 
93.00% 3,146 A129_011
74 
100.00% 455 A129_032
05 
85.00% 3,875 
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Table A7:  L. pneumophila branch one isolates from the West Bank genomic islands and their gene products  
GI 
Length 
(bp) 
Gene ID Locus Gene 
Length 
(bp) 
Product (A129_Gt64(74)_Ps) Product (A156_Gt64(74)_Ps) 
6,666 oxaA A129_00349 1,670 Preprotein translocase subunit YidC Preprotein translocase subunit YidC 
6,666  A129_00350 227 Putative membrane protein insertion efficiency factor Putative membrane protein insertion efficiency factor 
6,666 rnpA A129_00351 344 ribonuclease P protein component ribonuclease P protein component 
6,666 rpmH A129_00352 134 50S ribosomal protein L34 50S ribosomal protein L34 
6,666 dnaA A129_00353 1,358 chromosomal replication initiator protein DnaA chromosomal replication initiator protein DnaA 
6,666 dnaN A129_00354 1,103 DNA polymerase III beta chain DNA polymerase III beta chain 
6,666 recF A129_00355 1,061 DNA recombination and repair protein ATPase RecF DNA recombination and repair protein ATPase RecF 
8,619  A129_00411 908 transcriptional regulator, LysR family transcriptional regulator, LysR family 
8,619  A129_00412 719 hypothetical protein hypothetical protein 
8,619  A129_00413 404 putative regulator, MerR family transcription regulator putative regulator, MerR family transcription regulator 
8,619  A129_00414 743 hypothetical protein hypothetical protein 
8,619  A129_00415 1,091 hypothetical protein hypothetical protein 
8,619  A129_00416 281 phage related integrase phage related integrase 
8,619  A129_00417 182 hypothetical protein hypothetical protein 
8,619  A129_00418 665 methylase methylase 
8,619  A129_00419 1,178 multidrug resistance protein multidrug resistance protein 
8,619  A129_00420 1,271 hypothetical protein hypothetical protein 
16,241  A129_00500 1,304 hypothetical protein hypothetical protein 
16,241  A129_00501 659 phage repressor phage repressor 
16,241 lvrA2 A129_00502 884 Legionella vir region protein Legionella vir region protein 
16,241 csrA_2 A129_00503 266 global regulator (carbon storage regulator) global regulator (carbon storage regulator) 
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16,241  A129_00504 965 LvhB11 LvhB11 
16,241 trbC A129_00505 377 Conjugal transfer protein trbC Conjugal transfer protein trbC 
16,241 trbD A129_00506 299 Conjugal transfer protein trbD Conjugal transfer protein trbD 
16,241 trbE A129_00507 2,537 Conjugal transfer protein trbE precursor Conjugal transfer protein trbE precursor 
16,241 trbF A129_00508 743 Conjugal transfer protein trbF Conjugal transfer protein trbF 
16,241 trbG A129_00509 875 conjugal transfer protein trbG precursor conjugal transfer protein trbG precursor 
16,241  A129_00510 410 Conjugal transfer protein TrbH Conjugal transfer protein TrbH 
16,241 trbI A129_00511 1,241 Conjugal transfer protein trbI Conjugal transfer protein trbI 
16,241 trbJ A129_00512 740 Conjugal transfer protein trbJ precursor Conjugal transfer protein trbJ precursor 
16,241  A129_00513 212 hypothetical protein hypothetical protein 
16,241 trbL A129_00514 1472 putative conjugal transfer protein trbL putative conjugal transfer protein trbL 
16,241 traG A129_00515 1,889 Conjugal transfer protein traG Conjugal transfer protein traG 
16,241 traF A129_00516 545 Conjugal transfer protein traF precursor Conjugal transfer protein traF precursor 
16,241 traD A129_00517 164 Protein traD Protein traD 
16,241 traC A129_00518 2,186 DNA primase traC (Replication primase) DNA primase traC (Replication primase) 
16,856  A129_00527 482 cytidine/deoxycytidylate deaminase cytidine/deoxycytidylate deaminase 
16,856  A129_00528 1,442 hypothetical protein hypothetical protein 
16,856  A129_00529 359 hypothetical protein hypothetical protein 
16,856  A129_00530 653 putative HTH-type transcriptional regulator putative HTH-type transcriptional regulator 
16,856  A129_00531 248 hypothetical protein hypothetical protein 
16,856  A129_00532 206 hypothetical protein hypothetical protein 
16,856  A129_00533 1,205 Putative lambdoid prophage Rac integrase Putative lambdoid prophage Rac integrase 
16,856  A129_00534 815 hypothetical protein hypothetical protein 
16,856  A129_00535 791 hypothetical protein hypothetical protein 
16,856  A129_00536 203 hypothetical protein hypothetical protein 
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16,856  A129_02668 545 hypothetical protein hypothetical protein 
16,856  A129_02667 836 Integrase Integrase 
16,856  A129_02666 293 transposase, IS911 transposase, IS911 
16,856  A129_02665 329 hypothetical protein hypothetical protein 
16,856  A129_02664 1,370 hypothetical protein hypothetical protein 
16,856  A129_02663 1,340 hypothetical protein hypothetical protein 
16,856  A129_02662 1,358 KAP family P-loop domain protein KAP family P-loop domain protein 
16,856  A129_02661 1,064 hypothetical protein hypothetical protein 
16,856  A129_02660 515 acetyltransferase acetyltransferase 
16,856  A129_02659 224 hypothetical protein hypothetical protein 
64,062  A129_00172 587 hypothetical protein hypothetical protein 
64,062  A129_00171 413 putative exported protein putative exported protein 
64,062 csrA-2 A129_00170 200 carbon storage regulator carbon storage regulator 
64,062 lvrB_1 A129_00169 431 Legionella vir region protein Legionella vir region protein 
64,062 lvrA_1 A129_00168 899 LvrA LvrA 
64,062  A129_00167 254 putative phage repressor putative phage repressor 
64,062  A129_00166 851 putative secreted protein putative secreted protein 
64,062  A129_00165 146 hypothetical protein hypothetical protein 
64,062 ctpA_1 A129_00164 2,708 cation efflux transporter cation efflux transporter 
64,062 cebC_1 A129_00163 1,259 chemiosmotic efflux system B protein C chemiosmotic efflux system B protein C 
64,062 cebB_1 A129_00162 1,133 chemiosmotic efflux system B protein B chemiosmotic efflux system B protein B 
64,062 cebA_1 A129_00161 3,143 chemiosmotic efflux system B protein A chemiosmotic efflux system B protein A 
64,062  A129_00160 1,361 metallo-beta lactamase family protein metallo-beta lactamase family protein 
64,062 deoA A129_00159 1,517 thymidine phosphorylase TdRPase thymidine phosphorylase TdRPase 
64,062  A129_00158 905 ribose-phosphate pyrophosphokinase ribose-phosphate pyrophosphokinase 
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64,062  A129_00157 173 hypothetical protein hypothetical protein 
64,062 copA1 A129_00156 2,216 copper efflux ATPase copper efflux ATPase 
64,062 yegE_2 A129_00155 881 sensory box/GGDEF/EAL family protein sensory box/GGDEF/EAL family protein 
64,062  A129_00154 371 putative outer membrane lipoprotein putative outer membrane lipoprotein 
64,062 cecC_2 A129_00153 1,298 chemiosmotic efflux system C protein C chemiosmotic efflux system C protein C 
64,062 cecB A129_00152 953 chemiosmotic efflux system C protein B chemiosmotic efflux system C protein B 
64,062  A129_00151 3,212 Chemiosmotic efflux system protein A-like protein Chemiosmotic efflux system protein A-like protein 
64,062  A129_00150 452 hypothetical protein hypothetical protein 
64,062  A129_00149 311 hypothetical protein hypothetical protein 
64,062  A129_00148 1,679 hypothetical protein hypothetical protein 
64,062  A129_00147 155 hypothetical protein hypothetical protein 
64,062  A129_00146 527 hypothetical protein hypothetical protein 
64,062 copA2_2 A129_00145 3,086 copper efflux ATPase copper efflux ATPase 
64,062  A129_00144 461 hypothetical protein hypothetical protein 
64,062  A129_00143 611 hypothetical protein hypothetical protein 
64,062  A129_00142 173 hypothetical protein hypothetical protein 
64,062 artJ_2 A129_00141 509 arginine 3rd transport system periplasmic binding protein arginine 3rd transport system periplasmic binding protein 
64,062 helC_2 A129_00140 1,250 cobalt/zinc/cadmium efflux RND transporter, outer membrane 
protein 
cobalt/zinc/cadmium efflux RND transporter, outer membrane 
protein 
64,062 helB_2 A129_00139 1,253 cation efflux system HelB cation efflux system HelB 
64,062 helA_2 A129_00138 3,158 cobalt/zinc/cadmium efflux RND transporter, permease 
protein HelA 
cobalt/zinc/cadmium efflux RND transporter, permease protein HelA 
64,062  A129_00137 200 hypothetical protein hypothetical protein 
64,062 nmtR A129_00136 296 HTH-type transcriptional regulator NmtR HTH-type transcriptional regulator NmtR 
64,062  A129_00135 131 hypothetical protein hypothetical protein 
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64,062 cadA_2 A129_00134 2,141 cadmium translocating P-type ATPase CadA cadmium translocating P-type ATPase CadA 
64,062  A129_00133 98 hypothetical protein hypothetical protein 
64,062  A129_00132 173 hypothetical protein hypothetical protein 
64,062 xerC_2 A129_00131 575 Tyrosine recombinase XerC Tyrosine recombinase XerC 
64,062  A129_00130 1,520 hypothetical protein hypothetical protein 
64,062  A129_00129 1,280 Tn3 transposase DDE domain protein Tn3 transposase DDE domain protein 
64,062  A129_00128 302 Tn3 transposase DDE domain protein Tn3 transposase DDE domain protein 
64,062  A129_00127 296 hypothetical protein hypothetical protein 
64,062  A129_00126 665 putative S-isoprenylcysteine methyltransferase putative S-isoprenylcysteine methyltransferase 
64,062  A129_00125 500 hypothetical protein hypothetical protein 
64,062  A129_00124 821 hypothetical protein hypothetical protein 
64,062  A129_00123 761 hypothetical protein hypothetical protein 
64,062  A129_00122 1,889 oxidoreductase, FAD-binding oxidoreductase, FAD-binding 
64,062  A129_00121 869 hypothetical protein hypothetical protein 
64,062  A129_00120 1,472 ATP synthase F1, subunit alpha ATP synthase F1, subunit alpha 
64,062 atpF_1 A129_00119 743 ATP synthase subunit b ATP synthase subunit b 
64,062 atpE_1 A129_00118 275 ATP synthase subunit c ATP synthase subunit c 
64,062 atpB_1 A129_00117 692 ATP synthase F0, A subunit ATP synthase F0, A subunit 
64,062  A129_00116 278 Putative F0F1-ATPase subunit (ATPase_gene1) Putative F0F1-ATPase subunit (ATPase_gene1) 
64,062  A129_00115 410 F0F1 ATP synthase subunit epsilon F0F1 ATP synthase subunit epsilon 
64,062 atpD_1 A129_00114 1,424 ATP synthase F1, beta chain ATP synthase F1, beta chain 
64,062  A129_00113 440 hypothetical protein hypothetical protein 
64,062  A129_00112 152 hypothetical protein hypothetical protein 
64,062  A129_00111 263 anaerobic benzoate catabolism transcriptional regulator anaerobic benzoate catabolism transcriptional regulator 
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64,062  A129_00110 542 guanylate cyclase guanylate cyclase 
64,062 rre41_1 A129_00109 779 sensory box (GGDEF/EAL domain) regulatory protein sensory box (GGDEF/EAL domain) regulatory protein 
16,989  A129_00097 203 prophage regulatory protein-like protein prophage regulatory protein-like protein 
16,989  A129_00096 965 AbiD phage protein-like protein AbiD phage protein-like protein 
16,989 int_1 A129_00095 1,181 integrase, phage related integrase, phage related 
16,989  A129_00094 275 TnpA transposase TnpA transposase 
16,989  A129_02951 1,103 hypothetical protein hypothetical protein 
16,989  A129_02952 1,184 hypothetical protein hypothetical protein 
16,989  A129_02953 515 hypothetical protein hypothetical protein 
16,989  A129_02954 1,709 inner membrane protein inner membrane protein 
16,989  A129_02955 371 hypothetical protein hypothetical protein 
16,989  A129_02956 152 hypothetical protein hypothetical protein 
16,989  A129_02957 1,355 deoxyguanosinetriphosphate triphosphohydrolase deoxyguanosinetriphosphate triphosphohydrolase 
16,989  A129_02958 1,496 reverse transcriptase reverse transcriptase 
16,989  A129_02959 407 hypothetical protein hypothetical protein 
16,989  A129_02960 683 hypothetical protein hypothetical protein 
16,989  A129_02961 1,031 hypothetical protein hypothetical protein 
16,989  A129_02962 1,244 phage related integrase phage related integrase 
18,290  A129_02121 170 hypothetical protein 0 
18,290 cadA_4 A129_02120 2,135 cadmium translocating P-type ATPase CadA 0 
18,290 helA_4 A129_02119 3,149 cobalt/zinc/cadmium efflux RND transporter, permease 
protein HelA 
0 
18,290 helB_4 A129_02118 1,256 cation efflux system HelB 0 
18,290 helC_5 A129_02117 1,244 cobalt/zinc/cadmium efflux RND transporter, outer membrane 
protein 
0 
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18,290  A129_02116 662 phage repressor 0 
18,290 lvrA_2 A129_02115 872 Legionella vir region protein 0 
18,290 lvrB_2 A129_02114 383 Legionella vir region protein 0 
18,290 lvrC A129_02113 197 Legionella vir region protein 0 
18,290  A129_02112 434 putative exported protein 0 
18,290  A129_02111 614 hypothetical protein 0 
18,290  A129_02110 836 putative exported protein 0 
18,290  A129_02109 458 hypothetical protein 0 
18,290  A129_02108 698 hypothetical protein 0 
18,290  A129_02107 323 hypothetical protein 0 
18,290  A129_02106 263 hypothetical protein 0 
18,290  A129_02105 386 hypothetical protein 0 
18,290  A129_02104 350 hypothetical protein 0 
18,290  A129_02103 662 hypothetical protein 0 
18,290  A129_02102 782 hypothetical protein 0 
18,290  A129_02101 1,313 exported membrane protein 0 
18,290  A129_02100 389 hypothetical protein 0 
11,562  A129_02091 209 hypothetical protein 0 
11,562  A129_02090 968 hypothetical protein 0 
11,562  A129_02089 803 hypothetical protein 0 
11,562  A129_02088 899 putative integrase 0 
11,562  A129_02087 185 hypothetical protein 0 
11,562  A129_02086 506 antirestriction protein 0 
11,562  A129_02085 617 hypothetical protein 0 
11,562  A129_02084 491 hypothetical protein 0 
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11,562 dam_1 A129_02083 818 DNA adenine methylase 0 
11,562  A129_02899 1,025 Integrase core domain protein 0 
11,562 tnpA_3 A129_02900 1,418 Transposase for transposon Tn5 0 
11,562  A129_02901 209 cold shock DNA binding domain protein 0 
5,373  A129_01064 95 hypothetical protein hypothetical protein 
5,373 int_2 A129_01065 428 integrase, phage related integrase, phage related 
5,373  A129_01066 1,457 Divergent AAA domain protein Divergent AAA domain protein 
5,373  A129_01067 587 hypothetical protein hypothetical protein 
5,373  A129_01068 494 hypothetical protein hypothetical protein 
5,373  A129_01069 677 phage repressor phage repressor 
5,373  A129_01070 206 prophage regulatory protein-like protein prophage regulatory protein-like protein 
5,373  A129_01071 398 LvrA LvrA 
48,997  A129_00623 1,457 Tn3 transposase DDE domain protein 0 
48,997  A129_00624 965 Tn3 transposase DDE domain protein 0 
48,997  A129_00625 476 transcriptional regulator, MerR family, mercury resistance 0 
48,997  A129_00626 452 hypothetical protein 0 
48,997  A129_00627 584 site specific recombinase 0 
48,997  A129_00628 506 hypothetical protein 0 
48,997  A129_02669 305 hypothetical protein 0 
48,997  A129_02670 209 hypothetical protein 0 
48,997  A129_02671 425 single strand DNA binding protein 0 
48,997  A129_02672 224 hypothetical protein 0 
48,997  A129_02673 167 hypothetical protein 0 
48,997  A129_02515 275 TnpA transposase 0 
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48,997  A129_00538 227 hypothetical protein 0 
48,997  A129_02674 290 endonuclease 0 
48,997  A129_02949 755 Insertion sequence putative ATP-binding protein 0 
48,997  A129_02950 1,520 Putative transposase for insertion sequence element 0 
48,997 tufA A129_02965 1,190 translation elongation factor Tu (EF-Tu) 0 
48,997  A129_02675 878 Integrase 0 
48,997  A129_02676 287 transposase, IS911 0 
48,997  A129_00304 92 hypothetical protein 0 
48,997  A129_00305 2,621 hypothetical protein 0 
48,997  A129_00306 1,121 Sid related protein-like protein 0 
48,997 sdeC A129_00307 2,045 substrates of the Legionella pneumophila Dot/Icm system 
SdeC 
0 
12,225  A129_00648 989 hypothetical protein 0 
12,225  A129_00649 401 Cation efflux system protein cusA 0 
12,225  A129_00650 362 putative outer membrane lipoprotein 0 
12,225  A129_00651 404 Response regulator receiver domain protein 0 
12,225 cadA_3 A129_00652 2,150 cadmium translocating P-type ATPase CadA 0 
12,225  A129_00653 269 Double zinc ribbon 0 
12,225 kmtR_2 A129_00654 296 HTH-type transcriptional regulator KmtR 0 
12,225  A129_00655 206 hypothetical protein 0 
12,225 helA_3 A129_00656 3,149 cobalt/zinc/cadmium efflux RND transporter, permease 
protein HelA 
0 
12,225 helB_3 A129_00657 1,244 cation efflux system HelB 0 
12,225 helC_3 A129_00658 863 cobalt/zinc/cadmium efflux RND transporter, outer membrane 
protein 
0 
12,225 helC_4 A129_00659 323 cobalt/zinc/cadmium efflux RND transporter, outer membrane 
protein 
0 
12,225 artJ_4 A129_00660 788 arginine 3rd transport system periplasmic binding protein 0 
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59,011  A129_00008 548 ORF6N domain protein 0 
59,011 czcD_1 A129_00009 602 cation efflux system protein 0 
59,011 copA2_1 A129_00010 1,442 copper efflux ATPase 0 
59,011  A129_00011 449 hypothetical protein 0 
59,011  A129_00012 3,236 Chemiosmotic efflux system protein A-like protein 0 
59,011 ceaB_1 A129_00013 971 Chemiosmotic efflux system protein B-like protein 0 
59,011 cecC_1 A129_00014 1,316 chemiosmotic efflux system C protein C 0 
59,011  A129_00015 2,198 copper efflux ATPase 0 
59,011 csoR A129_00016 275 Copper-sensing transcriptional repressor CsoR 0 
59,011 yegE_1 A129_00017 839 sensory box/GGDEF/EAL family protein 0 
59,011  A129_00018 3,002 Tn3 transposase DDE domain protein 0 
59,011 pinR A129_00019 575 Putative DNA-invertase from lambdoid prophage Rac 0 
59,011  A129_00020 791 haloalkane dehalogenase 0 
59,011  A129_00021 164 hypothetical protein 0 
59,011  A129_00022 386 Response regulator receiver domain protein 0 
59,011 cadA_1 A129_00023 2,156 cadmium translocating P-type ATPase CadA 0 
59,011  A129_00024 269 Double zinc ribbon 0 
59,011 kmtR_1 A129_00025 296 HTH-type transcriptional regulator KmtR 0 
59,011 helA_1 A129_00026 3,152 cobalt/zinc/cadmium efflux RND transporter, permease 
protein HelA 
0 
59,011 helB_1 A129_00027 1,244 cation efflux system HelB 0 
59,011 helC_1 A129_00028 1,247 cobalt/zinc/cadmium efflux RND transporter, outer membrane 
protein 
0 
59,011 artJ_1 A129_00029 788 arginine 3rd transport system periplasmic binding protein 0 
59,011  A129_00030 188 carbon storage regulator CsrA 0 
59,011  A129_00031 602 inclusion membrane protein A 0 
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59,011  A129_00032 1,166 hypothetical protein 0 
59,011  A129_00033 899 hypothetical protein 0 
59,011  A129_00034 749 hypothetical protein 0 
59,011  A129_00035 851 hypothetical protein 0 
59,011  A129_00036 584 transposase (resolvase, DNA invertase) 0 
59,011  A129_00037 3,050 Tn3 transposase DDE domain protein 0 
59,011  A129_00038 707 inclusion membrane protein A 0 
59,011  A129_00039 950 hypothetical protein 0 
59,011  A129_00040 299 hypothetical protein 0 
59,011  A129_00041 842 hypothetical protein 0 
59,011  A129_00042 959 CobQ/CobB/MinD/ParA nucleotide binding domain protein 0 
59,011  A129_00043 1,151 hypothetical protein 0 
59,011  A129_00044 464 hypothetical protein 0 
59,011 parB_1 A129_00045 878 chromosome partitioning protein ParB (SpoOJ) 0 
59,011  A129_00046 1,043 sulfurylase ThiF 0 
59,011  A129_00047 1,412 hypothetical protein 0 
59,011  A129_00048 1,166 hypothetical protein 0 
59,011  A129_00049 128 hypothetical protein 0 
59,011  A129_00050 251 hypothetical protein 0 
59,011  A129_00051 1,034 YcaO-like family protein 0 
59,011  A129_00052 1,052 TfuA-like protein 0 
59,011  A129_00053 1,259 hypothetical protein 0 
59,011  A129_00054 1,010 hypothetical protein 0 
59,011  A129_00055 533 hypothetical protein 0 
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59,011  A129_00056 176 hypothetical protein 0 
59,011 csrA_1 A129_00057 227 global regulator (carbon storage regulator) 0 
59,011 ylpA A129_00058 752 Lipoprotein YlpA precursor 0 
59,011  A129_00059 461 putative exported protein 0 
59,011  A129_00060 647 hypothetical protein 0 
59,011  A129_00061 845 putative exported protein 0 
59,011  A129_00062 476 hypothetical protein 0 
59,011  A129_00063 746 hypothetical protein 0 
59,011  A129_00064 326 hypothetical protein 0 
59,011  A129_00065 257 hypothetical protein 0 
9,013  A129_00090 347 hypothetical protein 0 
9,013  A129_00091 236 hypothetical protein 0 
9,013  A129_00092 806 hypothetical protein 0 
9,013  A129_00093 899 putative integrase 0 
9,013  A129_01109 365 hypothetical protein 0 
9,013  A129_01110 209 hypothetical protein 0 
9,013  A129_01111 425 single strand DNA binding protein 0 
9,013  A129_01112 224 hypothetical protein 0 
9,013  A129_01113 167 hypothetical protein 0 
9,013 tnpA_2 A129_02677 1,418 Transposase for transposon Tn5 0 
GI: Genomic Island     
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Table A8:  L. pneumophila branch three  isolates from HZI genomic islands and their gene products   
GI Length 
(bp) 
Gene 
ID 
Locus Gene Length 
(bp) 
Product (H34_Gt22(102)_D) Product (H29_Gt22(100)_D) Product (H35_Gt22(102)_D) 
8,009 thdF H34_01366 1,334 GTP binding protein in thiophene and furan 
oxidation (GTPase) 
GTP binding protein in thiophene and furan 
oxidation (GTPase) 
GTP binding protein in thiophene and furan 
oxidation (GTPase) 
8,009 oxaA H34_01365 1,670 Preprotein translocase subunit YidC Preprotein translocase subunit YidC Preprotein translocase subunit YidC 
8,009 0 H34_01364 227 Putative membrane protein insertion efficiency 
factor 
Putative membrane protein insertion efficiency 
factor 
Putative membrane protein insertion efficiency 
factor 
8,009 rnpA H34_01363 344 ribonuclease P protein component ribonuclease P protein component ribonuclease P protein component 
8,009 rpmH H34_01362 134 50S ribosomal protein L34 50S ribosomal protein L34 50S ribosomal protein L34 
8,009 dnaA H34_01361 1,358 chromosomal replication initiator protein DnaA chromosomal replication initiator protein DnaA chromosomal replication initiator protein DnaA 
8,009 dnaN H34_01360 1,103 DNA polymerase III beta chain DNA polymerase III beta chain DNA polymerase III beta chain 
8,009 recF H34_01359 1,061 DNA recombination and repair protein ATPase RecF DNA recombination and repair protein ATPase RecF DNA recombination and repair protein ATPase RecF 
16,952 0 H34_01220 539 hypothetical protein hypothetical protein hypothetical protein 
16,952 0 H34_01219 275 Prophage CP4-57 regulatory protein alpA Prophage CP4-57 regulatory protein alpA Prophage CP4-57 regulatory protein alpA 
16,952 0 H34_01218 281 DNA primase DNA primase DNA primase 
16,952 0 H34_01217 2,084 hypothetical protein hypothetical protein hypothetical protein 
16,952 0 H34_01216 437 hypothetical protein hypothetical protein hypothetical protein 
16,952 0 H34_01215 680 hypothetical protein hypothetical protein hypothetical protein 
16,952 0 H34_01214 299 Helix-turn-helix domain protein Helix-turn-helix domain protein Helix-turn-helix domain protein 
16,952 0 H34_01213 2,477 hypothetical protein hypothetical protein hypothetical protein 
16,952 0 H34_01212 1,298 Competence protein CoiA-like family protein Competence protein CoiA-like family protein Competence protein CoiA-like family protein 
16,952 0 H34_01211 632 hypothetical protein hypothetical protein hypothetical protein 
16,952 0 H34_01210 548 hypothetical protein hypothetical protein hypothetical protein 
16,952 0 H34_01209 710 hypothetical protein hypothetical protein hypothetical protein 
16,952 0 H34_01208 806 Calcineurin-like phosphoesterase Calcineurin-like phosphoesterase Calcineurin-like phosphoesterase 
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16,952 0 H34_01207 662 hypothetical protein hypothetical protein hypothetical protein 
16,952 0 H34_01206 917 hypothetical protein hypothetical protein hypothetical protein 
16,952 0 H34_01205 755 hypothetical protein hypothetical protein hypothetical protein 
16,952 0 H34_01204 371 hypothetical protein hypothetical protein hypothetical protein 
16,952 0 H34_01203 506 Acetyltransferase (GNAT) family protein Acetyltransferase (GNAT) family protein Acetyltransferase (GNAT) family protein 
16,952 yfkM H34_01202 674 General stress protein 18 General stress protein 18 General stress protein 18 
7,152 0 H34_02053 992 multidrug resistance secretion protein multidrug resistance secretion protein multidrug resistance secretion protein 
7,152 0 H34_02052 398 hypothetical protein hypothetical protein hypothetical protein 
7,152 0 H34_02051 638 bacteriophage related DNA polymerase bacteriophage related DNA polymerase bacteriophage related DNA polymerase 
7,152 0 H34_02050 242 MFS transporter family protein MFS transporter family protein MFS transporter family protein 
7,152 0 H34_02049 995 MFS transporter family protein MFS transporter family protein MFS transporter family protein 
7,152 0 H34_02048 656 N-acetylmuramoyl-L-alanine amidase; amidase 2 N-acetylmuramoyl-L-alanine amidase; amidase 2 N-acetylmuramoyl-L-alanine amidase; amidase 2 
7,152 copA2_2 H34_02047 1,541 copper efflux ATPase copper efflux ATPase copper efflux ATPase 
7,152 0 H34_02046 434 hypothetical protein hypothetical protein hypothetical protein 
27,517 0 H34_00368 587 hypothetical protein hypothetical protein hypothetical protein 
27,517 0 H34_00369 413 putative exported protein 0 putative exported protein 
27,517 csrA-2 H34_00370 200 carbon storage regulator 0 carbon storage regulator 
27,517 lvrB_1 H34_00371 431 Legionella vir region protein 0 Legionella vir region protein 
27,517 lvrA_1 H34_00372 899 LvrA 0 LvrA 
27,517 0 H34_00373 254 putative phage repressor putative phage repressor putative phage repressor 
27,517 0 H34_00374 851 putative secreted protein putative secreted protein putative secreted protein 
27,517 0 H34_00375 146 hypothetical protein hypothetical protein hypothetical protein 
27,517 ctpA_1 H34_00376 2,705 cation efflux transporter cation efflux transporter cation efflux transporter 
27,517 cebC_1 H34_00377 1,259 chemiosmotic efflux system B protein C chemiosmotic efflux system B protein C chemiosmotic efflux system B protein C 
27,517 cebB_1 H34_00378 1,133 chemiosmotic efflux system B protein B chemiosmotic efflux system B protein B chemiosmotic efflux system B protein B 
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27,517 cebA H34_00379 3,143 chemiosmotic efflux system B protein A chemiosmotic efflux system B protein A chemiosmotic efflux system B protein A 
27,517 0 H34_00380 1,361 metallo-beta lactamase family protein metallo-beta lactamase family protein metallo-beta lactamase family protein 
27,517 deoA H34_00381 1,517 thymidine phosphorylase TdRPase thymidine phosphorylase TdRPase thymidine phosphorylase TdRPase 
27,517 0 H34_00382 932 ribose-phosphate pyrophosphokinase ribose-phosphate pyrophosphokinase ribose-phosphate pyrophosphokinase 
27,517 0 H34_00383 167 hypothetical protein hypothetical protein hypothetical protein 
27,517 copA1_1 H34_00384 2,216 copper efflux ATPase copper efflux ATPase copper efflux ATPase 
27,517 yegE H34_00385 881 sensory box/GGDEF/EAL family protein sensory box/GGDEF/EAL family protein sensory box/GGDEF/EAL family protein 
27,517 0 H34_00386 371 putative outer membrane lipoprotein putative outer membrane lipoprotein putative outer membrane lipoprotein 
27,517 cecC H34_00387 1,298 chemiosmotic efflux system C protein C chemiosmotic efflux system C protein C chemiosmotic efflux system C protein C 
27,517 cecB H34_00388 971 chemiosmotic efflux system C protein B chemiosmotic efflux system C protein B chemiosmotic efflux system C protein B 
27,517 0 H34_00389 3,212 Chemiosmotic efflux system protein A-like protein Chemiosmotic efflux system protein A-like protein Chemiosmotic efflux system protein A-like protein 
27,517 0 H34_00390 452 hypothetical protein hypothetical protein hypothetical protein 
27,517 0 H34_00391 1,055 Leucine carboxyl methyltransferase Leucine carboxyl methyltransferase Leucine carboxyl methyltransferase 
32779 0 H34_00405 173 hypothetical protein hypothetical protein hypothetical protein 
32779 artJ_1 H34_00406 509 arginine 3rd transport system periplasmic binding 
protein 
arginine 3rd transport system periplasmic binding 
protein 
arginine 3rd transport system periplasmic binding 
protein 
32779 helC_1 H34_00407 1,250 cobalt/zinc/cadmium efflux RND transporter, outer 
membrane protein 
cobalt/zinc/cadmium efflux RND transporter, outer 
membrane protein 
cobalt/zinc/cadmium efflux RND transporter, outer 
membrane protein 
32779 helB_1 H34_00408 1,253 cation efflux system HelB cation efflux system HelB cation efflux system HelB 
32779 helA_1 H34_00409 3,158 cobalt/zinc/cadmium efflux RND transporter, 
permease protein HelA 
cobalt/zinc/cadmium efflux RND transporter, 
permease protein HelA 
cobalt/zinc/cadmium efflux RND transporter, 
permease protein HelA 
32779 0 H34_00410 200 hypothetical protein hypothetical protein hypothetical protein 
32779 nmtR H34_00411 296 HTH-type transcriptional regulator NmtR HTH-type transcriptional regulator NmtR HTH-type transcriptional regulator NmtR 
32779 0 H34_00412 131 hypothetical protein hypothetical protein hypothetical protein 
32779 cadA_1 H34_00413 2,141 cadmium translocating P-type ATPase CadA cadmium translocating P-type ATPase CadA cadmium translocating P-type ATPase CadA 
32779 0 H34_00414 98 hypothetical protein hypothetical protein hypothetical protein 
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32779 0 H34_00415 173 hypothetical protein hypothetical protein hypothetical protein 
32779 xerC H34_00416 575 Tyrosine recombinase XerC Tyrosine recombinase XerC Tyrosine recombinase XerC 
32779 0 H34_00417 1,520 hypothetical protein hypothetical protein hypothetical protein 
32779 0 H34_00418 1,280 Tn3 transposase DDE domain protein Tn3 transposase DDE domain protein Tn3 transposase DDE domain protein 
32779 0 H34_00419 302 Tn3 transposase DDE domain protein Tn3 transposase DDE domain protein Tn3 transposase DDE domain protein 
32779 0 H34_00420 296 hypothetical protein hypothetical protein hypothetical protein 
32779 0 H34_00421 665 putative S-isoprenylcysteine methyltransferase putative S-isoprenylcysteine methyltransferase putative S-isoprenylcysteine methyltransferase 
32779 0 H34_00422 500 hypothetical protein hypothetical protein hypothetical protein 
32779 0 H34_00423 821 hypothetical protein hypothetical protein hypothetical protein 
32779 0 H34_00424 761 hypothetical protein hypothetical protein hypothetical protein 
32779 0 H34_00425 1,883 oxidoreductase, FAD-binding oxidoreductase, FAD-binding oxidoreductase, FAD-binding 
32779 0 H34_00426 374 hypothetical protein hypothetical protein hypothetical protein 
32779 0 H34_00427 869 hypothetical protein hypothetical protein hypothetical protein 
32779 0 H34_00428 1,472 ATP synthase F1, subunit alpha ATP synthase F1, subunit alpha ATP synthase F1, subunit alpha 
32779 atpF_1 H34_00429 743 ATP synthase subunit b ATP synthase subunit b ATP synthase subunit b 
32779 atpE_1 H34_00430 275 ATP synthase subunit c ATP synthase subunit c ATP synthase subunit c 
32779 atpB_1 H34_00431 692 ATP synthase F0, A subunit ATP synthase F0, A subunit ATP synthase F0, A subunit 
32779 0 H34_00432 278 Putative F0F1-ATPase subunit (ATPase_gene1) Putative F0F1-ATPase subunit (ATPase_gene1) Putative F0F1-ATPase subunit (ATPase_gene1) 
32779 0 H34_00433 410 F0F1 ATP synthase subunit epsilon F0F1 ATP synthase subunit epsilon F0F1 ATP synthase subunit epsilon 
32779 atpD_1 H34_00434 1,424 ATP synthase F1, beta chain ATP synthase F1, beta chain ATP synthase F1, beta chain 
32779 0 H34_00435 449 hypothetical protein hypothetical protein hypothetical protein 
32779 0 H34_00436 263 anaerobic benzoate catabolism transcriptional 
regulator 
anaerobic benzoate catabolism transcriptional 
regulator 
anaerobic benzoate catabolism transcriptional 
regulator 
32779 0 H34_00437 542 guanylate cyclase guanylate cyclase guanylate cyclase 
32779 0 H34_00438 353 putative diguanylate cyclase putative diguanylate cyclase putative diguanylate cyclase 
 160 
 
32779 0 H34_00439 1,163 inner membrane protein PLUS sensory box protein 
LssE 
inner membrane protein PLUS sensory box protein 
LssE 
inner membrane protein PLUS sensory box protein 
LssE 
32779 phbC_1 H34_00440 1,793 polyhydroxyalkanoic synthase polyhydroxyalkanoic synthase polyhydroxyalkanoic synthase 
16619 0 H34_02537 1,034 transposase (ISSod13) transposase (ISSod13) transposase (ISSod13) 
16619 0 H34_02538 1,529 TcdA/TcdB catalytic glycosyltransferase domain 
protein 
TcdA/TcdB catalytic glycosyltransferase domain 
protein 
TcdA/TcdB catalytic glycosyltransferase domain 
protein 
16619 0 H34_02539 566 peptidyl-prolyl cis-trans isomerase (rotamase) peptidyl-prolyl cis-trans isomerase (rotamase) peptidyl-prolyl cis-trans isomerase (rotamase) 
16619 0 H34_02540 2,096 hypothetical protein hypothetical protein hypothetical protein 
16619 0 H34_02541 2,933 hypothetical protein hypothetical protein hypothetical protein 
16619 0 H34_02542 1,565 hypothetical protein hypothetical protein hypothetical protein 
16619 0 H34_02543 227 hypothetical protein hypothetical protein hypothetical protein 
16619 0 H34_02544 113 hypothetical protein hypothetical protein hypothetical protein 
16619 0 H34_02545 560 transcriptional regulator, TetR family transcriptional regulator, TetR family transcriptional regulator, TetR family 
16619 0 H34_02546 749 hypothetical protein hypothetical protein hypothetical protein 
16619 0 H34_02547 242 hypothetical protein hypothetical protein hypothetical protein 
16619 0 H34_02548 1,793 Tpr Tpr Tpr 
16619 gst_1 H34_02549 623 glutathione S-transferase glutathione S-transferase glutathione S-transferase 
21177 0 H34_01023 395 hypothetical protein hypothetical protein hypothetical protein 
21177 0 H34_01024 1,907 cadmium efflux ATPase cadmium efflux ATPase cadmium efflux ATPase 
21177 0 H34_01025 170 hypothetical protein hypothetical protein hypothetical protein 
21177 cadA_2 H34_01026 2,135 cadmium translocating P-type ATPase CadA cadmium translocating P-type ATPase CadA cadmium translocating P-type ATPase CadA 
21177 helA_2 H34_01027 3,149 cobalt/zinc/cadmium efflux RND transporter, 
permease protein HelA 
cobalt/zinc/cadmium efflux RND transporter, 
permease protein HelA 
cobalt/zinc/cadmium efflux RND transporter, 
permease protein HelA 
21177 helB_2 H34_01028 1,256 cation efflux system HelB cation efflux system HelB cation efflux system HelB 
21177 helC_2 H34_01029 1,244 cobalt/zinc/cadmium efflux RND transporter, outer 
membrane protein 
cobalt/zinc/cadmium efflux RND transporter, outer 
membrane protein 
cobalt/zinc/cadmium efflux RND transporter, outer 
membrane protein 
21177 0 H34_01030 662 phage repressor phage repressor phage repressor 
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21177 lvrA_2 H34_01031 872 Legionella vir region protein Legionella vir region protein Legionella vir region protein 
21177 lvrB_2 H34_01032 383 Legionella vir region protein Legionella vir region protein Legionella vir region protein 
21177 lvrC H34_01033 197 Legionella vir region protein Legionella vir region protein Legionella vir region protein 
21177 0 H34_01034 434 putative exported protein putative exported protein putative exported protein 
21177 0 H34_01035 596 hypothetical protein hypothetical protein hypothetical protein 
21177 0 H34_01036 836 putative exported protein putative exported protein putative exported protein 
21177 0 H34_01037 458 hypothetical protein hypothetical protein hypothetical protein 
21177 0 H34_01038 698 hypothetical protein hypothetical protein hypothetical protein 
21177 0 H34_01039 323 hypothetical protein hypothetical protein hypothetical protein 
21177 0 H34_01040 263 hypothetical protein hypothetical protein hypothetical protein 
21177 0 H34_01041 386 hypothetical protein hypothetical protein hypothetical protein 
21177 0 H34_01042 350 hypothetical protein hypothetical protein hypothetical protein 
21177 0 H34_01043 662 hypothetical protein hypothetical protein hypothetical protein 
21177 0 H34_01044 782 hypothetical protein hypothetical protein hypothetical protein 
21177 0 H34_01045 1,313 exported membrane protein exported membrane protein exported membrane protein 
21177 0 H34_01046 389 hypothetical protein hypothetical protein hypothetical protein 
30124 0 H34_02359 965 major outer membrane protein heme exporter protein CcmC 0 
30124 tufA_2 H34_02301 917 translation elongation factor Tu (EF-Tu) heme exporter protein CcmD 0 
30124 0 H34_02302 341 preprotein translocase subunit SecE cytochrome c-type biogenesis protein CcmE 0 
30124 nusG H34_02303 548 transcription antitermination protein NusG cytochrome c-type biogenesis protein CcmF 0 
30124 rplK H34_02304 434 50S ribosomal protein L11 0 0 
30124 rplA H34_02305 695 50S ribosomal protein L1 0 0 
30124 rplJ H34_02306 533 50S ribosomal protein L10 0 0 
30124 rplL H34_02307 380 50S ribosomal protein L7/L12 Transposase DDE domain protein 0 
30124 rpoB H34_02308 4,106 DNA-directed RNA polymerase beta subunit hypothetical protein 0 
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30124 rpoC H34_02309 4,247 DNA-directed RNA polymerase subunit beta' transposase (ISSod13) 0 
30124 rpsL H34_02310 380 30S ribosomal protein S12 Transposase insI for insertion sequence element 
IS30B/C/D 
0 
30124 rpsG H34_02311 527 30S ribosomal protein S7 0 0 
30124 fusA H34_02312 2,084 translation elongation factor G (EF-G) 0 0 
30124 rpoD H34_02405 1,865 RNA polymerase sigma 70 factor (RpoD) RNA polymerase sigma 70 factor (RpoD) RNA polymerase sigma 70 factor (RpoD) 
30124  H34_02407 776 hypothetical protein hypothetical protein hypothetical protein 
30124 recD2 H34_02408 2,651 ATP-dependent RecD-like DNA helicase ATP-dependent RecD-like DNA helicase ATP-dependent RecD-like DNA helicase 
30124 0 H34_02409 1,487 reverse transcriptase reverse transcriptase reverse transcriptase 
30124 0 H34_02410 206 hypothetical protein hypothetical protein hypothetical protein 
30124 0 H34_02411 263 Conjugal transfer protein TraD Conjugal transfer protein TraD Conjugal transfer protein TraD 
30124 0 H34_02412 350 putative RNA helicase putative RNA helicase putative RNA helicase 
HZI: Helmholtz Center for Infection Research         GI: Genomic Island   
 
 
 
 
 
 
 
 
 163 
 
Table A9:  L. pneumophila branch six sub-lineage isolates from the West bank and Germany genomic islands and their gene products   
GI Length 
(bp) 
Gene 
ID 
Locus Gene Length 
(bp) 
Product (A193_Gt40(47)_Ps) Product (A195_Gt40(47)_Ps) Product (L04-545_Cl_Gt40(47)_D) 
6,667 oxaA A193_01430 1,670 Prep+K2:M74rotein translocase subunit YidC Preprotein translocase subunit YidC Preprotein translocase subunit YidC 
6,667  A193_01431 227 Putative membrane protein insertion efficiency 
factor 
Putative membrane protein insertion efficiency 
factor 
Putative membrane protein insertion efficiency 
factor 
6,667 rnpA A193_01432 344 ribonuclease P protein component ribonuclease P protein component ribonuclease P protein component 
6,667 rpmH A193_01433 134 50S ribosomal protein L34 50S ribosomal protein L34 50S ribosomal protein L34 
6,667 dnaA A193_01434 1,358 chromosomal replication initiator protein DnaA chromosomal replication initiator protein DnaA chromosomal replication initiator protein DnaA 
6,667 dnaN A193_01435 1,103 DNA polymerase III beta chain DNA polymerase III beta chain DNA polymerase III beta chain 
6,667 recF_1 A193_01436 1,061 DNA recombination and repair protein ATPase RecF DNA recombination and repair protein ATPase RecF DNA recombination and repair protein ATPase RecF 
19,317  A193_02966 365 hypothetical protein hypothetical protein hypothetical protein 
19,317  A193_02967 266 hypothetical protein hypothetical protein hypothetical protein 
19,317  A193_02968 326 hypothetical protein hypothetical protein hypothetical protein 
19,317  A193_02969 632 hypothetical protein hypothetical protein hypothetical protein 
19,317  A193_02970 431 hypothetical protein hypothetical protein hypothetical protein 
19,317  A193_02971 821 putative exported protein putative exported protein hypothetical protein 
19,317  A193_02972 587 hypothetical protein hypothetical protein hypothetical protein 
19,317  A193_02973 413 putative exported protein putative exported protein hypothetical protein 
19,317 csrA-2 A193_02974 200 carbon storage regulator carbon storage regulator putative exported protein 
19,317 lvrB A193_02975 362 Legionella vir region protein Legionella vir region protein hypothetical protein 
19,317 lvrA_2 A193_02976 899 LvrA LvrA putative exported protein 
19,317  A193_02977 254 putative phage repressor putative phage repressor carbon storage regulator 
19,317 copA2_2 A193_02978 482 copper efflux ATPase copper efflux ATPase Legionella vir region protein 
19,317  A193_02979 461 putative outer membrane lipoprotein putative outer membrane lipoprotein LvrA 
19,317  A193_02980 611 hypothetical protein hypothetical protein putative phage repressor 
 164 
 
19,317  A193_02981 173 hypothetical protein hypothetical protein copper efflux ATPase 
19,317 artJ_4 A193_02982 329 arginine 3rd transport system periplasmic binding 
protein 
arginine 3rd transport system periplasmic binding 
protein 
putative outer membrane lipoprotein 
19,317 helC A193_02983 1,250 cobalt/zinc/cadmium efflux RND transporter, outer 
membrane protein 
cobalt/zinc/cadmium efflux RND transporter, outer 
membrane protein 
hypothetical protein 
19,317 helB A193_02984 1,253 cation efflux system HelB cation efflux system HelB hypothetical protein 
19,317 helA A193_02985 3,158 cobalt/zinc/cadmium efflux RND transporter, 
permease protein HelA 
cobalt/zinc/cadmium efflux RND transporter, 
permease protein HelA 
arginine 3rd transport system periplasmic binding 
protein 
19,317  A193_02986 200 hypothetical protein hypothetical protein cobalt/zinc/cadmium efflux RND transporter, outer 
membrane protein 
19,317 nmtR A193_02987 296 HTH-type transcriptional regulator NmtR HTH-type transcriptional regulator NmtR cation efflux system HelB 
19,317  A193_02988 131 hypothetical protein hypothetical protein cobalt/zinc/cadmium efflux RND transporter, 
permease protein HelA 
19,317 cadA A193_02989 2,141 cadmium translocating P-type ATPase CadA cadmium translocating P-type ATPase CadA hypothetical protein 
19,317  A193_02990 167 hypothetical protein hypothetical protein HTH-type transcriptional regulator NmtR 
19,317  A193_02991 173 hypothetical protein hypothetical protein hypothetical protein 
19,317  A193_02992 254 anaerobic benzoate catabolism transcriptional 
regulator 
anaerobic benzoate catabolism transcriptional 
regulator 
cadmium translocating P-type ATPase CadA 
17,424  A193_03004 245 hypothetical protein hypothetical protein hypothetical protein 
17,424  A193_03005 218 prophage regulatory protein-like protein prophage regulatory protein-like protein hypothetical protein 
17,424  A193_03006 1,244 integrase, phage related integrase, phage related anaerobic benzoate catabolism transcriptional 
regulator 
17,424  A193_03007 650 hypothetical protein hypothetical protein hypothetical protein 
17,424  A193_03008 2,093 hypothetical protein hypothetical protein prophage regulatory protein-like protein 
17,424  A193_03009 272 hypothetical protein hypothetical protein integrase, phage related 
17,424  A193_03010 1,751 inner membrane protein inner membrane protein hypothetical protein 
17,424  A193_03011 809 hypothetical protein hypothetical protein hypothetical protein 
17,424 recF_2 A193_03012 1,985 DNA replication and repair protein RecF DNA replication and repair protein RecF hypothetical protein 
17,424 uvrD_2 A193_03013 1,856 DNA dependent ATPase I and helicase II DNA dependent ATPase I and helicase II inner membrane protein 
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17,424 dinJ_2 A193_03014 278 Antitoxin DinJ Antitoxin DinJ hypothetical protein 
17,424  A193_03015 359 hypothetical protein hypothetical protein DNA replication and repair protein RecF 
17,424  A193_03016 143 hypothetical protein Helix-turn-helix domain protein DNA dependent ATPase I and helicase II 
17,424  A193_03017 446 Helix-turn-helix domain protein hypothetical protein Antitoxin DinJ 
17,424  A193_03018 575 hypothetical protein putative regulator PrlF hypothetical protein 
17,424  A193_03019 218 putative regulator PrlF oxidoreductase (L-gululonolactone oxidase) hypothetical protein 
17,424  A193_03020 1,250 phage related integrase oxidoreductase, short chain 
dehydrogenase/reductase family protein 
Helix-turn-helix domain protein 
7,119  A193_00072 1,295 oxidoreductase (L-gululonolactone oxidase) transcriptional regulator, LysR family hypothetical protein 
7,119  A193_00073 722 oxidoreductase, short chain 
dehydrogenase/reductase family protein 
Transposase putative regulator PrlF 
7,119  A193_00074 926 transcriptional regulator, LysR family hypothetical protein oxidoreductase (L-gululonolactone oxidase) 
7,119  A193_00075 233 Transposase hypothetical protein oxidoreductase, short chain 
dehydrogenase/reductase family protein 
7,119  A193_00076 1,241 hypothetical protein hypothetical protein transcriptional regulator, LysR family 
7,119  A193_00077 1,196 hypothetical protein pyridoxamine 5'-phosphate oxidase Transposase 
7,119  A193_00078 197 hypothetical protein putative transcriptional regulator, MarR family hypothetical protein 
68,131 pdxH_2 A193_00453 587 pyridoxamine 5'-phosphate oxidase glucose-1-dehydrogenase, (3-oxoacyl-(acyl carrier 
protein) reductase) 
hypothetical protein 
68,131  A193_00452 380 putative transcriptional regulator, MarR family hypothetical protein hypothetical protein 
68,131  A193_00451 764 glucose-1-dehydrogenase, (3-oxoacyl-(acyl carrier 
protein) reductase) 
hypothetical protein pyridoxamine 5'-phosphate oxidase 
68,131  A193_00450 158 hypothetical protein F-box protein putative transcriptional regulator, MarR family 
68,131  A193_00449 941 hypothetical protein two component response regulator, CheY-like 
receiver domain 
glucose-1-dehydrogenase, (3-oxoacyl-(acyl carrier 
protein) reductase) 
68,131 pof1 A193_00448 518 F-box protein response regulator TutC hypothetical protein 
68,131  A193_00447 419 two component response regulator, CheY-like 
receiver domain 
hypothetical protein hypothetical protein 
68,131 stuC A193_00446 2,450 response regulator TutC hypothetical protein F-box protein 
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68,131  A193_00445 1,448 hypothetical protein hypothetical protein two component response regulator, CheY-like 
receiver domain 
68,131  A193_00444 1,178 hypothetical protein hypothetical protein response regulator TutC 
68,131  A193_00443 359 hypothetical protein aminoglycoside 6-adenylyltransferase hypothetical protein 
68,131  A193_00442 578 hypothetical protein multidrug resistance ABC transporter ATP-binding 
protein 
hypothetical protein 
68,131  A193_00441 866 aminoglycoside 6-adenylyltransferase substrates of the Legionella pneumophila Dot/Icm 
system SdeC 
hypothetical protein 
68,131 abcT3_1 A193_00440 1,796 multidrug resistance ABC transporter ATP-binding 
protein 
Sid related protein-like protein hypothetical protein 
68,131 sdeC A193_00439 4,607 substrates of the Legionella pneumophila Dot/Icm 
system SdeC 
hypothetical protein aminoglycoside 6-adenylyltransferase 
68,131  A193_00438 1,121 Sid related protein-like protein substrates of the Legionella pneumophila Dot/Icm 
system SdeB 
multidrug resistance ABC transporter ATP-binding 
protein 
68,131  A193_00437 2,627 hypothetical protein ankyrin repeat family protein substrates of the Legionella pneumophila Dot/Icm 
system SdeB 
68,131 sdeB_2 A193_00436 5,765 substrates of the Legionella pneumophila Dot/Icm 
system SdeB 
hypothetical protein ankyrin repeat family protein 
68,131  A193_00435 2,267 ankyrin repeat family protein hypothetical protein hypothetical protein 
68,131  A193_00434 992 hypothetical protein hypothetical protein hypothetical protein 
68,131  A193_00433 206 hypothetical protein hypothetical protein hypothetical protein 
68,131  A193_00432 13,811 hypothetical protein hypothetical protein hypothetical protein 
68,131  A193_00431 104 hypothetical protein hypothetical protein hypothetical protein 
68,131  A193_00430 359 hypothetical protein hypothetical protein hypothetical protein 
68,131  A193_00429 560 CrtF (hydroxyneurosporene (C20) 
methyltransferase) 
CrtF (hydroxyneurosporene (C20) 
methyltransferase) 
CrtF (hydroxyneurosporene (C20) 
methyltransferase) 
68,131 sdeB_1 A193_00428 2,468 hypothetical protein hypothetical protein hypothetical protein 
68,131  A193_00427 107 Alpha/beta hydrolase family protein Alpha/beta hydrolase family protein Alpha/beta hydrolase family protein 
68,131  A193_01961 1745 Glycosyltransferase sugar-binding region containing 
DXD motif protein 
Glycosyltransferase sugar-binding region containing 
DXD motif protein 
Glycosyltransferase sugar-binding region containing 
DXD motif protein 
68,131  A193_01960 623 hypothetical protein hypothetical protein hypothetical protein 
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68,131  A193_01959 1,091 hypothetical protein hypothetical protein hypothetical protein 
68,131  A193_01958 1,367 hypothetical protein hypothetical protein hypothetical protein 
68,131  A193_01957 2,258 hypothetical protein hypothetical protein hypothetical protein 
68,131  A193_01956 848 DNA primase DnaG DNA primase DnaG DNA primase DnaG 
68,131  A193_01955 428 RNA polymerase sigma 70 factor (RpoD) RNA polymerase sigma 70 factor (RpoD) RNA polymerase sigma 70 factor (RpoD) 
68,131  A193_01954 512 hypothetical protein hypothetical protein hypothetical protein 
68,131  A193_01953 1,259 ATP-dependent RecD-like DNA helicase ATP-dependent RecD-like DNA helicase ATP-dependent RecD-like DNA helicase 
28,258  A193_01759 443 Acetyltransferase (GNAT) family protein Acetyltransferase (GNAT) family protein Acetyltransferase (GNAT) family protein 
28,258 dnaG A193_01758 1,733 hypothetical protein hypothetical protein hypothetical protein 
28,258 rpoD A193_01757 1,865 Conjugal transfer protein TraD Conjugal transfer protein TraD Conjugal transfer protein TraD 
28,258  A193_01755 776 hypothetical protein hypothetical protein hypothetical protein 
28,258 recD2 A193_01754 2,651 hypothetical protein hypothetical protein hypothetical protein 
28,258  A193_01753 251 hypothetical protein hypothetical protein hypothetical protein 
28,258  A193_01752 206 inner membrane protein inner membrane protein inner membrane protein 
28,258  A193_01751 266 hypothetical protein hypothetical protein hypothetical protein 
28,258  A193_01750 371 hypothetical protein hypothetical protein hypothetical protein 
28,258  A193_01749 572 hypothetical protein hypothetical protein hypothetical protein 
28,258  A193_01748 1,655 hypothetical protein hypothetical protein hypothetical protein 
28,258  A193_01747 1,616 phage related integrase phage related integrase phage related integrase 
28,258  A193_01746 275 hypothetical protein hypothetical protein hypothetical protein 
28,258  A193_01745 857 hypothetical protein hypothetical protein hypothetical protein 
28,258  A193_01744 608 hypothetical protein hypothetical protein hypothetical protein 
28,258  A193_01743 233 hypothetical protein hypothetical protein hypothetical protein 
28,258  A193_01742 1,232 23S rRNA (uracil-C(5))-methyltransferase RlmCD 23S rRNA (uracil-C(5))-methyltransferase RlmCD 23S rRNA (uracil-C(5))-methyltransferase RlmCD 
28,258  A193_01964 185 SidC protein (substrate of the Dot/Icm system) SidC protein (substrate of the Dot/Icm system) SidC protein (substrate of the Dot/Icm system) 
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28,258  A193_01965 914 transposase (IS652) transposase (IS652) transposase (IS652) 
28,258  A193_01966 698 hypothetical protein hypothetical protein hypothetical protein 
28,258  A193_01967 932 hypothetical protein hypothetical protein hypothetical protein 
28,258 rlmCD A193_01968 638 putative protein kinase hypothetical protein hypothetical protein 
28,258 sidC_2 A193_01969 1,694 hypothetical protein putative integrase putative integrase 
28,258  A193_01970 1,175 hypothetical protein hypothetical protein hypothetical protein 
28,258  A193_01971 770 Putative type I restriction enzyme R protein Putative type I restriction enzyme R protein Putative type I restriction enzyme R protein 
19,749  A193_02172 842 hypothetical protein hypothetical protein hypothetical protein 
19,749  A193_02173 1,388 Putative type-1 restriction enzyme specificity 
protein MPN_089 
Putative type-1 restriction enzyme specificity 
protein MPN_089 
Putative type-1 restriction enzyme specificity 
protein MPN_089 
19,749  A193_02174 683 Putative type I restriction enzyme HindVIIP M 
protein 
Putative type I restriction enzyme HindVIIP M 
protein 
Putative type I restriction enzyme HindVIIP M 
protein 
19,749 cbpA_2 A193_02175 1,700 putative, uroporphyrin-III C- methyltransferase putative, uroporphyrin-III C- methyltransferase putative, uroporphyrin-III C- methyltransferase 
19,749  A193_02176 389 sporulation initiation inhibitor protein Soj sporulation initiation inhibitor protein Soj sporulation initiation inhibitor protein Soj 
19,749  A193_02177 179 chromosome partitioning protein ParB (SpoOJ) chromosome partitioning protein ParB (SpoOJ) chromosome partitioning protein ParB (SpoOJ) 
19,749  A193_02178 206 hypothetical protein hypothetical protein hypothetical protein 
19,749  A193_02179 524 ISSod6 transposase_ ISSod6 transposase_ ISSod6 transposase_ 
19,749  A193_02180 551 ISSod6 transposase_ ISSod6 transposase_ ISSod6 transposase_ 
19,749  A193_02181 833 hypothetical protein hypothetical protein hypothetical protein 
19,749  A193_02182 335 hypothetical protein hypothetical protein hypothetical protein 
19,749  A193_02183 377 Cytochrome c oxidase subunit 3 Cytochrome c oxidase subunit 3 Cytochrome c oxidase subunit 3 
19,749  A193_02184 896 Cytochrome c oxidase assembly protein CtaG Cytochrome c oxidase assembly protein CtaG Cytochrome c oxidase assembly protein CtaG 
19,749  A193_02185 125 Cytochrome c oxidase subunit 1 Cytochrome c oxidase subunit 1 Cytochrome c oxidase subunit 1 
19,749  A193_02186 3,149 cytochrome c oxidase, subunit II cytochrome c oxidase, subunit II cytochrome c oxidase, subunit II 
19,749  A193_02187 173 cytochrome c cytochrome c cytochrome c 
19,749  A193_02188 1,217 Naphthalene 1,2-dioxygenase system ferredoxin 
subunit 
Naphthalene 1,2-dioxygenase system ferredoxin 
subunit 
Naphthalene 1,2-dioxygenase system ferredoxin 
subunit 
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19,749  A193_02189 1,571 CapM protein, capsular polysaccharide biosynthesis CapM protein, capsular polysaccharide biosynthesis CapM protein, capsular polysaccharide biosynthesis 
19,749  A193_02191 377 transporter, LysE family transporter, LysE family transporter, LysE family 
18,487 parA A193_02503 770 hypothetical protein hypothetical protein hypothetical protein 
18,487 parB_2 A193_02504 899 ubiquinone/menaquinone biosynthesis 
methyltransferase UbiE 
ubiquinone/menaquinone biosynthesis 
methyltransferase UbiE 
ubiquinone/menaquinone biosynthesis 
methyltransferase UbiE 
18,487  A193_02505 335 hypothetical protein hypothetical protein hypothetical protein 
18,487  A193_02506 239 hypothetical protein hypothetical protein hypothetical protein 
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Table A10. List of L. pneumophila strains (n=180) isolated from the West Bank analysed in this study, MLVA-8(12) done by 
(97). 
Strain  Sgp, 
mAb 
ST Lpn 
PCR 
MLVA-
8(12) 
MLVA-8(12) profile MLVA_CC Location Sample 
type 
Year 
A1 1 OLDA 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1 Hospital D  Biofilm 
swab 
2012 
A10 6 1326 + Gt13(106) 8,8,11,1,4,16,1,1,3,3,6,4,8 VACC2  AQU Biofilm 
swab 
2013 
A100 1 NA + Gt38(109) 8,8,6,2,4,8,1,1,3,2,6,4,8 VACC2  Hospital F  Biofilm 
swab 
2013 
A101 1 NA + Gt63(83) 7,7,10,2,4,0,4,0,0,3,14,4,9 VACC1  Hospital H Biofilm 
swab 
2013 
A102 1 NA + Gt63(83) 7,7,10,2,4,0,4,0,0,3,14,4,9 VACC1  Hospital B  Biofilm 
swab 
2013 
A103 1 NA + Gt63(83) 7,7,10,2,4,0,4,0,0,3,14,4,9 VACC1  Hospital H Biofilm 
swab 
2013 
A104 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital B  Biofilm 
swab 
2013 
A105 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital B  Biofilm 
swab 
2013 
A106 1 1 + Gt6(15) 7,7,10,2,4,9,4,2,18,2,14,5,5 VACC1  Hospital G Biofilm 
swab 
2013 
A107 (2-14) 461 + Gt9(92) 9,8,11,2,4,13,3,4,17,3,10,4,8 VACC11 Hospital B  Biofilm 
swab 
2013 
A108 6 
Dresden 
461 + Gt10(93) 9,8,6,2,4,13,3,4,10,3,10,4,8 VACC11 Hospital F  Biofilm 
swab 
2013 
A109 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital F  Biofilm 
swab 
2013 
A110 6 
Dresden 
461 + Gt10(141) 9,8,6,2,4,13,3,4,10,3,10,0,8 VACC11 Hospital F  Biofilm 
swab 
2013 
A112 6 
Dresden 
461 + Gt10(93) 9,8,6,2,4,13,3,4,10,3,10,4,8 VACC11 Hospital F  Biofilm 
swab 
2013 
A114 6 
Dresden 
461 + Gt10(93) 9,8,6,2,4,13,3,4,10,3,10,4,8 VACC11 Hospital F  Water 
sample 
2013 
A115 (2-14) 461 + Gt10(93) 9,8,6,2,4,13,3,4,10,3,10,4,8 VACC11 Hospital F  Biofilm 
swab 
2013 
A116 6 
Dresden 
461 + Gt10(141) 9,8,6,2,4,13,3,4,10,3,10,0,8 VACC11 Hospital F  Biofilm 
swab 
2013 
A119 6 
Dresden 
9 + Gt64(74) 8,8,11,2,4,16,1,1,3,3,6,4,8 VACC2  Hospital F  Biofilm 
swab 
2012 
A12 1 OLDA 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  AQU Biofilm 
swab 
2012 
A121 6 
Dresden 
NA + Gt55(94) 9,8,6,2,4,13,3,0,10,3,10,4,8 VACC11 Hospital F Biofilm 
swab 
2012 
A122 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital D  Biofilm 
swab 
2012 
A123 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital B  Biofilm  2013 
A124 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital B  Biofilm 
swab 
2012 
A127 6 
Dresden 
461 + Gt10(93) 9,8,6,2,4,13,3,4,10,3,10,4,8 VACC11 Hospital F  Biofilm 
swab 
2012 
A128 6 
Dresden 
461 + Gt10(93) 9,8,6,2,4,13,3,4,10,3,10,4,8 VACC11 Hospital F  Biofilm 
swab 
2012 
 171 
 
A129 6 
Dresden 
9 + Gt64(74) 8,8,11,2,4,16,1,1,3,3,6,4,8 VACC2  Hospital F  Biofilm 
swab 
2012 
A13 1 OLDA 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  AQU Biofilm 
swab 
2012 
A130 1 1 + Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1  Hospital G Biofilm 
swab 
2012 
A131 1 1 + Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1  Hospital G Biofilm 
swab 
2012 
A132 1 1 + Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1  Hospital G Biofilm 
swab 
2014 
A133 1 1 + Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1  Hospital G Biofilm 
swab 
2014 
A134 1 1 + Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1  Hospital G Biofilm 
swab 
2014 
A135 1 1 + Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1  Hospital G Biofilm 
swab 
2012 
A137 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital B  Biofilm 
swab 
2013 
A138 6 
Dresden 
461 + Gt9(92) 9,8,11,2,4,13,3,4,17,3,10,4,8 VACC11 Hospital B  Biofilm 
swab 
2012 
A139 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital B  Biofilm 
swab 
2012 
A14 8 1358 + Gt12(84) 7,7,9,2,4,17,1,1,18,0,14,5,8  AQU Biofilm 
swab 
2012 
A140 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital B  Biofilm 
swab 
2012 
A141 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital B  Biofilm 
swab 
2012 
A142 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital E Biofilm 
swab 
2012 
A143 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital E Biofilm 
swab 
2012 
A144 (2-14) 1326 + Gt13(72) 8,8,11,2,4,16,1,1,3,2,6,4,8 VACC2  Hospital E Biofilm 
swab 
2012 
A145 1 1  Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital B  Biofilm 
swab 
2012 
A148 6 
Dresden 
461 + Gt10(141) 9,8,6,2,4,13,3,4,10,3,10,0,8 VACC11 Hospital F Water 
sample 
2012 
A149 6 
Dresden 
461 + Gt10(141) 9,8,6,2,4,13,3,4,10,3,10,0,8 VACC11 Hospital F Biofilm 
swab 
2012 
A15 8 1358 + Gt12(84) 7,7,9,2,4,17,1,1,18,0,14,5,8  AQU Biofilm 
swab 
2012 
A152 6 
Dresden 
461 + Gt10(93) 9,8,6,2,4,13,3,4,10,3,10,4,8 VACC11 Hospital F  Biofilm 
swab 
2012 
A153 6 
Dresden 
461 + Gt10(93) 9,8,6,2,4,13,3,4,10,3,10,4,8 VACC11 Hospital F  Biofilm 
swab 
2012 
A154 1 OLDA 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital F  Biofilm 
swab 
2012 
A156 6 
Dresden 
9 + Gt64(74) 8,8,11,2,4,16,1,1,3,3,6,4,8 VACC2  Hospital F  Biofilm 
swab 
2013 
A157 6 
Dresden 
461 + Gt10(141) 9,8,6,2,4,13,3,4,10,3,10,0,8 VACC11 Hospital F  Biofilm 
swab 
2014 
A159 6 461 + Gt10(141) 9,8,6,2,4,13,3,4,10,3,10,0,8 VACC11 Hospital F  Biofilm 2014 
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Dresden swab 
A16 8 1358 + Gt12(84) 7,7,9,2,4,17,1,1,18,0,14,5,8  AQU Biofilm 
swab 
2012 
A161 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital F Biofilm 
swab 
2012 
A162 1 1 + Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1  Hospital G Biofilm 
swab 
2012 
A163 1 1 + Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1  Hospital G Biofilm 
swab 
2012 
A164 1 1 + Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1  Hospital G Biofilm 
swab 
2012 
A165 1 1 + Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1  Hospital G Biofilm 
swab 
2014 
A166 (2-14) 1482 + Gt8(142) 10,8,8,2,4,13,2,2,18,3,10,4,8 VACC5  Hospital G Biofilm 
swab 
2012 
A167 1 1 + Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1  Hospital G Biofilm 
swab 
2012 
A168 1 1 + Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1  Hospital G Biofilm 
swab 
2012 
A169 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital A  Biofilm 
swab 
2012 
A17 8 1358 + Gt12(84) 7,7,9,2,4,17,1,1,18,0,14,5,8  AQU Biofilm 
swab 
2012 
A170 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital A  Biofilm 
swab 
2013 
A171 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital A  Biofilm 
swab 
2013 
A172 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital A  Biofilm 
swab 
2013 
A173 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital A  Biofilm 
swab 
2013 
A174 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital A  Biofilm 
swab 
2013 
A175 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital C Biofilm 
swab 
2013 
A176 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital C Biofilm 
swab 
2014 
A177 (2-14) 461 + Gt9(92) 9,8,11,2,4,13,3,4,17,3,10,4,8 VACC11 Hospital B Biofilm 
swab 
2014 
A178 6 
Dresden 
461 + Gt9(92) 9,8,11,2,4,13,3,4,17,3,10,4,8 VACC11 Hospital B Biofilm 
swab 
2014 
A179 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital B Biofilm  2014 
A18 8 1358 + Gt12(84) 7,7,9,2,4,17,1,1,18,0,14,5,8  AQU Biofilm 
swab 
2014 
A180 1 1 + Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1  Hospital G Biofilm 
swab 
2014 
A181 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital F  Biofilm 
swab 
2014 
A182 6 
Dresden 
461 + Gt10(93) 9,8,6,2,4,13,3,4,10,3,10,4,8 VACC11 Hospital F  Biofilm 
swab 
2014 
A183 6 
Dresden 
461 + Gt10(93) 9,8,6,2,4,13,3,4,10,3,10,4,8 VACC11 Hospital F  Biofilm 
swab 
2014 
A184 1 1 + Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1  Hospital G Biofilm 
swab 
2014 
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A186 1 1 + Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1  Hospital G Biofilm 
swab 
2014 
A187 1 1 + Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1  Hospital G Biofilm 
swab 
2014 
A188 1 1 + Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1  Hospital G Biofilm 
swab 
2014 
A189 1 1 + Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1  Hospital G Biofilm 
swab 
2014 
A19 (2-14) 461 + Gt10(93) 9,8,6,2,4,13,3,4,10,3,10,4,8 VACC11 Hospital F Biofilm 
swab 
2012 
A190 1 1 + Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1  Hospital G Biofilm 
swab 
2014 
A191 1 1 + Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1  Hospital G Biofilm 
swab 
2014 
A192 1 1 + Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1  Hospital G Biofilm 
swab 
2014 
A193 6 
Dresden 
292 + Gt40(47) 8,8,9,2,4,13,2,2,21,3,10,4,8 VACC5  Hospital H Biofilm 
swab 
2012 
A194 6 
Dresden 
292 + Gt40(47) 8,8,9,2,4,13,2,2,21,3,10,4,8 VACC5  Hospital H Biofilm 
swab 
2012 
A195 6 
Dresden 
292 + Gt40(47) 8,8,9,2,4,13,2,2,21,3,10,4,8 VACC5  Hospital H Biofilm 
swab 
2012 
A196 (2-14) 1326 + Gt13(143) 8,8,11,1,4,16,1,1,3,0,6,4,8 VACC2  Hospital E Biofilm 
swab 
2012 
A197 10 1326 + Gt13(143) 8,8,11,1,4,16,1,1,3,0,6,4,8 VACC2  Hospital E Biofilm 
swab 
2012 
A198 (2-14) 461 + Gt10(93) 9,8,6,2,4,13,3,4,10,3,10,4,8 VACC11 Hospital F Biofilm 
swab 
2012 
A2 1 OLDA 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital D Biofilm 
swab 
2012 
A20 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital F  Biofilm 
swab 
2012 
A21 (2-14) 461 + Gt10(93) 9,8,6,2,4,13,3,4,10,3,10,4,8 VACC11 Hospital F  Water 
sample 
2012 
A22 (2-14) 461 + Gt9(92) 9,8,11,2,4,13,3,4,17,3,10,4,8 VACC11 Hospital H Biofilm 
swab 
2012 
A23 (2-14) 1438 + Gt16(1) 9,8,8,2,4,13,2,2,18,3,10,4,8 VACC5  Hospital G Biofilm 
swab 
2012 
A24 (2-14) 1482 + Gt8(23) 10,8,8,2,4,13,2,2,18,3,14,4,8 VACC5  Hospital G Biofilm 
swab 
2012 
A25 1 1 + Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1  Hospital G Biofilm 
swab 
2012 
A26 1 1 + Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1  Hospital G Biofilm 
swab 
2012 
A27 1 1 + Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1  Hospital G Biofilm 
swab 
2012 
A28 1 1 + Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1  Hospital G Biofilm 
swab 
2012 
A29 1 1 + Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1  Hospital G Biofilm 
swab 
2012 
A3 1 OLDA 1 + Gt4(20) 7,7,10,2,4,9,4,2,17,3,14,4,5 VACC1  AQU Biofilm 
swab 
2012 
A30 1 1 + Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1  Hospital G Biofilm 
swab 
2012 
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A31 1 1 + Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1  Hospital G Biofilm 
swab 
2012 
A32 1 1 + Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1  Hospital G Water 
sample 
2012 
A33 1 1 + Gt6(18) 7,7,10,2,4,9,4,2,18,3,14,5,5 VACC1  Hospital G Biofilm 
swab 
2012 
A34 (2-14) 1438 + Gt16(1) 9,8,8,2,4,13,2,2,18,3,10,4,8 VACC5  Hospital A  Biofilm 
swab 
2012 
A35 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital A  Biofilm 
swab 
2012 
A36 (2-14) 1438 + Gt16(6) 9,8,8,2,4,13,2,2,18,2,10,4,8 VACC5  Hospital A  Biofilm 
swab 
2012 
A37 (2-14) 1326 + Gt13(72) 8,8,11,1,4,16,1,1,3,2,6,4,8 VACC2  Hospital A  Biofilm 
swab 
2012 
A38 (2-14) 1438 + Gt16(1) 9,8,8,2,4,13,2,2,18,3,10,4,8 VACC5  Hospital A  Biofilm 
swab 
2012 
A39 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital A  Biofilm 
swab 
2012 
A4 1 OLDA 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  AQU Biofilm 
swab 
2012 
A40 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital A  Biofilm 
swab 
2012 
A41 (2-14) 1326 + Gt13(72) 8,8,11,1,4,16,1,1,3,2,6,4,8 VACC2  Hospital A  Biofilm 
swab 
2012 
A42 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital A  Biofilm 
swab 
2012 
A43 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital A  Biofilm 
swab 
2012 
A44 (2-14) 1326 + Gt13(72) 8,8,11,1,4,16,1,1,3,2,6,4,8 VACC2  Hospital A  Biofilm 
swab 
2012 
A45 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital A  Biofilm 
swab 
2012 
A46 6 
Dresden 
1438 + Gt16(1) 9,8,8,2,4,13,2,2,18,3,10,4,8 VACC5  Hospital A  Biofilm 
swab 
2012 
A47 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital A  Biofilm  2012 
A48 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital A  Biofilm 
swab 
2012 
A49 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital A  Biofilm 
swab 
2012 
A5 1 OLDA 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  AQU Biofilm 
swab 
2012 
A50 (2-14) 1438 + Gt16(1) 9,8,8,2,4,13,2,2,18,3,10,4,8 VACC5  Hospital A  Water 
sample 
2012 
A51 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital A  Biofilm 
swab 
2012 
A52 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital A  Biofilm 
swab 
2013 
A53 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital A  Biofilm 
swab 
2013 
A54 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital A  Biofilm 
swab 
2014 
A55 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital A  Biofilm 
swab 
2014 
A56 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital D  Biofilm 2014 
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swab 
A57 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital D  Biofilm 
swab 
2014 
A58 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital D  Biofilm 
swab 
2014 
A59 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital D  Biofilm 
swab 
2014 
A6 1 OLDA 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital D  Biofilm 
swab 
2012 
A60 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital D  Biofilm 
swab 
2012 
A61 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital D  Biofilm 
swab 
2012 
A62 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital D  Biofilm 
swab 
2012 
A63 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital D  Biofilm 
swab 
2012 
A64 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital D  Biofilm 
swab 
2012 
A65 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital D  Biofilm 
swab 
2012 
A66 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital D  Biofilm 
swab 
2012 
A67 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital D  Biofilm 
swab 
2012 
A68 (2-14) 1326 + Gt13(72) 8,8,11,1,4,16,1,1,3,2,6,4,8 VACC2  Hospital D  Biofilm 
swab 
2012 
A69 (2-14) 1326 + Gt13(72) 8,8,11,1,4,16,1,1,3,2,6,4,8 VACC2  Hospital D  Biofilm 
swab 
2012 
A7 8 1358 + Gt11(87) 7,7,10,2,4,17,1,1,18,3,14,5,8  AQU Biofilm 
swab 
2012 
A70 (2-14) 1326 + Gt13(72) 8,8,11,1,4,16,1,1,3,2,6,4,8 VACC2  Hospital D  Biofilm 
swab 
2012 
A71 (2-14) 461 + Gt10(93) 9,8,6,2,4,13,3,4,10,3,10,4,8 VACC11 Hospital C Biofilm 
swab 
2012 
A72 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital C Biofilm 
swab 
2012 
A73 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital C Biofilm 
swab 
2012 
A74 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital B  Biofilm 
swab 
2012 
A75 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital B  Biofilm 
swab 
2012 
A76 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital B  Biofilm 
swab 
2012 
A77 1 1 + Gt4(16) 7,7,10,2,4,9,4,2,17,2,14,5,5 VACC1  Hospital B  Biofilm 
swab 
2012 
A78 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital B  Biofilm 
swab 
2012 
A79 (2-14) 1326 + Gt13(72) 8,8,11,1,4,16,1,1,3,2,6,4,8 VACC2  Hospital B  Biofilm 
swab 
2012 
A8 6 187 + Gt84(106) 8,8,11,1,0,16,1,1,3,3,6,4,8 VACC2  AQU Biofilm 
swab 
2012 
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A80 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital B  Biofilm 
swab 
2012 
A81 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital B  Biofilm 
swab 
2013 
A82 (2-14) 461 + Gt9(92) 9,8,11,2,4,13,3,4,17,3,10,4,8 VACC11 Hospital B  Biofilm 
swab 
2013 
A83 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital B  Biofilm 
swab 
2013 
A84 (2-14) 461 + Gt9(92) 9,8,11,2,4,13,3,4,17,3,10,4,8 VACC11 Hospital B  Biofilm 
swab 
2013 
A85 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital B  Biofilm 
swab 
2013 
A86 (2-14) 461 + Gt9(92) 9,8,11,2,4,13,3,4,17,3,10,4,8 VACC11 Hospital B  Biofilm 
swab 
2012 
A87 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital B  Biofilm 
swab 
2012 
A88 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital B  Biofilm 
swab 
2012 
A89 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital B  Biofilm 
swab 
2012 
A9 1 OLDA 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  AQU Biofilm 
swab 
2012 
A90 1 1 + Gt4(17) 7,7,10,2,4,9,4,2,17,3,14,5,5 VACC1  Hospital B  Biofilm 
swab 
2012 
A91 (2-14) 1482 + Gt8(7) 10,8,8,2,4,13,2,2,18,2,10,4,8 VACC5  Hospital E  Biofilm 
swab 
2014 
A92 (2-14) 1482 + Gt8(7) 10,8,8,2,4,13,2,2,18,2,10,4,8 VACC5  Hospital E  Biofilm 
swab 
2012 
A93 (2-14) 93 + Gt24(68) 8,8,11,2,0,16,1,1,3,0,6,4,8 VACC2  Hospital E  Biofilm  2012 
A94 (2-14) 1438 + Gt16(3) 9,8,8,2,4,13,2,2,18,2,10,5,8 VACC5  Hospital E  Biofilm 
swab 
2012 
A95 6 
Dresden 
1326 + Gt13(72) 8,8,11,2,4,16,1,1,3,2,6,4,8 VACC2  Hospital E  Biofilm 
swab 
2012 
A97 (2-14) 461 + Gt10(93) 9,8,6,2,4,13,3,4,10,3,10,4,8 VACC11 Hospital F  Biofilm 
swab 
2012 
A98 6 
Dresden 
1326 + Gt13(72) 8,8,11,2,4,16,1,1,3,2,6,4,8 VACC2  Hospital F  Biofilm 
swab 
2012 
A99 6 
Dresden 
461 + Gt10(93) 9,8,6,2,4,13,3,4,10,3,10,4,8 VACC11 Hospital F Biofilm 
swab 
2013 
1Serogroup, monoclonal subtype. NA: Not Avaiable. AQU: Al-Quds University    
3 MLVA allele order: Lpms1, Lpms3. Lpms13, Lpms17, Lpms19, Lpms31, Lpms33, Lpms34, Lpms35, 
Lpms38, Lpms39, Lpms40, Lpms44 
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